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Abstract 
DNA recognition is an essential biological process responsible for the reg-
ulation of cellular functions including protein synthesis and cell division and is 
implicated in the mechanism of action of some anticancer drugs. Studies directed 
towards defining the elements responsible for sequence specific DNA recognition 
through the study of the interactions of synthetic organic ligands with DNA are 
described. 
DNA recognition by poly-N-methylpyrrolecarboxamides was studied by the 
synthesis and characterization of a series of molecules where the number of con-
tiguous N-methylpyrrolecarboxamide units was increased from 2 to 9. The effect 
of this incremental change in structure on DNA recognition has been investigated 
at base pair resolution usillg affinity cleaving and MPE·Fe(II) footprinting tech-
niques. These studies led to a quantitative relationship between the number of 
amides in the molecule and the DNA binding site size. This relationship is called 
the n + 1 rule and it states that a poly-N-methylpyrrolecarboxamide molecule 
with n amides will bind n + 1 base pairs of DNA. This rule is consistent with a 
model where the carboxamides of these compounds form three center bridging 
hydrogen bonds between adjacent base pairs on opposite strands of the helix. 
The poly-N-methylpyrrolecarboxamide recognition element was found to pref-
erentially bind poly dA·poly dT stretches; however, both binding site selection 
and orientation were found to be affected by flanking sequences. Cleavage of 
large DNA is also described. 
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One approach towards the design of molecules that bind large sequences 
of double helical DNA sequence specifically is to couple DNA binding subunits 
of similar or diverse base pair specificity. Bis-EDTA-distamycin-fumaramide 
(BEDF) is an octaamide dimer of two tri-N-methylpyrrolecarboxamide subunits 
linked by fumaramide. DNA recognition by BEDF was compared to P7E, an oc-
taamide molecule containing seven consecutive pyrroles. These two compounds 
were found to recognize the same sites on pBR322 with approximately the same 
affinities demonstrating that fumaramide is an effective linking element for N-
methylpyrrolecarboxamide recognition subunits. Further studies involved the 
synthesis and characterization of a trimer of tetra-N-methylpyrrolecarboxamide 
subunits linked by ,8-alanine ((P4)sE). This trimerization produced a molecule 
which is capable of recognizing 16 base pairs of A·T DNA, more than a turn and 
a half of the DNA helix. 
DNA footprinting is a powerful direct method for determining the binding 
sites of proteins and small molecules on heterogeneous DNA. It was found that 
attachment of EDTA·Fe(II) to spermine creates a molecule, SE·Fe(II), which 
binds and cleaves DNA sequence neutrally. This lack of specificity provides evi-
dence that at the nucleotide level polyamines recognize heterogeneous DNA in-
dependent of sequence and allows SE·Fe(II) to be used as a footprinting reagent. 
SE·Fe(II) was compared with two other small molecule footprinting reagents, 
EDTA·Fe(II) and MPE·Fe(II). 
-Vl-
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DNA recognition is an essential biological process responsible for the regu-
lation of cellular functions including protein synthesis and cell division. 1 • 2 The 
mechanism of action of some anticancer drugs is also believed to involve se-
quence specific DNA complexation.3 Although this is an important area of in-
terest in molecular biology, the particular combination of hydrogen bonding, van 
der Waals contacts and electrostatic interactions required for sequence specific 
recognition of DNA are not well understood. The work that I describe here are 
studies directed towards defining the important elements responsible for spe-
cific DNA recognition through the study of the interactions of synthetic organic 
ligands with DNA. 
Distamycin A and Netropsin. Distamycin A 4 and netropsin5 are oligo-N-
methylpyrrolecarboxamide antibiotics isolated from Streptomyces distallicus and 
Streptomyces netropsis respectively. These compounds exhibit antifungal, an-
timitotic and antiviral properties in vivo. 6 - 8 They are believed to exert their bio-
logical effects via the formation of a tightly bound complex with double stranded 
DNA, possibly in promoter regions.9 
The molecular structure of each of these compounds has been determined 
by chemical analysis10 • 11 and verified by total synthesis. 12 • 13 Both drugs are 
optically inactive; however, x-ray analysis of the sulfate salt of netropsin14 and a 
precursor to distamycin 15 show that there is a helical twist of 4° or 26° between 
adjacent pyrrole rings creating asymmetric conformations for the two molecules. 
Both netropsin and distamycin are crescent-shaped with the amide hydrogens 
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Distamycin A Netropsin 
Figure 1.1 Distamycin A and Netropsin 
on the concave side and the carbonyls and N-methyls on the convex face (fig. 
1.1). 
Extensive biophysical studies on the interaction of distamycin A and 
netropsin with DNA have been carried out. These studies indicate that the 
molecules bind to A·T rich regions of DNA. This work has been extensively re-
viewed in a recent report by Zimmer. 16 The discussion here will concentrate on 
the nature of the N-methylpyrrolecarboxamide-DNA interaction and its effect 
on flanking sequences. 
Effects on DNA Structure. In addition to a high preference for A·T se-
quences, netropsin and distamycin have been found to be specific for B-form 
DNA. DNA in ethanolic solution may be converted to A-form by a lowering of 
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the water activity. 17 Either distamycin or netropsin reverts calf thymus DNA to 
B-form even in 82% ethanol.17 • 18 Polymers containing poly 2'-deoxy-21-fiouro-
adenylic acid are known to prefer the A-form in aqueous solution, but they 
too are converted to B-form by either drug.19 • 20 The same effect is seen with 
poly(dl) ·poly(2'-deoxy-2'-fiouro dC).20 Additional evidence for the B-form pref-
erence is the lack of binding to double stranded RNA or DNA-RNA hybrids 
both of which are known to exist in the A-form.8 • 19 • 21 • 22 
In addition to the ability to change the helical form of DNA, netropsin and 
distamycin can affect the structure of DNA. DNA viscosity measurements with 
distamycin and netropsin reveal differences in drug binding. Netropsin produces 
an increase in both the contour length and the persistence length of DNA. 23 • 24 
The persistence length increase is caused by stiffening of the DNA helix which 
freezes out some of the degrees of freedom. This effect was found to be depen-
dent on cationic counterions. 25 The contour length is increased by changing the 
DNA to a more extended configuration and was found to be counterion inde-
pendent. Distamycin causes no change in contour length, but displays a per-
sistence length characteristic of bending or kinking.26-28 Calculations by Rein-
ert concluded that the distamycin recognition pattern is about 0.01 nm larger 
than the DNA pattern.28 The original viscosometric titration and sedimenta-
tion coefficient studies showed no change in DNA winding by either netropsin or 
distamycin.21 • 29 Using a more sensitive technique, Malcolm and Snovnou have 
recently shown that netropsin winds DNA from plasmid pAT 153 approximately 
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+7.5° per bound netropsin while distamycin has either a small or no effect on 
the same plasmid.3 0 
The use of magnetic circular dicroism (MCD) permits the observation of 
the effect of the drugs on the circular dicroism (CD) of DNA.31 • 32 From these 
studies, radical changes in the tilt of the bases with respect to the helical axis 
upon distamycin or netropsin binding have been ruled out. Crothers et al. used 
electric dicroism studies to confirm these results and in addition show that the 
DNA is not substantially kinked or bent under 2.5 mM salt conditions.33 Un-
der the same low salt conditions as the electric dicroism studies, the Crothers 
group saw a very large increase in apparent DNA length of 14 A per drug bound 
with either netropsin or distamycin using two eukaryotic DNAs, calf thymus 
and chicken erythrocyte.33 • 34 However, under the same conditions another eu-
karyotic DNA, human placenta, did not show the large length increase nor did 
prokaryotic E. Coli DNA or the homopolymer poly(dA)·poly(dT). Because all 
the natural DNAs had approximately the same A·T content, the phenomenon 
was considered source dependent and independent of base content. 
Kinetoplast DNA is known to exist in a kinked form which arises from 
a repetitive sequence of A·T rich DNA. Crothers et al. have shown that dis-
tamycin will bind to this fragment and remove those kinks causing the fragment 
to run more slowly in an acrylamide gel.35 In the gel demonstrating this ef-
fect, distamycin also causes a fragment from pBR322 to run faster. This effect 
is consistent with the poly-N-methylpyrrolecarboxamide compound binding the 
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DNA and inducing bending. This is a clear example of distamycin producing 
changes in the structure of the DNA and, because it occurs on only a few of the 
restriction fragments, establishes that this effect is sequence dependent. 
DNA Complex Structure Studies. Recent crystal structure data on the 
complex of netropsin with a B-form dodecamer, 5'-CGCGAATTCGCG-3', 
provides a "snapshot" of the recognition of DNA by N-methylpyrrolecarbox-
amides. 36- 38 N etropsin sits symmetrically in the center of the minor groove of 
the right-handed DNA displacing the water molecules which had formed the 
spine of hydration. Each of the amide groups forms a bridged hydrogen bond 
with the adjacent adenine N-3 or thymine 0-2 atoms on opposite strands of 
the helix. Netropsin binding does not induce any major structural changes in 
the DNA neither unwinding nor elongating the dodecamer. It does, however, 
force open the minor groove by 0.5 to 2.0 A and bend the helix axis back by 
8° across the region of attachment. Dickerson and co-workers suggest that the 
sequence specificity of netropsin arises not from the bridging hydrogen bonds, 
but from close van der Waals contacts between adenine C-2 hydrogens and the 
CH-3 group on the pyrrole ring. Additionally, the guanine 2-amino group pro-
truding from the floor of the minor groove obstructs efficient recognition of G·C 
regions by netropsin. 
The netropsin-DNA co-crystal has provided valuable insight into the mech-
anism of DNA recognition by N-methylpyrrolecarboxamides; however, there are 
some important points to consider regarding a quantitative extrapolation of 
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Figure 1.2 X-tal Graphics 
(Left) Ball and stick model of the netropsin-DNA crystal structure data. Open 
circles are DNA atoms; crossed circles are netropsin atoms. (Right) Diagramatic 
representation of netropsin binding to the minor groove of the DNA. Dot-dashed 
lines represent distances short enough to be standard hydrogen bonds. Dotted 
lines indicate distances of 3.2A or more (fro:r;n ref. 37). 
these data from the crystal to the solution phase. In the crystal, the terminal 
three G·C base pairs of each duplex form five H-bonds with atoms of the next 
duplex above and below in a manner that requires a bend in the helix. 36- 38 This 
interaction effectively locks the base pair helical repeat, eliminating any effect 
that netropsin might have on this structural variable. There is also evidence 
from model building based on NMR and Raman data that the minor groove 
in this crystal structure may be anomalously narrow implying that netropsin 
does not necessarily have to sit symmetrically in the center of the groove.3 9 • 40 
Hydrogen bond distances from the crystal structure itself show a much tighter 
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interaction between the amides of the netropsin and the thymine 02 than with 
the adenine N3 indicating that the molecule may prefer to associate with the 
thymine residues (table 1.1). The structural features of the crystal structure 
may also have been influenced by the high concentration (33%) of 2-methyl-2,4-
pentanediol used to induce crystal formation. 
Table 1.1: Crystal Structure H-bond Distances37 
Netropsin DNA Distance 
atom atom A 
N-4 0-2 of T-20 2.68 
N-4 N-3 of A-18 3.28 
N-6 0-2 of T-19 3.86 · 
N-6 0-2 of T-7 3.54 
N-8 N-3 of A-18 3.45 
N-8 0-2 of T-8 2.56 
Atom numbers refer those in figure 1.3 (ref. 37) 
Studies directed at determining the optimal sequence for DNA recogni-
tion by N-methylpyrrolecarboxamides suggest that netropsin preferentially rec-
ognizes poly( dA) ·poly( dT) sequences of at least four base pairs; however, many 
sites appear to be longer sequences of five or more bases contained in longer 
stretches of A·T DNA.41- 46 These results argue that the sequence being recog-
nized by netropsin in this crystal structure may not be the one most efficiently 
recognized in solution and; therefore, the quantitative results may not be ap-
plicable to solution complexes. A final point is that predictions made from a 
quantitative interpretation of the crystal structure have been inaccurate: the 
estimate of the largest poly-N-methylpyrrolecarboxamide chain permissible for 
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DNA recognition was incorrect (vide infra) as was the prediction that replace-
ment of pyrrole by imidazole would result in a G·C specific molecule.47 
Other structural data on the N-methylpyrrolecarboxamide-DN A com-
plex has been aquired from NMR studies. The earliest NMR work with 
netropsin:DNA complexes was carried out by Patel et al. using homopolymer 
poly d(AT) DNA.48 From chemical shift differences, they determined that at 
a phosphate to drug (P /D) ratio of 50, netropsin not only stabilized the re-
gion of DNA that it bound, but also lowered the rate of melting in antibiotic 
free regions by 10-fold with respect to native poly d(AT). Of the DNA protons, 
the deoxyribose A(H-l')s and T(H-l')s showed the the largest chemical shift 
difference upon formation of the netropsin-DNA complex. These shifts repre-
sent netropsin induced changes in drug free regions of the DNA consistent with 
changes in the glycosidic tortional angles. The observation that netropsin bind-
ing changes both the rate of melting and the glycosidic torsional angles in drug 
free regions of DNA demonstrates that netropsin affects DNA structure remote 
from its binding site. 
Patel and co-workers then began to study oligonucleotides of defined se-
quence to investigate the netropsin-DNA interaction in more detail. Using the 
oligonucleotide d(CGCGAATTCGCG)2, Patel et al. employed imino exchange 
experiments to confirm that netropsin stabilizes the DNA duplex including the 
G·C residues adjacent to the netropsin binding site.49 They also found that this 
effect is not due to a change in the activation energy for base pair opening. 
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With a series of NOE experiments, Patel and co-workers found distances be-
tween the netropsin H-3 and adenine H-2 of 2.5 A.50 These data are consistent 
with netropsin binding in the minor groove with the amides directed towards 
the DNA helix. 
Recent work by Patel et al. has focused on the interaction of netropsin with 
the oligonucleotides d(GGTATACC)2 and d(GGAATTCC)2.51- 54 In these stud-
ies, Patel and co-workers found that the DNA remains right-handed and that 
the DNA conformation with netropsin bound is similar to that for the DNA 
free in solution. Nine contacts between netropsin and the minor groove were 
detected using two dimensional NOE experiments verifying that netropsin binds 
in the minor groove with approximately the same geometry seen in the crys-
tal structure. Some of the cross peaks expected forB-form DNA were missing 
in the 2D NOE experiments on the netropsin-DNA complexes indicating that 
small conformational changes occur at the binding site possibly extending into 
the G·C flanking regions. The 31 P NMR spectrum showed changes in the phos-
phorus resonances indicative of a change in the DNA backbone conformation 
with netropsin binding. 
The structural data for the two oligomer-DNA complexes are similar; how-
ever, there are some specific differences. The imino exchange rate for the 
d(TATA) and d(AATT) cores are not the same. The d(TATA) oligo shows 
rapid proton exchange determined by the loss of peak doubling at 35° C while 
the d(AATT) oligo does not show this effect until "'50°C. The chemical shift 
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of the netropsin amide protons upon complexation with the two DNAs are also 
different. With the d(TATA) core, the amide peaks are shifted to lower field 
than with the d(AATT) core. This is consistent with stronger H-bonding with 
d(TATA); however, the exchange rate data and results by other workers on _the_ 
stability of netropsin:DNA complexes has shown that the alternating A·T site 
is a poorer netropsin binding site. Patel and co-workers interpret this result 
as demonstrating that factors other than hydrogen bonding are important for 
stabilizing the netropsin-DNA complex. 
Reid et al. have used NMR to study the interaction between distamycin A 
and a dodecamer of DNA d(CGCGAATTCGCG)2.55 Binding the asymmetric 
distamycin molecule to the symmetric DNA destroys the DNA's C2 symmetry 
which results in a doubling of peaks in the NMR spectrum. Negative NOEs for 
the distamycin molecule show that it is tumbling with about the same correlation 
time as the much larger DNA molecule which means that the distamycin is very 
tightly bound to the DNA. The absence of distamycin·distamycin cross-peaks 
in the two-dimension exchange experiments is consistent with nearly all the 
drug being bound to DNA with a single binding mode. As the temperature is 
increased from 27°C, distamycin begins to exchange between DNA molecules 
causing the spectrum to broaden. 
The strongest NOEs observed with the non-exchangable protons in the com-
plex are between the pyrrole H3's and adenine C2H's, identifying these as the 
points ·of nearest contact between drug and DNA. There is one-to-one corre-
spondence between the pyrrole rings 1, 2, and 3 and the consecutive adenines 
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AS, A6, and A18, respectively, in the complex. This correlation is not seen with 
A6, A18, and A17, another 3 consecutive adenines, indicating that this alter-
nate binding site must consitute less than 10% of the total complex.. The NOE 
experiments confirm that distamycin binds in the minor groove with the amides 
directed towards the DNA and that of two possible binding sites distamycin 
predominantly recognizes only one. 
Some of the expected NOEs forB-DNA were missing in these studies consis-
tent with drug binding altering the conformation of the DNA slightly; however, 
only the resonances from AS through T7 give the double exchange peaks indica-
tive of major structural alteration. 'The resonances from the residues near the 
ends of the dodecamer are nearly superimposable before and after distamycin 
binding showing that they are little perturbed from the original structure. Some 
NOE measured distances in the complex are slightly changed from those mea-
sured in the netropsin-DNA co-crystal. The NOE measured distances between 
T20 methyl and C21 CH-S and CH-6 are 4 A instead of the S.O A and 6.8 A, 
respectively, measured from the crystal structure. The consequence of such a 
change is a greater separation between the edges of the tw_o bases in the minor 
groove than in the solution phase structure. 
Both free and bound forms of distamycin are found in the NMR spectrum; 
therefore, exchange must be slow on the NMR timescale. The limiting behavior 
for slow-exchange from a chemical shift standpoint is kex= l.6.w !. At 27° C, the 
smallest chemical shift difference between the free and bound forms is 1S Hz 
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(for the methyl resonance of T8). Since the binding constant of distamycin, 
Kapp, is around 107 M - 1 , kon is much greater than koff· This means that kex 
is essentially a measure of koff, and must be slower than 15 s - 1 . From diagonal 
peak intensities in the NOE, koff can be calculated to be ....... 4 s- 1 ; however, this 
number does not correct for relaxation processes that may have occurred during 
the mixing time. Another set of cross-peaks for the DNA is consistent with drug 
binding but no cross-peaks are observed for the distamycin. These peaks can 
be explained by "flip-flopping" of the distamycin on the binding site. The peak 
intensities were analyzed to give a measure of kflip as ....... 2 s- 1 at 27°C. 
Thermodynamics. Thermodynamic data on the netropsin/ distamycin inter-
action with DNA have been collected through binding constant and calorimetric 
studies. The first determination of the binding constant of netropsin to DNA was 
carried out by Wartell et al. using two standard techniques, equilibrium dialysis 
and spectral titration. The values they reported were between 105 M- 1 and 106 
M- 1 with a variety of DNAs with a buffer system of 0.1 M NaCl, 1 x 10-3 M 
phosphate, pH 6.4. 56 These standard methods of binding constant determina-
tion are complicated by both the instability of the compound in solution and the 
small amount of free drug at low concentration. Equilibrium dialysis assumes 
no netropsin degradation during the process and suffers from the small amount 
of unbound drug at low or even moderate DNA saturation. Spectral titrations 
are difficult because the ~€ of bound vs. unbound drug is small and this method 
must assume a linear relationship between optical change and extent of binding. 
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To circumvent these difficulties, McGhee used a method of fitting theoretical 
DNA melting curves to experimental ones with netropsin and poly d(AT).57 This 
approach is rapid, limiting netropsin degradation, and does not depend on the 
amount of unbound drug. From these data, he determined a binding site size of 
4 base pairs and a binding constant of 5 x 108 M- 1 for netropsin. The data were 
analyzed using an equation derived by Crothers. 58 
(1.1) 
T~ and T m are the Kelvin temperatures corresponding to the midpoints of the 
helix-to-coil transition in the absence and presence of netropsin, respectively . 
.6.H is the enthalpy change for the melting of a base pair in the absence of 
bound ligand. Kc and Kh are the binding constants to coil and helix forms 
respectively. nc and nh are the ligand size for coil and helix binding respectively. 
L is the free ligand activity. The curve fitting assumes that the drug does not 
bind single-stranded DNA and that binding is not cooperative. Thus, the only 
two adjustable parameters in eq. 1.1 are nh (size in base pairs) and Kh (binding 
constant). These values were determined in two ways. First nh was determined 
by the slope of the melting curve wfi.ich most closely matched that of the DNA-
only melting curve. According to theory, this match should occur at 200% 
saturation and in this study gave a value of 3.8 bp per bound netropsin. With 
nh and equation 1.1, the binding constant was determined to be 4 x 108 M- 1 . The 
second method McGhee used to determine nh was the generation of theoretical 
curves for the half-saturated case and comparison to experimental data. The 
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values producing the best fit were nh = 4 and Kh = 5 x 108 M- 1 . McGhee 
noted from his calculations that the height of the first melting phase depended 
almost solely on the binding site size and was nearly independent of the binding 
constant. The buffer concentr<;~.tions for these binding studies measurement was 
4x1o-3 M cacodylic acid, 2x10-3 M NaOH, 1x1o-4 M Na2 EDTA, pH 6.25. 
The co-sedimentation of distamycin or netropsin with calf thymus DNA 
was used by Luck et al. to determine their respective binding constants.59 This 
method assumes that all binding sites are independent and equivalent. Their 
data did not go below r = 0.05 (r =number moles of antibiotic bound per mole 
(total) DNA phosphate) to allow determination of a binding constant for the 
highest affinity sites because of the limited sensitivity of their scanning system. 
The data were analyzed using the equation: 
(1.2) 
Where [A] equals the molar concentration of nonbound ligand molecules, a is 
the number of DNA phosphates per binding site and K is the association con-
stant. Best fitting binding curves for the original data were calculated, assuming 
that the equilibrium is governed by the law of mass action for a single class of 
independent binding sites. This simplification avoided the problem of having 
points with relatively high experimental error disproportionately weighted. For 
netropsin the best fit was obtained with a = 6.0 and K = 2.9x 105 M- 1 . With 
distamycin the values were a= 6.1 and K = 11.6x105 M- 1 . These measure-
ments were carried out in 0.05 M tris·HCl, pH 7.8. Using data published by 
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Mazza et al.60 with a 14 C-labeled distamycin and SPP1 phage DNA in a prepar-
ative sucrose gradient, Luck et al. calculated the high affinity binding constant 
as 2.4x 109 M- 1 with-an a of 16.1 nucleotides. The r for this measurement was 
::::::: 0.06 with a free distamycin concentration of about 10-8 M. The Scatchard 
analysis indicated one type of binding site. No information was given about the 
buffer conditions. 
Gursky et al. used dansyl derivatives of distamycin to measure binding con-
stants by fluorescence. 61 • 62 These studies have the advantage of the high sen-
sitivity afforded by the dansyl probe; however, the attachment of this probe to 
the molecule almost certainly influences the efficiency of polypyrrole binding to 
DNA. However, because the dansyl group attachment did not appreciably affect 
the CD spectrum of the modified molecules compared with the natural antibi-
otic, they assumed that dansyl attachment did not affect the geometry of bind-
ing. Scatchard analysis of the titrations gave the following binding constants: 
5.5x107 M- 1 for poly(dA)·poly(dT), 1.8x107 M- 1 for poly d(AT), 5x104 M- 1 
for poly dG·poly dC, and 2x 104 M- 1 for poly d(AC)·poly d(TG). Assuming that 
the pyrrole interacts with only one chain of the double helix, they calculated the 
free-energy change for each base in a binding site (table 1.2). 
Gursky et al. also carried out experiments with a homologus series of dansyl 
polypyrrole compounds containing between one and three pyrrole units.61 In 
the case of poly( dA) ·poly( dT) DNA, the relationship between the free energy of 
binding and the number of amides in the molecule was a linear one with each 
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ST = 32 ± 6 
SA = 5.9 ± 2 
Sc = 4.2 ± 1.5 
Sc = 0.2:!:6.2 
Free-energy change 
(kcal/M) 
A= -2.1 ± 0.1 
A= -1.1 ± 0.2 
A= -0.9 ± 0.2 
A= +0.9 :t!o 
amide contributing ....... 2 kcal/mol. This means that individual pyrrole amides 
contribute an equal amount to DNA binding, consistent with the formation of a 
new hydrogen bond. While the values determined for poly d(AT)· poly d(AT) 
were close to those for poly(dA)·poly(dT), they were not the same indicating 
that the two polymers are recognized similarly, but not identically. 
The Crothers group employed a the phase partition method developed by 
Waring et al.63 to measure the binding constant for distamycin to calf thymus 
DNA.33 • 34 This method involves partitioning the drug between an aqueous and 
an organic phase providing the two advantages of rapid equilibration time ( ....... 2 
hours) and amplification of the free drug concentration in the organic phase pro-
vided the organic/ aqueous partition coefficient is large. The binding constants 
were determined by calculating the concentration of free drug using equation 
1.3. These results were checked by measuring the total distamycin present by 
dissociating the drug-DNA complex with an equal volume of DMSO and then 
measuring the distamycin concentration using an extinction coefficient deter-






Where K is the partition coefficient and Cf and Corg are the concentrations of free 
drug in the aqueous and the organic phases respectively. The amount of drug 
bound is calculated using: cb = Ca- Cf where cb is the amount of drug bound and 
Ca is the total amount of distamycin. Crothers and co-workers reported binding 
affinities for calf thymus DNA and found allosteric binding with high positive 
cooperativity at low r values and noncooperative binding at r values above 0.03. 
These results are consistent with the DNA length increases observed with electric 
dicroism at varying distamycin concentrations. The values determined for the 
allosteric binding of distamycin to calf thymus DNA are 0.95x105 M- 1 for the 
initial low affinity sites and 0.95x 106 M- 1 for the high affinity sites. The buffer 
used in these experiments was: 1M NaCl, 6 mM Na2HP04, 2 mM NaH2P04, 1 
mM EDTA, pH 6.5.33 The distamycin-calf thymus DNA binding constants were 
also measured under low salt conditions giving 3x 105 M- 1 and 4.8x 106 M- 1 
respectively for the low and high affinity sites (50 mM NaCl, 6 mM Na2P04, 
2 mM NaH2P04, 1 mM EDTA, pH 6.5).34 With E. Coli DNA under low salt 
conditions, no allosteric binding was observed. The main disadvantage of this 
method is that the measurements are made in a buffer saturated with organic 
solvent not in aqueous solution. n-Pentanol was used as the organic phase. 
Marky et al.64 • 65 used temperature-dependent UV absorbance to deter-
mine the binding constant of netropsin to poly(dA)·poly(dT) and poly d(A·T). 
This method measures the effect of netropsin on the thermal stability of the 
DNA duplex, similarly to the method used by McGhee.57 The thermal sta-
blity of a duplex is characterized by the temperature midpoint (tm) seen in 
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the UV melting observed at 260nm. Measuring the tm for a DNA duplex in 
the presence and absence of netropsin yields ~tms of 40°C for polyd(AT) and 
45°C for poly(dA)·poly(dT). Circular dichroism was used to verifiy that there 
was only one type of binding in the DNA-drug complex. Binding constants 
were calculated using a theoretical treatment of Crothers58 . At saturation, the 
ligand-induced shift in tm is specified by: 
1 1 R 
--- = --ln[1 + K(aL)] 
t~ tm n~H 
(1.4) 
t~ and tm are the Kelvin temperatures corresponding to the midpoints of the 
helix-to-coil transition in the absence and presence of netropsin, respectively. 
AH is the enthalpy change for the melting of a base pair in the absence of bound 
ligand (from differential scanning calorimetry). K and n are the binding param-
eters for drug binding according to the neighbor-exclusion model ( Crothers58 ) 
where n=1/r at saturation and K is the apparent binding constant. aL is the free 
ligand activity, which equals 1/2 of the total concentration of netropsin added. 
These calculated binding constants refer to the association of the drug with the 
duplex at the high temperature of duplex melting (tm)· McGhee did not correct 
for this effect. 57 The binding constant can be corrected to 25° C using the rela-
tionship: ~ ~n;~= ~:b. Batch calorimetry is used to measure the .6-Hb and found 
that ~Cp is 0 for both complexes. These measurements were carried out under 
a variety of salt conditions and are summarized in table 1.3. 
Based on the slopes and intercepts of the log K versus log [Na+] plots, as 
well as comparison to observed and predicted binding constants, Breslauer et 
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Table 1.3: Equilibrium Binding Constants at 25° C for the 
Association of Netropsin to DNA Duplexes 
at Various Salt Concentrations65 
[Na+] To m Tm ~ n K 
Host Duplex (mM) (oK) (oK) (kcal/bp) (bp) (M-1) 
16 317.9 355.9 2.25 X 109 M-1 
poly d(AT) 66 303.4 358.9 7.3 5 2.13 X 108 M- 1 
116 335.3 358.1 8.87 x 107 M-1 
16 323.5 367.3 8.76x108 M-1 
poly(dA)· 66 337.3 371.5 8.8 5 1.10x 108 M-1 
poly(dT) 116 342.8 372.3 4.29x 107 M-1 
al.64 conclude that netropsin binding of the DNA involves both charged ends 
of the molecule. This is the observation for both poly( dA) ·poly( dT), and poly 
d(AT). 
Table 1.4: Thermodynamic Binding Profile65 
Host Duplex 
poly d(AT) 
poly( dA) ·poly( dT) 





The free energy change for binding to either poly(dA)·poly(dT) or poly 
d(AT) is about the same; however, the relative contributions of enthalpy and 
entropy are vastly different. The driving force for poly d(AT) binding is pre-
dominantly enthalpic and for poly(dA)·poly(dT) it isentropic (table 1.4). Some 
of the factors which could contribute to the enthalpic changes upon binding in-
elude changes in the conformation of both netropsin and the DNA as well as 
changes in the net hydrogen bonding in the system. One of the factors which 
may contribute to the entropic changes is the release of bound water. This water 
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could be directly displaced by the binding of netropsin to the DNA and might 
also result from a change in the form of the DNA resulting in an overall change 
in DNA hydration. 
-22-
Chapter 2 
Poly-N-methylpyrrolecarboxamide Recognition of DNA 
-23-
Affinity Cleaving. Affinity cleaving is an analytical tool developed for study-
ing DNA-small molecule interactions. It is based on the principle that attach-
ment of a DNA cleaving functionality to a DNA binding subunit will create 
a bifunctional DNA binding/ cleaving molecule. Restriction endonucleases and 
anti-tumor compounds such as bleomycin and neocarzinostatin are examples 
of naturally occurring molecules employing this dual binding/ cleaving strategy. 
The first synthetic member of this class of compou~ds was MPE·Fe(II) prepared 
by Hertz berg and Dervan. 66 ' 67 This molecule combines the known DNA in-
tercalating functionality methidium with EDTA·Fe(II), a water-stable complex 
known to produce hydroxyl radicals. The bifuctional molecule, MPE ·Fe(II) , in 
the presence of molecular oxygen and a reducing agent was found to efficiently 
cleave double helical DNA under a variety of salt, buffer and temperature con-
ditions. 
The DNA cleaving specificity of MPE·Fe(II) was low. This result is not 
unexpected because the sequence specificity of the intercalator methidium is 
known to be low.68 The ability of MPE·Fe(II) to recognize and cleave DNA in a 
sequence neutral fashion has been utilized in the technique of DNA footprinting, 
a method for determining the binding site of small molecules on heterogeneous 
DNA by cleavage inhibition.41- 43• 46 Based on the findings from MPE·Fe(II), 
Schultz, Taylor, and Dervan explored the possibility of attaching EDTA to a 
sequence specific DNA binding molecule. The DNA recognition element chosen 
for these studies was the tri-N-methylpyrrolecarboxamide subunit found in the 
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Figure 2.1 (Left) Distamycin A. (Center) DE·Fe. (Right) ED·Fe. 
naturally occurring compound distamycin A, a molecule known to preferentially 
bind A·T rich DNA in the minor groove.6 - 8 • 16 
Two tri-N-methylpyrrolecarboxamide molecules, DE and ED, were prepared 
by modifying the tripeptide subunit with EDTA at either the amino- or carboxy-
terminus, respectively (fig. 2.1).69 • 70 These bifunctional DNA binding/cleaving 
molecules, in the presence of 02 and reducing agent, are capable of reporting 
their location on DNA via oxidative degradation of the deoxyribose backbone 
leading to strand scission. DNA recognition by DE and ED was studied by high 
resolution denaturing gel electrophoresis (fig. 2.2) on a 381 bp fragment (BamH 
I-EcoR I) from pBR322 singly labeled at either the 31 or 51 end with 32P. The 
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Figure 2.2 (Left) Oligopeptid~EDTA·Fe(II) complex can assume two binding 
orientations on the DNA affording cleavage patterns at both ends of the binding 
site. Electrophoresis of the reactions carried out with DNA singly labeled at 
either the 3' or 51 end with 32P separates the DNA to nucleotide resolution 
based on charge and size (center). The DNA is visualized by autoradiography 
and the cleavage is quantitated by densitometry and converted into histogram 
form where arrow length is proportional to the amount of cleavage observed 
(right). 
and converted into histogram form (fig. 2.3). 
There are a number of lines of evidence that point to ·OH as the DNA 
cleaving species generated by these compounds. The DNA termini produced 
by MPE·Fe(II) or DE·Fe(II) cleavage of DNA are 5' phosphate and 3' phos-
phate and 3' phosphoglycolate.67 • 71 The same 31 termini, 31 phosphate and 
31 phosphoglycolate,72 are observed with either EDTA·Fe(II) catalyzed cleav-
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Figure 2.3 Histograms of the DNA cleavage patterns ofDE·Fe(ll) and ED·Fe(II) 
on a 381 bp restriction fragment (from ref. 70). 
radicals .66 • 73 ')'-radiation decomposes water as shown below: 
Udenfriend's reagent, an EDTA·Fe(ll)/asorbate system, catalyzes oxidations 
which are consistent with the intermediacy of hydroxyl radicals. 74 Both the 
EDTA·Fe(TI) and ')'-radiation induced degradation of DNA can be inhibited by 
radical scavengers such as thiols or DMSO providing further evidence for a dif-
fusible oxidizing species. 75 • 76 
The multiple cut cleavage pattern seen with DE·Fe(II) also suggests a dif-
fusible cleaving species. This pattern of cleavage is distributed over 4-5 base pairs 
indicating that only one face of the helix' is exposed to the oxidative species as 
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would be expected for a diffusible species generated from a fixed position re-
mote from the DNA. An alternate explanation for the multiple cut pattern is 
an iron-oxo species which is delivered to the DNA. MPE·Fe(II) has been shown 
to behave like a monocation in its interactions with DNA. 77 This demonstrates 
that the negatively charged EDTA moiety is removed from the first few shells of 
DNA hydration and, therefore, does not interact directly with the DNA causing 
it to _be unable to directly deliver an oxidative species. 
The specific mechanism of hydroxyl radical mediated DNA degradation is 
not known. Evidence from '"Y-radiolysis of DNA suggests that the C4' is the hy-
drogen most susceptible to abstraction. 78 Once formed, this radical could then 
trap 0 2 and form the C-4'-00H compound. A model compound was prepared 
by Japanese workers to explore the mechanism of bleomycin mediated oxidative 
DNA strand scission (fig. 2.4). 79 Treatment of this compound with acid, even 
as mild as chromatography on silica gel, results in base propenal formation. 
Base propenal is a product from bleomycin mediated DNA degradation but it 
is not observed with the EDTA·Fe(II) compounds which afford only free base 
release.67 Treatment of the model hydroperoxide compound under the redox 
active conditions of aqueous Fe(II) (0.05 M phosphate buffer, pH 7.2) and atmo-
spheric oxygen was found to generate only free base release. More insight into 
the cleavage mechanism is provided by product analysis of the reaction of 2,5-
dimethyl-2-hydroperoxidetetrahydrofuran and 2-hydroperoxidetetrahydrofuran 
with aqueous Fe(II) (fig. 2.5).80 • 81 The products of this reaction are consistent 
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with a-bond scission as the major breakdown pathway for these hydroperoxide 
compounds. Based on the DNA endproduct analysis and the model compound 
studies, a plausible mechanism for deoxyribose degredation by ·OH is C4' hy-
drogen abstraction followed by hydroperoxide formation which, under the redox 
conditions of the cleavage reaction, decomposes via a-bond scission to give free 
base release and DNA strand cleavage. 
0 
OR 
Figure 2.4 Model C-41 Peroxide compound. R=benzyl, acetyl, or p-methoxy-
benzyl. 
The multiple cut cleavage patterns produced by the DE·Fe(II) and ED·Fe(II) 
are shown in histogram form in figure 2.3. There are two important features 
to note in these patterns. The first is that changing the end of the molecule 
to which EDTA is attached reverses the orientation of the cleavage patterns. 
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Figure 2.5 
polypyrrole subunit remaining independent of EDTA attachment. The second 
point is that the cleavage patterns on opposite strands are shifted to the 3' side 
with respect to each other. This 31 shift results from the helical nature of the 
DNA (fig. 2.6). The right-handed helical twist of DNA causes deoxyribose units 
on opposite strands proximal to a fixed position in the minor groove to be shifted 
approximately two base pairs to the 3' side in the primary structure. 
The cleavage pattern can be interpreted as resulting from a diffusible cleav-
ing species such as hydroxyl radical generated from a fixed or average position in 
the minor groove. The position of the EDTA·Fe(II) moiety is then assigned from 
the approximate two-fold rotational symmetry of the cleavage pattern. With the 
EDTA·Fe(II) position and knowledge of the length of the linking element, the 
first base pair boundary for the polypyrrole compound can be ~signed (fig. 2.7). 
The two sets of cleavage patterns are assumed to result from two binding ori-
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5' 
Figure 2.6 Model for Asymmetric Cleavage Pattern. 
entations at the same binding site. This assumption is in accord with cleavage 
protection data from footprinting experiments. 
Using the asymmetric cleavge model for binding site assignment and data 
from other labeled DNA fragments, DE·Fe(II) and ED·Fe(II) were both found 
to recognize the same five base pair binding sites. 69- 71 This verified that 
the attachment of EDTA does not alter the binding specificity of the N-
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Figure 2. 7 Two Binding Orientations and Assigned Site. 
the binding site size data is shown in figure 2.8. It depicts the amide hydrogens 
forming three-center, bifurcated hydrogen bonds between adjacent A· T base 
pairs on opposite strands of the DNA helix. The hydrogen bonds bridge the 
thymine 02 and adenine N3. According to this model, the A·T specificity of 
these compounds results not only from the hydrogen bonds which can form with 
A·T base pairs but the steric obstruction in the minor groove presented by the 
guanine 2-amino group. A recent crystal structure of a netropsin-DNA complex 
has verified this as the mechanism of N-methylpyrrolecarboxamide recognition 
of DNA.36- 38 
Several groups have shown that ~alogs of distamycin containing four and 
five pyrroles bind to DNA more tightly than distamycin itself. 82- 86 To study the 
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Figure 2.8 Model for poly-N-methylpyrrolecarboxamide recognition of DNA. 
Circles with two dots represent lone pairs of electrons on the N-3 of adenine or 
the 0-2 of thymine. Dotted lines are bridged hydrogen bonds to amide NH's. 
binding of an extended pyrrole chain to DNA, a five pyrrole analog of DE·Fe(II) , 
P SE · Fe(II), was synthesized by Schultz and Dervan. 87 • 88 This molecule showed 
a larger DNA binding site size of 6-7 base pairs as compared with only 5 bp for 
DE·Fe(II). In addition, PSE·Fe(II) showed an increase in DNA cleavage efficiency 
over DE·Fe(II). 
From the netropsin-DNA co-crystal, Dickerson et al. have suggested that the 
amide to amide distance in poly-N-methylpyrrolecarboxamides is approximately 
0.1 nm too long for the base pair repeat of B-form DNA.89 This would mean 
that the polypyrrole compounds should eventually fall out of register with the 
DNA base pairs as the pyrrole chain is extended. 
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The studies with DE·Fe(II) , ED·Fe(II) and P5E·Fe(II) demonstrate the util-
ity of affinity cleaving and pose number of questions. What are the factors which 
determine the DNA binding specificity of poly-N-methylpyrrolecarboxamides? 
How do additional pyrrole units affect a compound's binding site size and speci-
ficity and at what point do they cease to contribute to binding? To address 
these issues, a homologous series of poly-N-methylpyrrolecarboxamide-EDTA 
compounds containing 3-9 pyrrole units was synthesized and their recognition 
of DNA was studied (fig. 2.9 and 2.10). In addition, another series of acetamide 
compounds containing 2-7 N-methylpyrrolecarboxamide units were synthesized 
for footprinting and biophysical studies (fig. 2.11). 
Synthesis. The key synthetic intermediate, tripyrrole nitro ester 14, was 
prepared using a procedure reported by Bialer et al. with the following 
improvements.g0 The 4-nitro-N-methylpyrrolecarboxylic acid intermediate 15 
can be purified from the nitration reaction mixture and the 5-nitro isomer by 
crystallization from 1:1 acetic acid:water. This crystallization eliminates a chro-
matography step and an esterification/saponification sequence." The second ma-
jor improvement in the synthesis is to replace the aqueous sodium bicarbonate 
base in the coupling reactions with triethyl amine. These two improvements 
increase the overall yield of tripyrrole nitro ester 14 from ,...,.12% to ,..,.50% based 
on the commercially available N-methylpyrrole-2-carboxylic acid. 
By procedu~es analogous to those used to synthesize the tri-N-methylpyrrole 
nitro ester 14, the N-methylpyrrolecarboxamide chain was extended to four 
-----~ 
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Figure 2.9 (upper left) DE·Fe (l·Fe), (upper right) P4E·Fe (2·Fe), (lower 
left) P5E·Fe . (3·Fe), (lower right) P6E·Fe (4·Fe). 
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Figure 2.10 (top) P7E·Fe (5·Fe), (center) P8E·Fe (6·Fe), (lower) P9E·Fe (7·Fe). 
Figure 2.11 (top left) P2 (8), (top right) P3 (9), (center left) P4 (10), (center 
right) PS (11), (lower left) P6 (12), (lower right) P7 (13) . 
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and five pyrrole units (scheme 2.1). Each oligopeptide nitro ester was then hy-
drolyzed to the nitro acid and condensed with 3-(dimethylamino)-propylamine to 
give the corresponding nitro amine. Condensation of the N-hydroxysuccinamide 
ester of EDTA triethylester 16 prepared according to the method of Hay and 
Nolan 91 with '/-amino butyric acid produced the EDTA-triethylester-linker 17.70 
Reduction of the corresponding nitro amines and condensation with the imida-
zolide of EDTA-triethylester-linker 17 produced the triesters of DE 18, P4E 19, 
and PSE 20. The triesters were hydrolyzed with lithium hydroxide to afford the 
tri-, tetra-, and penta-N-methylpyrrolecarboxamide-EDTA molecules. 
As the pyrrole chain is lengthened both the solubility of the compound 
and the reactivity of the terminal nitro group to reduction decrease. These 
two factors make the synthetic approach used for DE, P4E, and PSE untenable 
for the longer pyrrole compounds. The difficulties were circumvented by the 
synthetic route shown in scheme 2.2. The triethyl ammonium salt of the tri-or 
tetra-pyrrole nitro acid (21 and 22, respectively) was hydrogenated and coupled 
to the imidazolide of EDTA-triethylester-linker 17 affording the corresponding 
poly-N-methylpyrrolecarboxylic acid-EDTA-triethylester 23 or 24, respectively. 
This acid was activated as the N-hydroxybenzotriazole ester with dicyclohexyl-
carbodiimide and condensed with the appropriate reduced nitro amine to give 
the triethylesters of P6E 25, P7E 26, P8E 27, and P9E 28. In chromatograph-
ing these triesters, it was important to use 1:1 CH2Ch:MeOH with ammonium 
hydroxide as the solvent system to avoid precipitation of the compounds on the 
1) DCC, NHS 
0 
O EtO) 
'--_ _rN 0 
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Scheme 2.1 P4E Synthesis. 
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column. The triethylesters were hydrolyzed with lithium hydroxide to give the 
hexa-, hepta-, octa-, and nona-N-methylpyrrolecarboxamide-EDTA molecules. 
The synthesis of the acetamide compounds was carried out similarly. 
The corresponding nitro amine for each of the two, three, four and five N-
methylpyrrolecarboxamide compounds was hydrogenated at atmospheric pres-
sure and the resulting amine was acetylated with acetyl chloride or acetyl imi-
dazolide (scheme 2.3). Again, because of low solubility and low reactivity of the 
terminal nitro group to reduction, synthesis of the longer pyrrole compounds 
required an alternate strategy. The tripyrrole nitro ester 14 was hydrogenated 
under atmospheric pressure and acetylated with acetyl chloride to afford the 
tripyrrole acetyl ester 29. Subsequent hydrolysis yielded the tripyrrole acetyl 
acid 30. The three or four pyrrole nitro amines were hydrogenated and cou-
pled to the tri-N-methylpyrrolecarboxamide acetyl acid 30 with dicyclohexyl-
carbodiimide and N-hydroxybenzotriazole to produce the hexa- and hepta-N-
methylpyrrolecarboxamide acetyl compounds, 12 and 13, respectively (scheme 
2.4). 
The specificities of the di-, tri-, tetra-, penta-, hexa-, and hepta-N-
methylpyrrolecarboxamide acetamide compounds were examined by MPE·Fe(II) 
footprinting on a 517 bp 32P-endlabeled restriction fragment from plasmid 
pBR322, EcoR I-Rsa I (4363-3847). The specificities of the tri-, tetra-, penta-
' and hexa-N-methylpyrrolecarboxamide-EDTA compounds were examined on 
three 32 P-endlabeled restriction fragments from plasmid pBR322: a 167 bp frag-
ment, EcoR I-Rsa I (1-167); a 381 bp fragment, BamH I-EcoR I (318-1); and 
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Figure 2.12 Illustration of MPE·Fe(II) footprinting on a high resolution dena-
turing gel with native and ligand protected segments of double helical DNA. 
a 517 bp fragment, EcoR I-Rsa I (4363-3847). Because of the higher bind-
ing site requirements for the longer polypyrrole compounds, a different frag-
ment was chosen to study the specificities of the complete series of poly-N-
methylpyrrolecarboxamide-EDTA compounds containing 3-9 pyrroles; a 205 bp 
fragment of DNA containing the 5174-129 region of SV40 and 6 base pairs of the 
polylinker region of pUC 18 isolated from plasmid SV-CAT (Xba !-Hind III).92 
DNA Footprinting with MPE·Fe(II). DNA footprinting is a powerful di-
rect method for determining the binding sites of proteins and small molecules 
on heterogeneous DNA.41- 44• 46 • 93 • 94 This technique is based on a sequence 
specific DNA binding molecule's ability to protect an endlabeled DNA fragment 
from cleavage at its binding site. The binding site is visualized as a region of 
diminished cleavage on an autoradiogram of a high resolution denaturing gel 
(fig. 2.12). 
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The footprinting reactions were run with 2:5000 cpm of a 32 P endlabeled 
517 bp, EcoR I-Rsa I, restriction fragment from pBR322 and made up to a final 
concentration of 100 J.£M (in base pairs) with sonicated calf thymus DNA. Each of 
the poly-N-methylpyrrolecarboxamide acetamides compounds were equilibrated 
with the DNA at 2.5 J.LM (1:40 acetyl compound to bp ratio) for 1 hat 65°C. The 
cleavage was produced by partial digestion of the DNA with MPE·Fe(II). The 
reactions were carried out after equilibrating the MPE·Fe(II) at 2 J.LM (1:50 MPE 
to bp ratio) with the DNA for 15 minutes at 37°C. Clea;,a,ge was initiated by the 
addition of reducing agent (3 mM DTT, final concentration) and the reactions 
were allowed to continue for 15 minutes at 37°C. The reaction mixtures were 
frozen, lyophilized, and resuspended in formamide loading buffer. After heat 
denaturation, they were run on a 0.2-0.6 mm wedge-shaped 8% high resolution 
denaturing polyacrylamide gel. The gel was dried and exposed to photographic 
film to produce the autoradiogram shown in figure 2.13. The addition of the 
polypyrrole compounds produced region of diminished MPE·Fe(II) DNA cleav-
age. These features were quantitated by scanning the gel and plotting distance 
scanned versus absorbance. Binding sites were assigned from the cleavage inhi-
bition patterns as well as from the trends in the series of compounds and visual 
examination of the gel. The cleavage inhibition patterns and assigned binding 
sites are given in histogram form in figure 2.14. 
517 bp Restriction Fragment. Two common regions of cleavage inhibi-
tion are observed for the series of poly-N-methylpyrrolecarboxamide acetamide 
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Figure 2.13 Autoradiogram of high resolution denaturing gel electrophoresis · 
of 32 P-endlabeled 517 bp pBR322 restriction fragment (EcoR 1-Rsa I). The 
reactions were 100 J.LM in DNA base pairs (final concentration). The acetyl 
compounds were allowed to equilibrate with the DNA for one hour at 65°C. 
MPE·Fe(II) was added to a final concentration of 2 J.LM (1:50 MPE to bp ratio) 
and equilibrated with the DNA for 15 min. at 37°C. Cleavage was initiated by 
the addition of DTT to a final concentration of 3 mM and allowed to proceed 
for 15 min. at 37°C. The reaction buffer was prepared to final concentrations of 
50 mM NaCl and 10 mM Tris (pH 7.4). 
Lanes 1-9 are 51-labeled DNA. Lanes 10-18 are 3'-labeled DNA. Lanes 1 and 10 
are intact DNA control lanes after incubation under reaction conditions. Lanes 
2 and 11 are chemical sequencing lanes containing the products of Ma:xam-
Gilbert G-specific cleavage reactions. Lanes 3-9 and 12-18 are DNA cleavaged 
by MPE·Fe(II) at 2 J.LM. Lanes 4 and 13 contain P2 at 2.5 J.LM (1:50 P2 to bp 
ratio); Lanes 5 and 14 contain P3 at 2.5 J.LM (1:50 P3 to bp ratio); Lanes 6 and 
15 contain P4 at 2.5 J.LM (1:50 P4 to bp ratio); Lanes 7 and 16 contain P5 at 2.5 
J.LM (1:50 P5 to bp ratio); Lanes 8 and 17 contain P6 at 2.5 J.LM (1:50 P6 to bp 
ratio); Lanes 9 and 18 contain P7 at 2.5 J.LM (1:50 P7 to bp ratio). 
---
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G GTTTCTT A GACGTCA G GTG GC A-3' 
CCAAAGAATCTGCAGTCCACCG~~ 
GGTTTCTT AGACGT CA GGTG GC A-3' 
CCAAAGAATCTGCAGTCCACCG~~ 
GTTTCTT A GACGTCAG GTGG C A-3' 
CAAAGAATCTGCAGTCCACCG~~ 
GTT AA TG TCA TGA T A AT A A TGGTTTC TT AGA C GTCA G GTG GC A-3' 
CAATTACAGTACTATTATTACCAAAGAATCTGCAGTCCACCG~~ ... 
Figure 2.14 Histograms of the DNA cleavage inhibition patterns for P2, P3, 
P4, P5, P5, P6, and P7 on the 517 bp restriction fragment from pBR322. Bars 
represent the amount of MPE·Fe(II) cleavage inhibition produced by each com-
pound. Boxes define binding site location and size. 
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compounds (5'-ATTTTTTATA-3', base pairs 4331-4325 and 5'-ATAATAAT-
3', base pairs 4308-4301). The size of the cleavage inhibition patterns increases 
as the number of N-methylpyrrolecarboxamide units in the molecule increases. 
This increase is about one base pair per added carboxamide unit (fig. 2.14). In 
addition, the relative affinities of the oligopeptides for the two sites vary with P6 
and P7 showing a much lower affinity for the upper site (base pairs 4308-4301). 
Affinity Cleaving. The iron chelates of the polypeptide-EDTA compounds 
were prepared by mixing at high concentration (1-10 m.M) with 1-2 equivalents 
of Fe(NH4 )2(S04 )·6H2 0 followed by dilution to the appropriate concentration. 
The cleavage reactions were carried out with 2:5000 cpm 32 P endlabeled restric-
tion fragment and made up to a final DNA concentration of 100 J.LM (in base 
pairs) with sonicated calf thymus DNA. Each polypyrrole-EDTA·Fe(II) complex 
was allowed to equilibrate with the buffered DNA solution and cleavage was 
initiated by the addition of a dithiothreitol (DTT) solution to give a final DTT 
concentration of 5 m.M. The final concentrations of the cleaving compounds and 
equilibration and reaction times and conditions are given in the gel legends. 
After the reactions had run to completion, the reaction mixtures were frozen, 
lyophilized and resuspended in formamide loading buffer. The samples were 
then heat denatured and run on a denaturing polyacrylamide gel. The gels were 
exposed to photographic film and the cleavage patterns were quantified by den-
sitometry. The binding sites were assigned using the asymmetric cleavage model 
described earlier. 
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Figure 2.15 Autoradiogram of high resolution denaturing gel electrophoresis 
of 32P-endlabeled 167 bp pBR322 restriction fragment (EcoR I-Rsa I). The 
reactions were 100 f.LM in DNA base pairs (final concentration). The iron chelates 
of the compounds were allowed to equilibrate with the DNA for one hour at 37° C. 
Cleavage was initiated by the addition of DTT to a final concentration of 5 mM 
and allowed to proceed for 2 hours at 25° C. The reaction buffer was prepared 
to final concentrations of 40 mM Tris base and 5 mM sodium acetate and was 
adjusted to pH 7.9 with acetic acid. 
Lanes 1-6 are 3'-labeled DNA. Lanes 7-12 are 51-labeled DNA. Lanes 1 and 7 
are intact DNA control lanes after incubation under reaction conditions. Lanes 
2 and 8 are chemical sequencing lanes containing the products of Maxam-Gilbert 
G-specific cleavage reactions. Lanes 3 and 9 are DNA cleavage reactions with 
DE·Fe(II) at 10 f.LM; Lanes 4 and 10 are DNA cleavage reactions with P4E·Fe(II) 
at 5 f.LM; Lanes 5 and 11 are DNA cleavage reactions with P5E·Fe(II) at 3 11-M; 
Lanes 6 and 12 are DNA cleavage reactions with P6E·Fe(II) at 3 11-M. 
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Figure 2.16 Histograms of the DNA cleavage patterns from the 167 bp restriction fragment from pBR322. 
Arrows represent the amount of cleavage resulting in the removal of the indicated base. Boxes define binding site 





Figure 2.17 Autoradiogram of high resolution denaturing gel electrophoresis 
of 32 P-endlabeled 381 bp pBR322 restriction fragment (BamH I-EcoR I). The 
reactions were 100 J.£M in DNA base pairs (final concentration). The iron chelates 
of the compounds were allowed to equilibrate with the DNA for one hour at 37°C. 
Cleavage was initiated by the addition of DTT to a final concentration of 5 mM 
and allowed to proceed for 2 hours at 25° C. The reaction buffer was prepared 
to final concentrations of 40 mM Tris base and 5 mM sodium acetate and was 
adjusted to pH 7.9 with acetic acid. 
Lanes 1--6 are 31-labeled DNA. Lanes 7-12 are 51-labeled DNA. Lanes 1 and 7 
are intact DNA control lanes after incubation under reaction conditions. Lanes 
2 and 8 are chemical sequencing lanes containing the products of Maxam-Gilbert 
G-specific cleavage reactions. Lanes 3 and 9 are DNA cleavage reactions with 
DE·Fe(II) at 10 J.£M; Lanes 4 and 10 are DNA cleavage reactions with P4E·Fe(II) 
at 5 J.£M; Lanes 5 and 11 are DNA cleavage reactions with P5E·Fe(II) at 3 J.£M; 
Lanes 6 and 12 are DNA cleavage reactions with P6E·Fe(II) at 3 J.£M. 
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Figure 2.18 Histograms of the DNA cleavage patterns from the 381 bp restriction fragment from pBR322. 
Arrows represent the amount of cleavage resulting in the removal of the indicated base. Boxes define binding site 






Figure 2.19 Autoradiogram of high resolution denaturing gel electrophoresis 
of 32P-endlabeled 517 bp pBR322 restriction fragment (EcoR I-Rsa I). The 
reactions were 100 J.LM in DNA base pairs (final concentration). The iron chelates 
of the compounds were allowed to equilibrate with the DNA for one hour at 37°C. 
Cleavage was initiated by the addition of DTT to a final concentration of 5 mM 
and allowed to proceed for 2 hours at 25° C. 
Lanes 1-6 are 3'-labeled DNA. Lanes 7-12 are 5'-labeled DNA. Lanes 1 and 7 
are intact DNA control lanes after incubation under reaction conditions. Lanes 
2 and 8 are chemical sequencing lanes containing the products of Maxam-Gilbert 
G-specifi.c cleavage reactions. Lanes 3 and 9 are DNA cleavage reactions with 
DE·Fe(II) at 10 J.LM; Lanes 4 and 10 are DNA cleavage reactions with P4E·Fe(II) 
at 5 J.LM; Lanes 5 and 11 are DNA cleavage reactions with P5E·Fe(II) at 3 J,LM; 
Lanes 6 and 12 are DNA cleavage reactions with P6E·Fe(II) at 3 J.LM. The 
reaction buffer was prepared to final concentrations of 40 mM Tris base and 5 
mM sodium acetate and was adjusted to pH 7.9 with acetic acid. 
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Figure 2.20 Histograms of the DNA cleavage patterns from the 517 bp restriction fragment from pBR322. 
Arrows represent the amount of cleavage resulting in the removal of the indicated base. Boxes define binding site 






Figure 2.21 Autoradiogram of high resolution denaturing gel electrophoresis 
of 32P-endlabeled 205 bp restriction fragment from SV-CAT (Xba !-Hind III). 
The reactions were 100 p.M in DNA base pairs (final concentration). The iron 
chelates of the compounds were allowed to equilibrate with the DNA for one hour 
at 65°C. Cleavage was initiated by the addition of DTT to a final concentration 
of 5 mM and allowed to proceed for 2 hours at 37°C. The reaction buffer was 
prepared to final concentrations of 40 mM Tris base and 5 mM sodium acetate 
and was adjusted to pH 7.9 with acetic acid. 
Lanes 1-9 are 51-labeled DNA. Lanes 1Q-18 are 3'-labeled DNA. Lanes 1 and 10 
are intact DNA control lanes after incubation under reaction conditions. Lanes 2 
and 11 are chemical sequencing lanes containing the products of Maxam-Gilbert 
G-specific cleavage reactions. Lanes 3 and 12 are DNA cleavage reactions with 
DE·Fe(II) at 0.9 p.M; Lanes 4 and 13 are DNA cleavage reactions with P4E·Fe(II) 
at 0.4 p.M; L~nes 5 and 14 are DNA cleavage reactions with P5E·Fe(II) at 0.3 
p.M; Lanes 6 and 15 are DNA cleavage reactions with P6E·Fe(II) at 0.3 p.M; 
Lanes 7 and 16 are DNA cleavage reactions with P7E·Fe(II) at 0.3 p.M; Lanes 8 
and 17 are DNA cleavage reactions with P8E·Fe(II) at 0.3 p.M; Lanes 9 and 18 




32p5'- CTCCGCCCCA TGGCT GACT AA[IIII[ttiAT'ffAJTG CAGAG GCCGAG G CC-3' 
., ................ ,,,,,.,,,,,r~~·············~· 
..... lll!Jj .. 
32p5'- CTC C GCCCCA TG GCTGACT AA[TTTTmT A TTT A TG CAGAGGCC GAGG CC-3' .. _ ................. ;::· ·t!JrF"!l ................ -5. 
... .J! l!~. 
32p5'- CTC CG CC CCA TG G CTGACT AA[tTTTTT[ A TTT A TG CAGAG G C C GAG G C C-3' 
··- .................. !l' 'tiJfll;:"'"""'"'"""-5' 
.. j!ll!J. 
npS:- C TC CG CC CCA TG G CTGACT AA[TTTTTTT~ TTT A TG CAGAGG CCGA GG C C-3' 
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Figure 2.22 Histograms ofthe DNA cleavage patterns for DE·Fe(II), P4E·Fe(II), 
PSE·Fe(II), and P6E·Fe(II) on the 205 bp restriction fragment from SV-CAT. 
Arrows represent the amount of cleavage resulting in the removal of the indi-




32 p 5'- CTCCG c c CCA TGGCTGACT AAU TTTTTTT§IITT A TG CAGAG G c CGAG G c C-31 
3'- """'", AO """!, ... trJFii; !'"'"'""", ,_,. 
.. ,J!ll!J,. 
32 p 5'- CTCCG CCCCA TGG CTGACT A~TTTTTTT A TttT A TGCAGAGGCCGAGG CC-31 
3'- ""' oom AO """!' '"lif)f!Jl w """""'' 00-5' 
.. ,. .,!Jlll!l. 
n p 5'- CT C C GCCCCA TGG CTGACT A~TTTTTTT A Tm A TG CAGAG GCCGAGGCC-3' 
3'- OAOOOOOO OT AOOOA"~! n "''tf11)Jil ~00 TOTO 0 """00-5' 
Figure 2.23 Histograms of the DNA cleavage patterns for P7E·Fe(II), P8E·Fe(II) , 
and P9E·Fe(II) on the 205 bp restriction fragment from SV-CAT. Arrows repre-
sent the amount of cleavage resulting in the removal of the indicated base. Boxes 
define binding site location and size based on the asymmetric cleavage model. 
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167 bp Restriction Fragment. This restriction fragment shows one 
binding site that is conserved for all four compounds, DE·Fe(II)-P6E·Fe(II) (5'-
GTTAAATT-3', base pairs 65-72 on pBR322) . This high affinity site is easily 
resolved on the autoradiograms and shows an increase in the recognition se-
quence of one base for each additional N-methylpyrrolecarboxamide unit added 
in the series. There is a slight preference for the amino terminus of the polypyr-
role binding unit to orient towards the 5' end of this site (figs. 2.15 and 2.16). 
This fragment also contains minor sites with lower cleavage intensity for 
DE·Fe(II), P4E·Fe(II), and P5E·Fe(II) in the region of base pairs 30-38, 5'-
AGTTTAT-3', on pBR322. These sites are assigned binding sites of 5 bp for 
DE·Fe(II) and 7 bp for P4E·Fe(II) and P5E·Fe(IT). An orientation preference is 
difficult to assign because of the small amount of cleavage. This site does not 
appear in the P6E·Fe(ll) lane. 
The final site on this fragment, 5'-AGCTTTAA-3', is also weak and is only 
resolved for P5E·Fe(II) and P6E·Fe(II). In the case of the smaller compounds an 
increased cleavage background is seen in this area, but no defined binding site 
is apparent. With P5E·Fe(ll) and P6E·Fe(II), 7 and 8 base pair binding sites, 
respectively, are observed. 
381 bp Restriction Fragment. One common binding location is seen 
for each of the four homologous oligopeptide-EDTA compounds on the 381 bp 
restriction fragment (5'-TAGAAATT-3', base pairs 252-259 on pBR322). At 
this location, there is an increase in binding site size of one base pair with each 
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additional N-methylpyrrolecarboxamide unit. In addition, the orientation pref-
erence of the oligopeptide-EDTA changes with increasing chain length. The 
DE·Fe(II) pattern shows a bias for the tripeptide amino terminus to orient to-
wards the 5' end of the binding site, 5'-AAATT-3'. The tetra- and penta-
N-methylpyrrolecarboxamides, P4E·Fe(II) and P5E·Fe(II), show equi-energetic 
orientational preference. With P6E·Fe(II), the amino terminus of the oligopep-
tide orients toward the 3' end of the sequence, 5'-TAGAAATT-3' (figs. 2.17 and 
2.18). 
517 bp Restriction Fragment. Two common binding locations are ob-
served for the four oligopeptide-EDTA·Fe(II) molecules. At both sites there 
is an increase in binding site size of one base pair for each additional N-
methylpyrrolecarboxamide unit (figs. 2.19, 2.20). All four oligopeptides pref-
erentially orient their amino terminus towards the 3' side of the lower binding 
site (5'-ATTTTTAT-3', base pairs 4331-4324). There is little orientation pref-
erence at the 5'-ATAATAAT-3'site (base pairs 4308-4301). In addition, the 
relative affinities of the oligopeptides for the two sites change as a function of 
the number of N-methylpyrrole groups. For DE and P6E the base pair 4331-4324 
location appears to be the stronger of the two binding sites. 
SV-CAT 205 bp Restriction Fragment. This fragment contains one 
common binding locus for all seven polypyrrole compounds (5'-TTTTTTTTA-
TT-3', 18-28 on SV-40). DE·Fe(II) has two well defined binding sites within this 
region and one poorly resolved site much farther up the gel. As the polypyrrole 
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chain is extended, the unresolved upper site becomes weaker until it is no longer 
apparent in the compounds with five or more pyrroles. At the lower, well resolved 
site the series of compounds shows cleavage consistent with an increase in binding 
site size of one base pair with each additional pyrrole subunit (figs. 2.21, 2.22 
and 2.23) . There is also a very strong orientation preference for the compounds 
to orient their amino terminus towards the 31 end of the run of thymines. 
Binding Site Size. The series of poly-N-methylpyrrolecarboxamide acetamide 
compounds inhibit MPE·Fe(II) mediated DNA degradation of the 517 bp frag-
ment at two strong common locations. The binding site sequences and sizes 
for the series of acetamide compounds are given in table 2.1. The four ho-
mologous oligopeptide·Fe(II) compounds, DE·Fe(TI)-P6E·Fe(II), cleave the three 
pBR322 restriction fragments strongly at four common locations. The series of 
DNA cleaving compounds containing 3-9 N-methylpyrrolecarboxamide units also 
cleave a restriction fragment containing the SV 40 promoter region at a single 
strong common site. The binding site sizes and sequences for the affinity cleav-
ing compounds, DE, P4E, P5E, P6E, P7E, P8E, and P9E are given in table 2.2. 
The footprinting results are consistent with the two cleavage patterns observed 
with the affinity cleaving compounds resulting from two binding orientations 
at a single recognition sequence. This establishes the validity of the asymmet-
ric cleavage model used for binding site assignment with the affinity cleaving 
compounds. The observation of the same binding sites with both the affinity 
cleaving compounds and the acetamide compounds also demonstrates that the 
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Figure 2.24 Densitometry Scans of the 51 data from the high· resolution gels 
of the affinity cleaving compounds on the SV40 promoter aligned by sequence 
(from fig . 2.21). 
attachment of EDTA has no apparent effect on the binding site selection by the 
poly-N-methylpyrrolecarboxamide recognition element. 
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Table 2.1: Oligopeptide binding sites on the 
517 restriction fragment observed 




peptide (base pairs) 
P2 3 ATTTT t a t a 5 
P3 4 aTTTTTa t a 5 
P4 5 ATTTTTA t a 7 
P5 6 ATTTTTATa 8 
P6 7 ATTTTTATa 8 
P7 8 ATTTTTATA 9 
P2 3 atAATAat 4 
P3 4 atAATAAt 5 
P4 5 aTAATAAt 6 
P5 6 aTAATAAT 7 
P6 7 ATAATAAT 8 
*Number of amide units. 
In each sequence, bases contained in the site are symbolized with capital letters 
and the the neighboring nucleotides are designated by lower case letters. 
The oligopeptides with three, four, five, six, seven, eight and nine N-
methylpyrrolecarboxamide units containing four, five, six, seven, eight, nine, 
and ten amide NH's, bind sites of A·T-rich DNA consisting of five, six, seven, 
eight, nine, ten, and eleven contiguous base pairs, respectively. This result leads 
to a general rule for poly-N-methylpyrrolecarboxamide recognition of DNA in 
which a molecule containing n amides recognizes a binding site of n + 1 base 
pairs. This rule is consistent with the oligopeptides binding in the minor groove 
of right-handed DNA with the amide NH groups forming three center bridging 
hydrogen bonds between adjacent N-3 and 0-2 atoms of adenine or thymine, 
respectively, on opposite strands of the DNA helix (fig. 2.8). 
-67-
Table 2.2: Oligopeptide binding sites on the 
517, 167, 381, and SV40 restriction fragments 




peptide (base pairs) 
517 bp Fragment 
DE 4 aTTTTTat 5 
P4E 5 aTTTTTAt 6 
P5E 6 aTTTTTAT 7 
P6E 7 ATTTTTAT 8 
DE 4 atAATAAt 5 
P4E 5 aTAATAAt 6 
P5E 6 aTAATAAT 7 
P6E 7 ATAATAAT 8 
167 bp Fragment 
DE 4 g ttAAATT 5 
P4E 5 gtTAAATT 6 
P5E 6 gTTAAATT 7 
P6E 7 GTTAAATT 8 
381 bp Fragment 
DE 4 t agAAATT 5 
P4E 5 t aGAAATT 6 
P5E 6 tAGAAATT 7 
P6E 7 TAGAAATT 8 
SV 40 Fragment 
DE 4 T T T T T t t t a t t 5 
P4E 5 TTTTTTtt a t t 6 
P5E 6 TTTTTTTt a t t 7 
P6E 7 TTTTTTTTa t t 8 
P7E 8 TTTTTTTTAt t 9 
P8E 9 TTTTTTTTATt 10 
P9E 10 TTTTTTTTATT 11 
*Number of amide units. 
In each sequence, bases contained in the site are symbolized with capital letters 
and the the neighboring nucleotides are designated by lower case letters . 
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The largest of these compounds, P9E·Fe(II), contains 10 amides and rec-
ognizes 11 bp of DNA. Distamycin and netropsin are known to bind B-form 
DNA17-22 and the helical repeat of B-form DNA is 10._4 bp/turn.95 Therefore, 
if the DNA-P9E·Fe(II) complex is in the B-form, P9E·Fe(II) is recognizing more 
than a complete turn of the DNA helix. 
Orientation. From the relative intensity of the two affinity cleavage patterns 
flanking the binding sites, one can estimate the relative orientation preference 
of the oligopeptide on DNA. A number of factors may influence the orienta-
tion of the pyrrole compound at its binding site including: the local sequence, 
the flanking sequence and the number of N-methylpyrrolecarboxamides in the 
molecule. It is important to note that, the two faces of the pyrrole ring are 
prochiral; therefore, they have a diastereomeric interaction with the chiral DNA 
which could potentially result in a difference in energy for the two binding ori-
entations. The binding orientations could also be effected by the molecule in-
teracting preferentially with one or the other of the two strands of DNA at the 
binding site. This interpretation is not supported by the observations from the 
co-crystal of netropsin and DNA which indicate that the polypyrrole molecule 
binds in the center of the minor groove. However, this crystal structure showed 
a significantly shorter distance between the amide NH's and the thymine 02's 
than with the adenine N3's (table 2.3). Additionally, netropsin may sit in the 
center of the minor groove of the dodecamer because the sequence is symmetri-
cal. There is also evidence that the minor groove in the crystal structure may 
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be anomalously narrow.39 • 40 On an unsymmetrical sequence, the minor groove 
may be wider allowing the poly-N-methylpyrrolecarboxamides to preferentially 
associate with one of the strands possibly the thymine rich strand. Because 
the edge of the pyrrole interacting with the minor groove is not symmetrical, 
one binding orientation should provide better H-bonding than the other. Sites 
containing long runs of poly dA·poly dT show a very pronounced preference for 
the amino terminus of the polypyrrole subunit to orient towards at the 3' end 
of the· pyrimidine strand (figs. 2.22 and 2.23). This suggests that, if hydrogen 
bond formation is the controlling factor in binding orientation, this orientation 
provides optimal interaction between the amide NH's and the hydrogen bond 
acceptors on poly(dA)·poly(dT) possibly the thymine 02 in particular. 
Table 2.3: Crystal Structure H-bond Distances37 
Netropsin DNA. Distance A Distances 
atom atom A A 
N-4 0-2 of T-20 2.68 
0.60 
N-4 N-3 of A-18 3.28 
N-6 0-2 of T-19 3.86 
0.34 
N-6 0-2 of T-7 3.54 
N-8 N-3 of A-18 3.45 
0.89 
N-8 0-2 of T-8 2.56 
Atom numbers refer those in figure 1.2 from ref. 37 
The influence of flanking sequences on the local structure of the binding 
site may be important in DNA recognitio!l. An example of the effect of flank-
ing sequences can be seen in a comparison of two DE·Fe(II) sites. On the 381 
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bp fragment, the sequence 5'-agAAATTgc-3' has a 70:30 orientation preference 
for the amino end of the tripyrrole subunit of DE to lie at the 51 side of the 
site. The 167 bp fragment with pE shows no orientation preference at the site 
5'-ttAAATTgc-3'. Since the binding sites are identical except they occur in dif-
ferent contexts, the difference in orientation at the recognition sequence must be 
induced by the flanking sequences and the alterations they impose on the local 
structure. One mechanism by which neighboring regions could exert their effect 
on binding sequences is by influencing the minor groove width. Distamycin foot-
printing studies with DNase have been reported to show cleavage modulations 
consistent with changes in the minor groove width.93 This demonstrates that 
there is a relationship between poly-N-methylpyrrolecarboxamides binding to 
DNA and this structural variable. Because of their sensitivity to DNA tertiary 
structure, these oligopeptide-EDTA molecules may be useful as sensitive probes 
of variations in B-form DNA and the influence of flanking sequences. 
Salt Effect. Because high salt appears to break up weak and non-specific in-
teractions between poly-N-methylpyrrolecarboxamides and DNA,7 • 8 P6E·Fe(II) 
cleavage reactions were run with a range of 0-2 M added NaCl (fig. 2.25). Two 
major effects of increasing salt concentration were observed. The first observa-
tion was that some binding sites faded out as the salt concentration increased. 
The second was that the cleavage patterns became broader covering more bases. 
Increasing the salt concentration in affinity cleaving reactions has two ma-
jor consequences: it decreases the strength of electrostatic interactions and the 
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Figure 2.25 The effect of added salt on the affinity cleaving reaction. Autora-
diograms of high resolution denaturing gel electrophoresis pBR322 restriction 
fragments. (Left) 5' endlabeled 167 bp fragment (EcoR I-Rsa I) and (Right) 5' 
endlabeled 517 bp fragment (EcoR I-Rsa I). The reactions were 100 J.LM in DNA 
base pairs final concentration. The P6E·Fe(II) was allowed to equilibrate with 
the DNA for 1 hour at 37°C. Cleavage was initiated by the addition of DTT 
to a final concentration of 5 mM and allowed to proceed for 2 hours at 25°C. 
Reactions were halted by ethanol precipitation and were washed once with 70% 
ethanol/water before being taken up in loading buffer. The reaction buffer was 
prepared to final concentrations of 40 mM Tris base and 5 mM sodium acetate 
and was adjusted to pH 7.9 with acetic acid. 
Lanes 1 and 9 are intact DNA controls after incubation under reaction condi-
tions. Lane 2 and 10 are chemical sequencing lanes containing the products of of 
Maxam-Gilbert G-specific cleavage reactions. All reactions in lanes 3-8 and 11-
16 were carried out with P6E·Fe(II) at 3 J.LM. Lanes 3 and 11 contain no added 
sodium chloride; Lanes 4 and 12 contain 0.1 M added sodium chloride; Lanes 
5 and 13 contain 0.25 M added sodium chloride; Lanes 6 and 14 contain 0.5 
Madded sodium chloride; Lanes 7 and 15 contain 1 Madded sodium chloride; 
Lanes 8 and 16 contain 2 M added sodium chloride. 
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32p5'- AT A A GC T TT A ATGCGGT A GTTT A TC A CAjG TT AAA TTIG CT AA c G c A G T c A G G- 3' 
3'- T A TT CGAAA TT A C GC CA TCAAA TAG TGTCA ATTTAA C GATT G C G TC A GT C C- 5' 
Figure 2.26 Histograms of the DNA cleavage patterns from cleavage of the 167 
bp restriction fragment shown in figure 2.25. Arrows represent the amount of 
cleavage resulting in the removal of the indicated base. Boxes define binding site 







Figure 2.2 7 Histograms of the DNA cleavage patterns from cleavage of the 517 
bp restriction fragment from shown in figure 2.25. Arrows represent the amount 
of cleavage resulting in the removal of the indicated base. Boxes define binding 
site location and size based on the asymmetric cleavage model. 
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salt cations compete with Fe2+ /S+ for the EDTA. These two factors combine to 
decrease the amount of cleavage observed with affinity cleaving compounds by 
making the DNA cleaving functionality less efficient and by lowering the bind-
ing constant of the binding portion of the _mo_lecule as a result of lowering the 
attraction between the positively charged amino terminus of the molecule and 
the negatively charged DNA. 
Interestingly, the cleavage does not decline uniformly at all of the sites. On 
the 167 bp fragment one of the sites is cleaved at 1M added NaCl and with the 
517 bp fragment efficient cleavage is still observed at the lower site with 2 M 
added salt (figs. 2.26 and 2.27). Because the added electrolyte is decreasing the 
electrostatic contribution to binding, it is makes the non-ionic interactions, such 
as hydrogen bonding, relatively more important in determining the recognition 
of DNA by N-methylpyrrolecarboxamides, although it may also be altering the 
form of the DNA. Therefore, of the sites we have observed on the 167 bp and 
the 517 bp fragments, the one most efficiently recognized by P6E·Fe(IT) is the 
5'-ATTTTTAT-3' site on the 517 bp fragment. 
The broadening of the cleavage pattern could anse in three ways. The 
pyrrole compound could be sliding one or two base pairs in the groove. This 
effect is not seen under normal salt conditions and there is no reason to expect 
decreasing electrostatic interactions to produce it. The DNA may have changed 
conformation under the high salt conditions resulting in a larger set of bases 
accessible to the cleaving species. No sharp change in the cleavage patterns is 
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observed as would be expected for a DNA structure change and it is known 
that N-methylpyrrolecarboxarnide compounds recognize B-form DNA and will 
convert A- or Z-form DNA to B-form upon binding.17-22 The third possibility 
is that the negatively charged EDT~ moiety is no longer held in a fixed position 
away from the DNA. With the higher salt to neutralize its negative charge, the 
EDTA does not have the strong repulsion from the phosphates causing it to 
be maximally extended from the DNA. The wider range of available delivery 
positions would make a greater number of bases accessible to the DNA cleaving 
species causing the cleavage pattern to be broadened. 
DNA Binding Specificity. According to the n+l rule and the bifur-
cated hydrogen bond model, the minimum recognition element for the N-
methylpyrrolecarboxamide on B-DNA is two base pairs. If the recognition el-
ements for the NH of the carboxarnide are on adjacent residues on opposite 
strands of the helix, there are 10 bridged base possibilities: A-A, A-T, A-C, A-G, 
T-T, T-C, T-G, C-C, G-G, and C-G. The observed binding sites for the homol-
ogous series of poly-N-methylpyrrolecarboxarnide compounds reveals that the 
preferences for bridged three center hydrogen bonds between adjacent bases on 
opposite helix strands decreases in the following order: A-T>> A-A> T-T > A-
C, T-C, T-G >> A-G, C-G, C-C, G-G (table 2.4). From these data, the preferred 
two base-pair DNA recognition sequences for the N-methylpyrrolecarboxamide 
DNA binding unit are, in decreasing order, (5'-3') TT >> TA, AT > GA, GT, 
CT » CA, CC, GG, CG. 
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Table 2.4: Bridged Hydrogen Bonds from Affinity Cleaving Data 
Oligo-
peptide Bridged bases on opposite strands 
517 bp Fragment 
DE t - t T-,A .T-A T-A T-A a-a t - t 
P4E t - t T-A T-A T-A T-A A-A t - t 
PSE t - t T-A T-A T-A T-A A-A T-T 
P6E T-T T-A T-A T-A T-A A-A T-T 
DE t - t a-a A-T T-T A-A A-T t - t 
P4E t - t A-A A-T T-T A-A A-T t - t 
PSE t - t A-A A-T T-T A-A A-T T-T 
P6E T-T A-A A-T T-T A-A A-T T-T 
167 bp Fragment 
DE t - c t -a a-a A-T A-T T-T T-A 
P4E t - c t -a A-A A-T A-T T-T T-A 
PSE t - c T-A A-A A-T A-T T-T T-A 
P6E T-C T-A A-A A-T A-T T-T T-A 
381 bp Fragment 
DE a-a g- t a-a A-T A-T T-T T-A 
P4E a-a g- t A-A A-T A-T T-T T-A 
PSE a-a G-T A-A A-T A-T T-T T-A 
P6E A-A G-T A-A A-T A-T T-T T-A 
SV 40 Fragment 
DE T-A T-A T-A T-A t -a t -a t -a t - t a-a t -a 
P4E T-A T-A T-A T-A T-A t -a t -a t -a a-a t -a 
PSE T-A T-A T-A T-A T-A T-A t -a t - t a-a t -a 
P6E T-A T-A T-A T-A T-A T-A T-A t - t a-a t -a 
P7E T-A T-A T-A T-A T-A T-A T-A T-T a-a t -a 
P8E T-A T-A T-A T-A T-A T-A T-A T-T A-A t -a 
P9E T-A T-A T-A T-A T-A T-A T-A T-T A-A T-A 
In each sequence, bases contained in the site are symbolized with capital letters 
and the lowercase letters show the neighboring nucleotides. 
The observation of G·C base pairs in the binding sites of these small 
molecules is something of a suprise. The crystal structure of netropsin bound 
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to a dodecamer of DNA has visualized the mode of A·T DNA recognition by 
N-methylpyrrolecarboxamides.36- 38 However, the fit of netropsin to the DNA 
is very tight in this crystal structure and it is not readily apparent how such 
an interaction could adjust to accommodate the guanine 2-amino group pro-
truding into the minor groove. Perhaps the complex can adjust to remove· the 
close van der Walls nonbonding contact between the pyrrole CH and the NH2 
group of guanine. As will be discussed subsequently, the recognition sequences 
containing G·C base pairs appear to be weaker binding sites and possibly the 
poly-N-methylpyrrolecarboxamide backbone simply is not fitting as deeply into 
the minor groove. 
A more detailed statistical analysis of the binding site sequences is compli-
cated by the fact that the number of unique sequences increases exponentially 
as the size of the binding site is increased. For a five base pair site, there are 
45 /2 or 512 unique DNA sequences. For a six base pair binding site, there are 
46 /2 or 2080 unique DNA sequences. In the 263 base pairs of DNA for which 
I have presented a high resolution analysis, 173 of the possible five base pair 
sequences are represented, about 34% of the total, but only 219 of the possible 
six base pair sites are observed, about 10% of the total. Because only DE·Fe(II) 
has representation of a significant fraction of its possible recognition sequences, 
it is the only affinity cleaving compound for which a more detailed analysis will 
be presented. 
On the four DNA restriction fragments a total of 263 base pairs with 173 
unique five base pair sequences have been studied and five strong and one weak 
-79-
five base pair binding sites for DE·Fe(II) have been observed. The six DE·Fe(II) 
binding sites comprise only four unique recognition sequences (the 167 bp and 
381 bp sites are the same as are one of the 517 bp and SV40 fragment sites) 
which is less than 3% of the unique 5 bp sequences assayed. This illustrates 
the high sequence specificity of the tri-N-methylpyrrolecarboxamide recognition 
element. 
The highest affinity binding sites for DE·Fe(II) contain only A·T base pairs. 
For five base pair A·T sites there are 25 /2 or 16 unique sites. The four fragments 
studied here contain 15 of the 16 unique sites (table 2.5). DE·Fe(II) recognizes 
three of the A· T sequences strongly and a fourth one weakly. There is no readily 
apparent characteristic of this subset of recognized A·T sites which would explain 
their high affinity for tri-N-methylpyrrolecarboxamide compounds, although 
they have some interesting characteristics. One of the features of the strongest 
binding sites is that they tend to include few purine/pyrimidine switches, 51-
AAAAA-31 on the 517 bp and SV40 fragments (0 switches) and 5'-AAATT-3' 
on the 381 and 167 base pair fragments (1 switch). The preferred binding sites 
also tend to be included in longer runs of A·T base pairs. It may be that the 
stucture of a sequence within an A·T tract is better for polypyrrole binding. It 
has been shown that the groove width of G·C regions is wider than in A·T.95 
Perhaps the widening of the groove in a G·C region extends into the A·T region 
decreasing the hydrophobic contacts between the polypyrroles and the sugar 
residues of the DNA backbone. 
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Table 2.5: Occurance of 5 base pair A·T Sites 
on the 167, 381, 517, and SV40 Fragments 
Site 167 381 517 SV40 Total 
AAAAA + + + 
AAAAT X X X 
AAATA X X X 
AATAA + X + 
ATAAA X X X X 
TAAAA X X X 
ATATA X X 
ATTAA X X X 
ATAAT X X 
AATTA X X 
TTAAA X X 
TATAA X X 
TAAAT X + + 
TAATA 
AATAT X X 
AAATT + + X + 
Total Sites 5/16 2/16 10/16 9/16 15/16 
The X indicates the site is found on the fragment. The + indicates that the site 
is both found on the fragment and recognized by DE·Fe(II). The- indicates that 
the site is not found on the fragment. 
These correlations can be used as a general rule of thumb for poly-N-
methylpyrrolecarboxamide specificity, but it is important to remember that 
other factors influence this specificity as well. We have already seen that flanking 
sequences can influence the binding orientation of the small molecules at their 
binding site. In the SV40 restriction fragment, there is a run of eight consecu-
tive adenine residues. Thus for DE·Fe(II) there are four possible binding sites 
containing five A·T base pairs with identical primary sequence, for P4E·Fe(II) 
there three identical six base pair poly(dA)·poly(dT) sites and for P5E·Fe(II) 
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there two identical five base pair poly( dA) ·poly( dT) sequences; however, each 
of these compounds demonstrates well defined DNA cleavage patterns consis-
tent with the recognition of a unique binding site. Therefore, all three of these 
compounds must be able to efficiently differentiate between two binding sites 
with the identical primary sequence. This differentiation must be based on the 
structural heterogeneity of the region produced by long-range interactions from 
outside the binding site sequence. Therefore, the DNA sequence specificity of 
the polypyrrole compounds is not dictated solely by the primary sequence of the 
binding site, but includes a combination of steric, electronic, and conformation 
effects. 
Footprinting studies have detected other binding sites for the tri-N-
methylpyrrolecarboxamide DNA recognition subunit which are not seen with 
the affinity cleaving compound. In addition, Crothers et al. reported a large 
cooperative interaction between distamycin and ethidium bromide binding to 
DNA.34 To explore the possibility of allosteric binding with the footprinting 
reagent MPE·Fe(ll) and poly-N-methylpyrrolecarboxamide compounds, affinity 
cleaving studies were carried out in the presence of a range of ethidium bro-
mide concentrations. These studies showed no change in DNA recognition by 
DE·Fe(ll). Another explanation for the difference in the number of binding sites 
observed with the two methods is a difference in binding site saturation between 
the two experiments. To examine the effect of binding site saturation with affin-
ity cleaving reagents, reactions were carried out with increasing concentrations 
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of P4E·Fe(II) using varied reaction times (fig. 2.28). These studies show that 
increasing concentrations of P4E·Fe(II) produce an increasing number of cleav-
age loci (fig. 2.29). This is consistent with a greater number of binding sites 
occupied at the higher polypyrrole concentrations establishing that it is the dif-
ference in binding site saturation which produced the apparent discrepancy in 
the observed binding sites between footprinting and affinity cleaving. 
At the higher P4E·Fe(II) concentrations (40 J.LM, 5 min fig. 2.29), more 
sites are occupied, but all the sites show approximately the same amount of 
cleavage. This result could be interpreted as demonstrating that all sites have 
about the same affinity for the small molecule. Using a much lower P4E·Fe(II) 
concentration, it becomes apparent that one site, 51- TAAATT -3', has a much 
higher binding affinity than the others (5 J.LM, 1 hour fig. 2.29). Because the 
affinity cleaving method produces a positive signal on the autoradiogram, it can 
be used at much lower binding site saturation than footprinting allowing only 
the highest affinity sites to be detected. 
These studies show that each of the tri-, tetra-, penta-, and hexa-, hepta-, 
octa-, and nona-N-methylpyrrolecarboxamide-EDTA compounds follow the n + 
1 rule binding one base pair more than their number of amides. This result is 
consistent with a common DNA recognition model in which each of the amides 
form bridging three-center hydrogen bonds between adjacent base pairs on op-
posite strands of the DNA. This result demonstrates that, up to at least nine 
N-methylpyrrolecarboxamide units, the DNA complex of these compounds does 
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Figure 2.28 Autoradiograms of high resolution denaturing gel electrophoresis 
of 3' endlabeled 167 bp pBR322 restriction fragment (EcoR I-Rsa I) with varying 
P4E·Fe(II) concentrations and reaction times. The reactions were 100 J.LM in 
DNA base pairs (final concentration). The P4E·Fe(II) was allowed to equilibrate 
with the DNA for 1 hour at 37°C. Cleavage was initiated by the ~ddition of DTT 
to a final concentration of 5 mM and allowed to proceed at 25° C for the time 
indicated. The reaction buffer was prepared to final concentrations of 40 mM 
Tris base and 5 mM sodium acetate and was adjusted to pH 7.9 with acetic acid. 
Lane 1 is an intact DNA control lane after incubation under reaction conditions. 
Lane 2 is a chemical sequencing lane containing the products of a Maxam-Gilbert 
G-specific cleavage reaction. All reactions in lanes 3-22 were carried out with 
P4E·Fe(II). Lanes 3-7 contain 40 J.LM P4E·Fe(IT); Lanes 8-12 contain 20 J.LM 
P4E·Fe(II); Lanes 13-17 contain 10 J.LM P4E·Fe(II); Lanes 18-22 contain 5 J.LM 
P4E·Fe(II). Lanes 3, 8, 13, and 18 were allowed to react 5 minutes at 25°C; 
Lanes 4, 9, 14, and 19 were allowed to react 15 minutes at 25°C; Lanes 5, 10, 
15, and 20 were allowed to react 30 minutes at 25°C; Lanes 6, 11, 16, and 21 
were allowed to react 1 hour at 25° C; Lanes 7, 12, 17, and 22 were allowed to 
react 1 hour at 25°C but without pre-eqilibration with the DNA. 
-83-







,,,. t ::1;;..-;.. :::i 
illll=. =iiji 
iiJ .. ,~. -t:l:l:l· .:::: . - -.... . : - . . 
• • • • • • • ••• 





I 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 
-85-
40~M for 5 min . 
20~M for 15 min . 
lO~M for 1 hour 
5~M for 1 hour 
Figure 2.29 Histograms of the DNA cleavage patterns from cleavage of the 167 
bp restriction fragment from shown in figure 2.28. Arrows represent the amount 
of cleavage resulting in the removal of the indicated base. Boxes define binding 
site location and size based on the asymmetric cleavage model. 
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not fall out of register with the DNA base pairs. The largest in this series of 
compounds, P9E·Fe(II), binds eleven base pairs, which is more than a complete 
turn of the B-form helix. 
These studies also establish that the highest allinity sites for poly-N-
methylpyrrolecarboxamide compounds on heterogeneous DNA are A·T se-
quences favoring those with a high polypyrimidine character. Their optimal 
binding sites are not solely dictated by the primary sequence of the binding 
site, but includes longer range influences from neighboring sequences. For com-
pounds with binding site sizes larger than 5 bp, determining specificity by high 
resolution gels is impractical due to the exponential increase in unique sites. 
Further studies require a new assay that will permit the analysis of larger DNA 
fragments. 
Large fragments of DNA were targeted because they allow simultaneous 
comparison of many potential binding sites. This facilitates the study of the 
relationship between the binding site size of a poly-N-methylpyrrolecarboxamide 
compound and the specificity with which it recognizes DNA. By assaying many 
potential binding sites, the optimum recognition sequences for the compound 
can be rapidly determined. 
Large DNA is studied with a double strand cleavage assay requiring that 
both strands of the DNA be cleaved within a distance that allows denaturation 
of the intervening base pairs to produce two double strand DNA fragments (fig. 
2.30). The reactions were run with linearized pBR322 in the same manner as the 
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reactions used for the high resolution gels. After the reactions were completed, 
they were electrophoresed on a non-denaturing agarose gel which separates dou-
ble strand DNA based on size. If the double cleavage occurs randomly or with 
very low specificity, a continuum of fragments will be produced and no band-
ing will be observed. On the other hand, with DNA cleaving agents of high 
specificity such as restriction enzymes a clear banding pattern will result. The 
number of bands produced by a compound is proportional to the frequency with 
which it finds its binding site; the greater the number of bands, the more often 
a recognition sequence occurs. 
Studies with X-ray damaged DNA under a variety of salt and temperature 
conditions indicate that the two breaks must be within 3-24 bp.96 Because this 
distance is so small, double strand breaks are assumed to result predominantly 
from two cleavage events at a single binding site and not two cleavage events at 
neighboring sites. However, this does not preclude the possibility that two or 
more distinct sites will be too close together to be resolved by the gel. These 
sites will then appear as one site with an average position on the DNA. 
This type of experiment illustrates the power of the affinity cleaving method. 
The other commonly used method .for determining the binding site of small 
molecules on heterogeneous DNA is footprinting which is capable of simultane-
ously assaying only about 100-200 base pairs. The affinity cleaving method can 
be used to simultaneously study thousands of base pairs and has been applied 
to DNA as large as 48 Kb (vide infra). 
1) linearize with 
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1% non-denaturing agarose gel 
Scheme 2.5 The scheme for the double strand cleavage experiment. (Left) Supercoiled pBR322 is linearized with 
a restriction endonuclease. (Center) The DNA is labeled and reacted with an affinity cleaving compound under 
conditions which produce double strand cleavage. (Right) Non-denaturing agarose gel showing intact linearized 






The DNA used in these studies was pBR322linearized by Sty I. This restric-
tion endonuclease cleaves at an asymmetric recognition sequence on pBR322. 
This allows the DNA to be selectively radio-labeled at one or both ends with 
the appropriate choice of radio-labeled nucleotide using the standard 3' labeling 
techniques outlined in the experimental section of this thesis. In these studies, 
CTP was chosen to label both ends of pBR322 and ATP was chosen to selectively 
label one end. The DNA was purified after labeling by preparative low melting 
agarose gel electrophoresis. Cleavage reactions were carried out under the same 
conditions as the high resolution gels described earlier and final concentrations, 
conditions, and reaction times are given in the gel figure legends. 
The results of the double strand cleavage experiments are shown in figures 
2.31 and 2.32. The most important initial observation is that all of the pyrrole 
compounds produce discrete banding patterns. Within this series of compounds, 
the three pyrrole compound, DE·Fe(II), shows the greatest number of bands on 
the gel and the total number of bands decreases as the number of pyrroles m 
the compound increases. 
The molecular weights of the bands were determined by comparison with 
a molecular weight marker. For greater accuracy in molecular weight deter-
mination, some reactions were "spiked" with molecular weight standard. This 
provided a direct comparison of the mobilities of the reaction fragments with 
the molecular weight standard and avoided error introduced by lane to lane 
variations in electrophoretic mobility. Because each cleavage site produces two 
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Autoradiograms of non-denaturing agarose gel electrophoresis of 32 P-end-labeled 
pBR322. The reactions were 100 JLM in DNA base pairs (final concentration). 
The iron chelates of the compounds were allowed to equilibrate with the DNA 
for one hour at 65°C. Cleavage was initiated by the addition of DTT to a final 
concentration of 5 mM and allowed to proceed for 2 hours at 37°C. The reaction 
buffer was prepared to final concentrations of 40 mM Tris base and 5 mM sodium 
acetate and was adjusted to pH 7.9 with acetic acid. 
Figure 2.31 pBR322 labeled at both ends of the Sty I site. 
Figure 2.32 pBR322 labeled at one end of the Sty I sites 
Lane 1 is an intact DNA control lane after incubation under reaction conditions. 
Lanes 2 and 10 contain molecular weight markers. Lane 3 is a DNA cleavage 
reaction with DE·Fe(ll) at 1.2 JLM; Lane 4 is a DNA cleavage reaction with 
P4E·Fe(II) at 0.8 J,£M; Lane 5 is a DNA cleavage reaction with P5E·Fe(II) at 0.6 
J,£M; Lane 6 is a DNA cleavage reaction with P6E·Fe(II) at 0.6 JLM. Lane 7 is 
a DNA cleavage reaction with P7E·Fe(II) at 0.6 J,£M; Lane 8 is a DNA cleavage 
reaction with P8E·Fe(II) at 0.6 ttM; Lane 9 is a DNA cleavage reaction with 
P9E·Fe(II) at 0.6 JLM. 
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Figure 2.33 Histogram analysis of the gels in figures 2.31 and 2.32. Arrows 
represent the amount of cleavage observed at each location on pBR322. Broken 
line indicates the limit of resolution. 
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fragments of DNA which sum to 436797 the cleavage of double labeled pBR322 
should produce symmetrical banding pattern where both fragments are labeled 
and are produced in equal amounts. This symmetry facilitates the pairing of the 
observed bands. In the series of reactions with singly labeled DNA, only one of 
the two fragments resulting from cleavage is radio-labeled. These data provide 
the information necessary to determine the direction to measure from the point 
of Sty I linearization towards the site of double strand cleavage. 
The sites of cleavage were measured from the gel and compiled. Exami-
nation of the sequence of pBR322 at each of these sites found that with one 
exception there was a long run of A·T DNA within 5-30 bp with the strong 
sites more likely to be off by fewer bases (table 2.6). The exception is the site at 
3855; however, this site is symmetrically positioned between several shorter runs 
of A·T DNA and may be a composite of unresolved bands resulting from cleavage 
at those sites. To examine the possibility that these A·T sites were the actual 
sites of DNA cleavage, the fragment lengths corresponding to cleavage of Sty I 
linearized pBR322 DNA at these sites were calculated. These values were then 
plotted against the band migrations measured from the gels and the correlation 
coefficient for the line was determined (r=0.9992). Comparison of this value 
with the correlation coefficient for the molecular weight marker lane (r=0.9991) 
in which all the molecular weights are known showed that these assignments 
were within the accuracy of the experiment. The results of this analysis were 
quantitated and converted into histogram form (fig. 2.33) and listed in tabular 
form (table 2. 7). 
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Table 2.6: A Comparison of Measured and Proposed N-methylpyrrolecarbox-
amide Recognition Sequences on pBR322. 
Measured Proposed Measured Proposed 
Site Site Site Site 
63 60 3695 3710 
2335 2292 3855 3855 
2531 2515 3975 3945 
3068 3080 4130 4115 
3215 3235 4260 4245 
3460 3465 4343 4325 
Specificity. For each position in a DNA nucleotide sequence there four possible 
bases which can recognize each other to form A·T and G·C complementary base 
pairs. With these constraints, the frequency of occurrence for a unique binding 
site of n base pairs is (4n)/2 for odd nand (4n)/2+(4nf2 )/2 for even n (table 
2.8) . If the sequence contains only A·T base pairs, the possible permutations 
are given by (2n)/2 for odd nand (2n)/2+(2nf2 )/2 for even n (table 2.8). The 
ratio of possible sites with n base pairs containing only A· T bases to those 
sites containing all four bases gives the frequency with which the A·T sites 
occur. From table 2.8, a five base pair A·T binding site such as that recognized 
by DE·Fe(II) occurs with a frequency of 3.1 X 10-2 or about once every 32 bp. 
It is remarkable then that DE·Fe(II) digestion of pBR322 produces a distinct 
banding pattern of only 12 distinguishable bands on the ,..,.,3700 bp analyzed. This 
result provides additional evidence that DE·Fe(II) does not simply recognize five 
consecutive A·T base pairs, but only a subset of these sequences. 
~he histograms state quantitatively what is qualitatively apparent from 
the gels themselves; increasing the number of N-methylpyrrolecarboxamides in 
Table 2. 7 Major Double Strand Cleavage Loci on pBR322 
Site Sequence DE P4E P5E P6E P7E P8E P9E 
60 CACAGTTAAATTGCTAACGC w w 
2335 CGTAAGGAGAAAATACCGCA w 
2515 GAACCGTAAAAAGGCCGCGT w w 
3080 GGTGGTTTTTTTGTTTGCAA s s s s M M w 
3235 GATCCTTTTAAATTAAAAAT s s s s s s s 
3465 CAGATTTATCAGCAATAAAC w I (0 
GTACTCAACCAAGTCATTCT w cr 3855 
3795 CAGCACTGCATAATTCTCTT w 
3945 GCAGAACTTTAAAAGTGCTC w 
4115 AATGCCGCAAAAAAGGGAAT w 
4245 TGTATTTAGAAAAATAAACA s s s s M M w 
4325 TTAACCTATAAAAATAGGCG M s s M M w 
S, strong; M, moderate; W, weak. 
Table 2.8:Binding Site Frequency for DNA Binding Molecules 
Site Unique Unique Site Unique A·T Site 
Size (n) Sites (N) Frequencya A·T Sites Frequencyb 
1 2 5.0x10-1 1 5.0x w- 1 
2 10 l.Oxlo-1 3 3.0x w- 1 
3 32 3.1xlo-2 4 1.3xw-1 
4 136 7.4x10-3 10 7.4xw-2 
5 512 2.0xw-3 16 3.1xlo-2 
6 2,080 4.8x10-4 36 1. 7x w-2 
7 8,192 1.2x10-4 64 7.8x w-3 I 
c.o 
8 32,896 3.0x10-5 136 4.1xw-3 ..... I 
9 131,072 7.6xlo-6 256 2.0xw-3 
10 524,800 1.9x10-6 528 l.Oxw-3 
11 2,097,152 4.8xlo-7 1,024 4.9xw- 4 
12 8,390,656 1.2xlo-7 2,080 2.5x 10-4 
13 33,554,432 3.0xlo-s 4,096 1.2x w- 4 
14 134,225,920 7.5xlo-9 8,256 6.2x w-o 
15 536,870,912 1.9xw-9 16,384 3.1x10-5 
16 2,147,516,416 4.7x10- 10 32,896 1.5xw-5 
a=1/N b=Unique A-T Sites/N 
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a molecule increases the specificity of the compound (fig. 2.33). Extending the 
pyrrole chain from 3 to 4 pyrroles decreases the number of cleavage loci observed 
from 12 to 6. The number of sites also diminishes moving from P4E·Fe(II) to 
P5E·Fe(II); however, further increases in the number of pyrroles in the molecules 
manifests an increase in DNA binding specificity primarily as a decrease in the 
cleavage intensity observed at the minor cleavage sites. 
For P9E, one major cleavage site and two minor sites are observed. A unique 
6 base pair binding site such as that recognized by a restriction enzyme occurs 
approximately every 2000 bp or with a frequency of about 5xlo-4 (table 2.8). 
Therefore, on pBR322 a unique six base pair site should occur approximately 
twice. This is in qualitative agreement with the number of sites recognized by 
P9E, one strong and two weak, demonstrating that P9E, a synthetic organic 
molecule, shows at least formally the specificity of a restriction enzyme. 
The sequences of the major cleavage sites are shown in table 2.7. There are 
six A· T stretches of 8 or more base pairs. 98 Of these six, only three are recog-
nized as strong poly-N-methylpyrrolecarboxamide binding sites (table 2.9). The 
three sites not recognized by the pyrrole compounds contain a maximum of two 
consecutive pyrimidines while the three highest affinity sites have a minimum 
of 5 consecutive pyrimidines. This is consistent with earlier observations that 
the poly-N-methylpyrrolecarboxamide compounds preferentially bind recogni-
tion sequences of homopyrimidine A·T DNA. 
A comparison of the cleavage at the 3235 and 4325 sites is shown in graph-
ical form in figure 2.30. The site at 3235 contains the longest run of consecutive 
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*This sequence contains 2 runs of ~8bp which do not 
resolve on the agarose gel. 98 
A·T base pairs on pBR322 with 15. The site 4325 contains the second longest 
A·T sequence with 10 base pairs and few purine/pyrimidine switches. Both of 
these sites contain the sequence 5'-ATTTTTA-3'. The entire recognition se-
quence of DE·Fe(II) and P4E·Fe(II) as well as at least six of the seven base pairs 
in P5E·Fe(II)'s binding site have been shown to be included in this region in the 
high resolution gel studies. The 4325 site is found on the 517 bp fragment dis-
cussed earlier. Because the relative cleavage efficiency for DE·Fe(II), P4E·Fe(II), 
and P5E·Fe(II) are similar for both the 3235 and 4325 sites, they may be recog-
nizing the same base sequence at both sites. As the binding site requirement is 
increased to eight base pairs with P6E·Fe(II), the sequence recognized at the two 
sites must be different and experimentally the efficiency of cleavage observed at 
these sites begins to diverge. As the pyrrole chain is further extended, the dif-
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Figure 2.34 Comparison of the double strand cleavage of pBR322 at the 3235 and 4325 sites with DE-Fe(II)-
P9E-Fe(II). Data points represent the fraction of the total cleavage observed for each compound at each site. The 






Further examination of the sequence at the 4325 site shows that each addi-
tional base added to the recognition sequence beyond 5 bp is in an alternating 
purine/pyrimidine arrangment. At the 3235 site, the additional base pairs con-
tain fewer purine/pyrimidine switches. The cleavage efficiency observed for these 
two sites again points to preferential recognition of homopyrimidine A·T regions 
by poly-N -methylpyrrolecarboxamides. 
The cleavage efficiency of the polypyrrole-EDTA compounds at the 3080 site 
shows a maximum at P4E·Fe(II) and a steady decline in cleavage efficiency to 
P9E·Fe(II) (fig. 2.35). The sequence of the 3080 site contains seven consecutive 
adenines, the longest run of polypyrimidine A·T DNA on pBR322. It is the 
most efficiently recognized site on pBR322 for P4E·Fe(II) and is very efficiently 
recognized by P5E·Fe(II) (fig. 2.33). The reason that it is not the most efficiently 
recognized site for P5E·Fe(II), a compound containing 6 amides and binding 7 
bp, may result from the flanking sequences exerting an influence which is not 
accommodating to N-methylpyrrolecarboxamide DNA recognition. 
Time Course. Reaction time course studies with DE·Fe(II), P6E·Fe(II), and 
P9E·Fe(II) were carried out and the results of these studies are shown in graph-
ical form in figure 2.36. The initial rate of cleavage is inversely proportional to 
the number of pyrroles in the molecule. 
There are two mechanisms for double strand cleavage; in which the com-
pound binds to the DNA and undergoes the redox cycle twice cleaving both 
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Figure 2.35 Comparison of the double strand cleavage of pBR322 at the 3080 site with DE-Fe(II)-P9E-Fe(II). 
Data points represent the fraction of the total cleavage observed for each compound at each site. The line is 
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Figure 2.36 A time course study of the cleavage of pBR322 with DE-Fe(II)-P9E-Fe(II). Data points are ratios of 
the cleavage at the indicated time to the cleavage observed at four hours. The lines are provided to emphasize 







is reduced, rebinds and cleaves the opposite strand. It is likely that the bind-
ing constant of the small molecules increases as the number of pyrroles in the 
molecule is increased or at least the kinetics of binding are slower with longer 
pyrrole chains. 61 Because the reaction path is so complicated, nothing quanti-
tative can be said about the specific steps involved in double strand cleavage; 
however, the initial rates of double strand cleavage increase as the number of 
pyrroles in the molecule decreases consistent with the initial rate of cleavage 
being inversely related to the residence time of the molecules on the DNA. 
This result lends credence to the cleavage model which requires the polypyr-
role compound to dissociate from the DNA and be reduced before returning 
to the binding site and cleaving the opposite strand. Inactivation of the poly-
N-methylpyrrolecarboxamide-EDTA compounds may result from attack by the 
DNA cleaving species which could mediate pyrrole oxidation or EDTA degrada-
tion. 
Pre-equilibration. For efficient DNA cleavage with the longer polypyrrole 
compounds, pre-equilibration with DNA is required before the initiation of cleav-
age. Pre-equilibration is typically carried out at 65°C for one hour. To ad-
dress the importance of this step in DNA recognition, the following study with 
P9E·Fe(II) was carried out. P9E·Fe(II) cleavage of radio-labeled pBR322 DNA 
was run as usual except without pre-equilibration with the DNA. In another re-
action, P9E·Fe(II) was equilibrated with unlabeled calf thymus DNA and after 
equilibration, radiolabeled restriction fragment and reducing agent were added. 
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In a third reaction, the DNA was equilibrated without P9E·Fe(II) and after-
wards, P9E·Fe(II) and reducing agent were added. These result were compared 
to the control reaction with all components except reducing agent present in the 
reaction during equilibration and the results are tabulated in table 2.10. 








P9E·Fe(II) added after equilibration 
32P DNA added after equilibration 
Without equilibration, DNA cleavage is inefficient and if the equilibra-
tion is carried out without P9E·Fe(II) the DNA cleavage is also low (table 
2.10). Because both the reaction without equilibration and the reaction without 
P9E·Fe(II) show inefficient cleavage, the increase in cleavage efficiency observed 
upon equilibration is not solely dependent on a change in the DNA with heat-
ing. When the equilibration is carried out without the labeled DNA, cleavage 
is almost as efficient as when it is carried out with the intact reaction mixture. 
This demonstrates that both DNA and P9E·Fe(II) are needed to produce the 
increase in cleavage efficiency seen with equilibration. It also demonstrates that 
the effect is not due to an irreversible or very slowly reversible binding reaction 
between P9E·Fe(II) and the DNA because P9E·Fe(II) can exchange with the 
labeled DNA to produce cleavage which is almost as efficient as that observed 
with the intact reaction mixture. It is suprising that exchange is so facile be-
cause P9E·Fe(II) recognizes 11 bp of the DNA, about one B-form helical turn. 
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To exchange binding sites, P9E·Fe(II) must unwrap itself from one site and not 
only rewrap around another site, but locate an optimal site on DNA and then 
rebind. 
The pre-equilibration effect could be explained by a simple aggregation of 
the compound in solution which is broken up by binding to DNA. UV studies 
with the pyrrole compounds follow Beer's Law demonstrating no indication of 
stacking of the aromatic pyrrole rings in solution. These studies were run over 
the concentration range of about 1-10 J.LM. The DNA cleavage reactions are 
typically run in the range of 0.1-1 J.LM. 
Reorganization of the P9E·Fe(II) upon equilibration with DNA from an 
inactive conformation to one competent to bind DNA is also consistent with 
these results. A study was made of the entire series of compounds, DE·Fe(II)-
P9E·Fe(II), comparing the efficiency of cleavage by each compound with and 
without equilibration. The results of this study are expessed as a ratio of cleavage 
observed without equilibration to cleavage observed with equilibration and are 
shown in graphical form in figure 2.33. An important feature of this graph is that 
there is an almost linear relationship between the increase in cleavage efficiency 
by equilibration and the number of pyrroles in the molecule with P9E·Fe(II) 
showing the greatest effect. This result is consistent with a polypyrrole reorga-
nization dependent on the number of pyrroles in the molecule. 
One conformational change which fits this criteria for the reorganization 
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Figure 2.37 A study of the effect of pre-equilibration of the cleavage of pBR322 with DE-Fe(II)-P9E·Fe(II). Data 
points are ratios of cleavage without pre-equilibration to cleavage with pre-equilibration at 65°C for one hour. 






pyrrole rings. It is known from the X-ray crystal studies of dipyrrole compounds 
that the pyrrole rings do not lie in a plane. 14 • 15 This non-planarity gives the 
molecule a helical twist. B-form DNA is right-handed, so for recognition of 
DNA, the polypyrrole molecule must also adopt a right-handed conformation. 
If the angle between the pyrrole rings is in equilibrium, it is likely that the right 
or left handedness of the twist between any two pyrrole rings will be random. 
DNA could serve as a template to align the twist into a right-handed form. 
Alternatively, the DNA may act as a conformational sink binding the compound 
which has adopted the all right-handed conformation, driving the equilibrium in 
that direction. This mechanism requires that the conformational change is slow 
with respect to the rate at which the polypyrrole molecule exchanges between 
DNA molecules. This type of conformational change could explain the effect of 
equilibration on cleavage efficiency for the entire series of compounds because the 
ones with the most pyrroles would have the most angles to align and, therefore, 
would require the greatest reorganization. This model is also consistent with the 
pre-equilibration requirements observed with (P4)3E which are closer to those 
for P4E than what would be expected for compound containing 12-14 pyrroles 
and the observations with BED which behaves like DE. 71 This result establishes 
that it is not the total number of N-methylpyrrolecarboxamides in the molecule 
which dictates the pre-equilibration requirements but the number of contiguous 
pyrroles in each of the subunits suggesting a reorganization of the subunits as 
the limiting factor. 
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These double strand cleavage studies with pBR322 have established that the 
poly-N-methylpyrrolecarboxamide EDTA·Fe(II) compounds are capable of dou-
ble strand cleavage of DNA in the kilobase range to afford a set of discrete DNA 
fr~gments. Preliminary studies with SV 40 provide evidence that this property is 
general for DNA of this size range. In order to acertain whether .the specificities 
of these compounds are great enough to allow them to selectively cleave larger 
DNA substrates, preliminary studies with .A-phage DNA were undertaken . 
.A-phage is a 48,502 bp E. Coli bacteriophage. The reactions were run with 
0.25 J.tg of DNA in 10 J.tL ("'100 J.tM in DNA base pairs). Cleavage reactions 
were run as previously described for the high resolution gels. The reaction 
mixtures were loaded onto a 0.3% nondenaturing agarose gel and electrophoresed 
at 4°C with buffer recirculation. The DNA was stained with ethidium bromide, 
visualized by fluorescence and photographed. The results of this experiment are 
shown in figure 2.38. 
This gel shows a distinct banding pattern with each of the three affinity 
cleaving reagents used in the study: DE·Fe(II), P8E·Fe(II), and BED·Fe(II). 
Increasing the size of the DNA recognition element increases the specific cleavage 
observed as evidenced by the sharpening of the bands in the P8E·Fe(II) lanes as 
compared with DE·Fe(II). It also increases the efficiency with which the DNA 
is cleaved as shown by the lower concentration of P8E·Fe(II) needed to digest 
the DNA. The third compound on this gel is BED·Fe(II), a dimer of two tri-
N-methylpyrrolecarboxamide subunits which will be discussed in chapter 3. .A-
phage DNA contains four stretches of 16 A·T base pairs as well as three longer 
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Figure 2.38 Photograph of a 0.3% non-denaturing agarose gel with .A-phage 
DNA stained with ethidium bromide and visualized by fluorescence. The reac-
tions were 100 J.LM in total DNA base pairs (final concentration). The affinity 
cleaving compounds were allowed to equilibrate with the DNA for two hours at 
65°C. Cleavage was initiated by the addition of DTT to a final concentration of 
5 mM and allowed to proceed for 2 hours at 65°C. 
Lane 1 Molecular weight marker lane containing the products of Xho I digestion 
and Kpn I digestion of .A-phage DNA as well as intact .A-phage DNA. Lane 
2 contains .A-phage cleaved with BED·Fe(II) at 0.07 J.LM. Lane 3 contains .A-
phage cleaved with BED·Fe(II) at 0.14 J.LM. Lane 4 contains .A-phage cleaved 
with P8E·Fe(II) at 0.28 J.LM. Lane 5 contains .A-phage cleaved with P8E·Fe(II) 
at 0.14 J.LM. Lane 6 contains .A-phage cleaved with DE·Fe(II) at 0.45 J.LM. Lane 
7 contains .A-phage cleaved with DE·Fe(II) at 0.28 J.LM. Lane 8 is an intact DNA 
control lane incubated under reaction conditions. 
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stretches of 17, 19, and 23 base pairs. The observed cleavage is consistent with 
scission preferentially, although not exclusively, at these locations. 
It is very suprising tliat DE·Fe(II) produces a banding pattern at all with 
.A-phage DNA. There are 512 unique 5 base pair sequences and even if we assume 
that DE·Fe(II) preferentially recognizes a unique 5 bp sequence it should find 
about 100 such sequences on .A-phage. Cleavage at these sites would result in 
200 bands on the gel since each double strand cleavage event produces two DNA 
fragments. However, the distribution of these sites may not be random. If the 
resolution of the 0.3% agarose gel is ±500 bp, then if 10 high affinity sites occur 
within 500 base pairs the band produced will appear to be 10 times as strong as 
that produced from a 500 bp region containing only one high affinity site. 
This points out another means for increasing the apparent specificity of 
the affinity cleaving compounds. Statistically, they will preferentially cleave 
the DNA in regions with a high concentration of binding sites causing their 
specificity to be greater than would be predicted from their recognition sequence 
alone. There is also evidence from biophysical studies for allosteric binding of 
poly-N-methylpyrrolecarboxamide compounds to DNA.33 • 34• 51 • 99 Cooperative 
binding could enhance the binding affinity of the affinity cleaving compounds 
for regions with clusters of recognition sequences. 
In practice this means that poly-N-methylpyrrolecarboxamide-EDTA·Fe(II) 
compounds may be capable of cleaving very large DNA on the order of chromo-
somes. One of the limiting factors in using the largest of the pyrrole compounds 
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with large DNA was that they had to be pre-equilibrated with the DNA at 65° C. 
These conditions are too rigorous for chromosomal DNA. The pre-equilibration 
studies with pBR322 suggest that it will be possible to equilibrate the affinity 
cleaving molecules with a smaller DNA and add that mixture to the large DNA. 
This would allow the entire reaction sequence to be carried out without ever 
raising the temperature of the chromosomal DNA above 37°C. The studies with 
A-phage DNA suggest that these compounds may have the specificity required to 
cleave chromosomal DNA into discrete bands, preferentially cleaving in regions 
with a large number of recognition sequences. Cleavage of chromosomal DNA in 
A ·T regions may be useful because enhancer and promoter regions which occur 
just before genes have been shown to be very A·T rich. 
Summary. These studies have involved the synthesis and characterization 
of two series of poly-N-methylpyrrolecarboxamide molecules, one with EDTA 
attached and another with acetamide, where the number of contiguous N-
methylpyrrolecarboxamide units has been incrementally increased. The effect 
of this incremental change on DNA recognition has been investigated at base 
pair resolution by both affinity cleaving and MPE·Fe(II) footprinting tech-
niques. It was found that each incremental increase in the number of N-
methylpyrrolecarboxamides in a molecule results in an increase the binding site 
size of one base pair. This observation led to a quantitative relationship between 
the number of amides in the molecule and the binding site size. This relationship 
is called the n + -1 rule and it states that a poly-N-methylpyrrolecarboxamide 
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molecule with n amides will bind n + 1 base pairs of DNA. This is consistent 
with the carboxamides of these compounds forming three center bridging hy-
drogen bonds between adjacent base pairs on opposite strands of the helix. The 
poly-N-methylpyrrolecarboxamide recognition element was found to prefe!"en-
tially bind poly dA ·poly dT stretches; however, both binding site selection and 
orientation were found to be effected by flanking sequences. Using the affinity 
cleaving compounds on large pieces of DNA, it was demonstrated that increasing 
the binding site size increases the DNA binding specificity. Experiments with 
oX-phage DNA have shown that these compounds have the specificity required 
to efficiently cleave DNA into discrete bands at the 50 kb level and suggest that 




Oligomers of Poly-N-methylpyrrolecarboxamide Compounds 
-116-
The studies with the poly-N-methylpyrrolecarboxamide compounds have 
shown that increasing the number of contiguous pyrrole units in a molecule 
increases its DNA binding specificity. The number of N-methylpyrrolecarbox-
amides in a molecule may also be increased by oligpmerizing polypyrrole sub-
units. The approach could be generalized to include the coupling of base-specific 
recognition elements of similar or diverse base pair specificities. With this strat-
egy it could be possible to design molecules which are capable of recognizing 
DNA of any sequence. 
Bisnetropsin derivatives linked in both a parallel and anti-parallel orien-
tation have been reported.62 • 100 The tail-to-tail anti-parallel dimers employed 
hydrocarbon diacid linkers containing 4, 6, 8, or 12 carbons which were attached 
to the netropsin subunits through glycine residues. The interaction of the dimers 
with DNA was measured by circular dicroism (CD) . From these studies, the au-
thors concluded that both ends of the dimers interacted with the DNA. The 
binding site sizes observed by CD titration were: netropsin 5 bp; C4 linker 7 bp; 
Ca linker 10 bp; Cs linker 10 bp, and C12 linker 11 bp. Comparison of satu-
ration binding studies with poly(dA)·poly(dT) and calf thymus DNA indicated 
that the dimers bound the DNA more specifically that the monomer, netropsin. 
The dimers were also found to bind the DNA more strongly through competitive 
binding between the C8 dimer and a flourescent netropsin analog. This study 
concluded that the binding constant of the Cs dimer was at least 2 orders of 
magnitude greater than that of the netropsin monomer (5x106 ) . 
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Schultz and Dervan prepared an affinity cleaving bisdistamycin compound. 101 
This molecule, bis(EDTA-distamycin) (BED), was a tail-to-tail dimer ofED·Fe(II) 
which utilized a flexible linking element, heptanedioic acid. BED·Fe(II) was 
found to efficiently cleave supercoiled pBR322 at nanomolar concentration, al-
most three orders of magnitude lower than the monomer ED·Fe(II). High res-
olution gel studies revealed both monomeric and dimeric binding sites. This 
demonstrated that for BED·Fe(II) monomeric binding was competitive with 
dimeric binding. Recent footprinting studies with the bisnetropsin dimers indi-
cate that these molecules also bind DNA in monomeric as well as dimeric binding 
modes. 102 
BEDF·Fe(II). In an effort to overcome the problem of competing monomeric 
and dimeric binding modes with bis-N-methylpyrrolecarboxamide compounds, 
the linking element was redesigned. Important considerations for both the 
linking and recognition elements are that they must be compatible with the 
same groove (e.g., minor or major) and conformational state (e.g., B, A, 
Z) of the DNA. Fumaramide was chosen to link two ED subunits because 
it is more rigid than heptanedioic acid and can more closely mimic the N-
methylpyrrolecarboxamide in size and shape (fig. 3.1). This dimerization created 
the sequence-specific DNA binding molecule bis(EDTA-distamycin)fumaramide 
31 (BEDF) (fig. 3.2). 103 
Synthesis. The tripyrrole nitro amine 32 is available from the tripyrrole nitro 
acid 21 using a procedure reported_ by Schultz (scheme 3.1).71 • 101 The primary 
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Figure 3.1 Circles with two dots represent lone pairs of electrons on N3 of 
adenine and 02 of thymine at the edges of the base pairs on the floor of the minor 
groove of the right-handed E-DNA helix. Dotted lines are bridged hydrogen 
bonds to the amide NHs. (Left) Model of N-methylpyrrolecarboxamide binding 
two base pairs in the minor groove at A·T DNA. (Right) Model of fumaramide 
binding two base pairs in the minor groove of A·T DNA. 
amine on 32 was protected as the tert-butyl carbamate with di-tert-butyl di-
carbonate. The terminal nitro group of the t-boc tripyrrole compound 33 was 
hydrogenated under atmospheric pressure and the resulting amine was dimerized 
on fumaric acid using dicyclohexylcarbodiimide and N-hydroxybenzotriazole as 
the coupling reagents to afford the t-boc protected dimer 34. Deprotection of 
the primary amines with anhydrous TFA/CH2 Cl2 (1:2) followed by acylation 
with the imidazolide of EDTA triethyl ester afforded BEDF-hexaethyl ester 35. 
The ethyl ester groups were removed by hydrolysis with lithium hydroxide to 
yield the final compound, BEDF 31. 
DNA recognition by BEDF·Fe(II) was examined on two 32 P-endlabeled re-
striction fragments from plasmid pBR322: the 167 bp fragment, EcoR I-Rsa I 















R: Et (35) , H (31) 
Scheme 3.1 Synthesis of BEDF 
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(1-167); and the 517 bp fragment, EcoR l-Rsa I (4363-3847). For comparison 
the hepta-N-methylpyrrolecarboxamide-EDTA compound P7E·Fe(II) was also 
studied. Subsequent work optimized equilibration and reaction conditions for 
BEDF·Fe(II) making cleavage more efficient. Cleavage of the 517 bp fragment 
by BEDF·Fe(II) under the optimized condition is also presented. The cleavage 
reactions were carried out as described earlier and the final reaction conditions 
and concentrations are given in the figure legends. 
167 bp Fragment. This fragment shows a complex cleavage pattern for 
BEDF·Fe(II) at the sequence 5'-GTTAAATTGCTA-3' (base pairs 55-66 on 
pBR322). Analysis of the pattern is consistent with two overlapping binding 
sites {fig. 3.8). These two sites are assigned sizes of 8 and 9 base pairs, respec-
tively. For P7E·Fe{II), one clearly resolved 9 bp binding site at the sequence 
5'-AAGCTTTAA-3' (base pairs 29-37 on pBR322) is observed. A second bind-
ing site for P7E·Fe{II) is also seen in the same region as the overlapping binding 
sites for BEDF·Fe{II). This cleavage is interpreted as a single 9 bp binding site. 
517 bp Fragment. Two binding sites were observed for BEDF·Fe(II) on this 
fragment, 5'-ATTTTTATA-3' and 5'-ATAATAAT-3' (base pairs 4330-4322 
and 4308-4301 on pBR322, respectively). The site at base pairs 4330-4322 is the 
stronger of the two and is assigned a binding site size of 9 base pairs. The weaker 
site at base pairs 4308-4301 is assigned a binding site size of 8 bp. P7E·Fe(II) 
has only one binding site in this region and it is assigned a binding site size of 
9 base pairs (base pairs 4330-4322 on pBR322). 
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Figure 3.3 Autoradiogram of high resolution denaturing gel electrophoresis 
of 32P-endlabeled 167 bp pBR322 restriction fragment (EcoR l-Rsa I). There-
actions were 100 J.LM in total DNA base pairs (final concentration). The iron 
chelates of the compounds were allowed to equilibrate with the DNA for one hour 
at 25°C. Cleavage was initiated by the addition of DTT, to a final concentration 
of 5 m.M, and allowed to proceed one hour at 25°C. 
Odd numbered lanes are 5'-endlabeled DNA. Even numbered lanes are 3'-
endlabeled DNA. Lanes 1 and 2 are intact DNA control lanes after incubation 
under reaction conditions. Lanes 3 and 4 are chemical sequencing lanes con-
taining the products of Maxam-Gilbert G reactions. Lanes 5 and 6 are DNA 
cleavage reactions with BEDF·Fe(II) at 2.5 J,LM; Lanes 7 and 8 are DNA cleavage 
reactions with P7E·Fe(II) at 6.6 J.LM. 
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3~GCTATTCGAAATTACGCCATCAAATAGT~TCAATTTAA~GATTGCGTCAGT-5 
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Figure 3.4 Histograms of the DNA cleavage patterns for BEDF·Fe(II) and 
P7E·Fe(II) on the 167 bp restriction fragment from pBR322. Arrows represent -
the amount of cleavage resulting in the removal of the indicated base. Boxes 
define binding site location and size based on the asymmetric cleavage model. 
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Figure 3.5 Autoradiogram of high resolution denaturing gel electrophoresis 
of 32P-endlabeled 517 bp pBR322 restriction fragment (EcoR I-Rsa I). There-
actions were 100 ttM in total DNA base pairs (final concentration). The iron 
chelates of the compounds were allowed to equilibrate with the DNA for one hm.1r 
at 25°C. Cleavage was initiated by the addition of DTT, to a final concentration 
of 5 mM, and allowed to proceed one hour at 25°C. 
Odd numbered lanes are 51-endlabeled DNA. Even numbered lanes are 3'-
endlabeled DNA. Lanes 1 and 2 are intact DNA control lanes after incubation 
under reaction conditions. Lanes 3 and 4 are chemical sequencing lanes con-
taining the products of Maxam-Gilbert G reactions. Lanes 5 and 6 are DNA 
cleavage reactions with BEDF·Fe(II) at 2.5 ttM; Lanes 7 and 8 are DNA cleavage 
reactions with P7E·Fe(II) at 6.6 ttM. 
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Figure 3.5 Histograms of the DNA cleavage patterns for BEDF·Fe(II) and 
P7E·Fe(II) on the 517bp restriction fragment from pBR322. Arrows represent 
the amount of cleavage resulting in the removal of the indicated base. Boxes 
define binding site location and size based on the asymmetric cleavage model. 
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Figure 3.6 Autoradiogram of high resolution denaturing gel electrophoresis 
of 32P-endlabeled 517 bp pBR322 restriction fragment (EcoR I-Rsa I) utilizing 
optimized BEDF·Fe(II) cleaving conditions. The reactions were 100 JLM in to-
tal DNA base pairs (final concentration). The iron chelates of the compounds 
were allowed to equilibrate with the DNA for two hours at 37°C. Cleavage was 
initiated by the addition of DTT, to a final concentration of 5 mM, and allowed 
to proceed two hours at 37°C. 
Odd numbered lanes are 5'-endlabeled DNA. Even numbered lanes are 3'-
endlabeled DNA. Lanes 1 and 2 are intact DNA control lanes after incubation 
under reaction conditions. Lanes 3 and 4 are chemical sequencing lanes con-
taining the products of Maxam-Gilbert G reactions. Lanes 5 and 6 are DNA 
cleavage reactions with BEDF·Fe(II) at 1.5 JLM; Lanes 7 and 8 are DNA cleavage 
reactions with BEDF·Fe(IT) at 0.5 JLM. 
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Figure 3.7 Histograms of the DNA cleavage patterns for BEDF.Fe(II) under optimized cleavage conditions on 
the 517 bp restriction fragment from pBR322. Arrows represent the amount of cleavage resulting in the removal 
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32p5,- AT AA GC TTT A AT G c G G T A GTT T A TC AC A G TTIAAA TT G c T 11A c GC AG T c A-3' 
3- TA TTCGAAA TTACGCCA TCAAA TAGTGrrrnr AArr TTrG TC AG T-5' 
Fig. 3.8 (above) Histogram of the cleavage pattern for BEDF ·F~(II) on the 
167bp fragment (EcoR I- Rsa I, 1-167) from pBR322. (center, below) Histograms 
of the cleavage components used to assign each of the overlapping binding sites. 
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Subsequent work with BEDF·Fe(II) found that equilibration at 37°C for 2 
hours followed by reaction at 37°C for 2 hours resulted in increased cleavage 
efficiency. Comparison of BEDF·Fe(II) cleavage under both the original and op-
timized reaction conditions on the 517 bp fragment results in the same binding 
sites and sizes (fig. 3.6 and fig. 3.8). This is consistent with the optimized condi-
tions simply increasing the percentage of BEDF·Fe(II) that binds productively 
without changing either site selection or relative binding affinities. 
Binding Site Size. From the studies with the homologous series of polypyrroles 
a relationship between the number of carboxamides· and binding site size was 
determined. This rule states that a poly-N-methylpyrrolecarboxamide molecule 
containing n amides will bind n + 1 base pairs of DNA. Both BEDF·Fe(II) and 
P7E·Fe(II) contain 8 amides and therefore would be predicted to have binding 
site sizes of 9 base pairs. Each of the binding sites for P7E·Fe(II) are nine base 
pairs as calculated. BEDF·Fe(II) was assigned two 9 base pair binding sites and 
two 8 base pair binding sites (table 3.1). Importantly, no five base pair binding 
sites were observed as in the case of BED·Fe(II). This demonstrates that the 
incorporation of a rigid fumaramide linking element into an ED·Fe(II) dimer 
produces a molecule which binds the DNA exclusively in a dimeric mode. 
Interestingly, both eight and nine base pair binding sites for BEDF·Fe(II) 
were observed. This may be due to the inability to assign the binding site 
boundaries exactly based on the asymmetric cleavage model described earlier. 
The element linking the EDTA to the polypyrrole subunit is different than in the 
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Table 3.1: Observed BEDF·Fe(II) and P7E·Fe(II) binding sites on the 


























homologous series of compounds containing 3-9 N-methylpyrrolecarboxamide 
units. This results in subtle differences in the cleavage patterns. Binding site 
assignment in the homologous series of compounds is simplified because it is 
possible to look for incremental changes between two consecutive members of 
the series. A second explanation for the eight and nine base pair binding site 
sizes is that there are different conformations for the fumaramide linking element. 
This could result in two different binding site sizes. The fumaramide linker was 
chosen because of its ability to adopt an s-trans, s-cis conformation similar in size 
and shape to an N -methylpyrrolecarboxamide, but this may not be the lowest 
energy conformation for fumaramide. If the fumaramide linking element adopted 
the s-trans, s-trans conformation, CPK models indicate that the polypyrrole 
compound would have a sharp kink which could decrease the binding site size 
by one base pair. 
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DNA Recognition. DNA is recognized by BEDF·Fe(II) and P7E·Fe(II) simi-
larly as would be expected for two octaamide pyrrole compounds. Each of the 
affinity cleaving compounds recognizes the same region strongly on each of the 
restriction fragments; however, the weaker binding sites are different in each case. 
P7E·Fe(II) contains a string of seven consecutive N -methylpyrrolecarboxamide 
residues causing all of the DNA recognition elements to have the same orienta-
tion (fig. 3.2). BEDF·Fe(II) is a tail-to-tail dimer on fumarate. This causes the 
three pyrroles of one subunit to have an orientation opposite that of the other 
subunit producing a a molecule with an approximate 2-fold symmetry. Possibly, 
the differences in DNA recognition result from the differences in pyrrole orienta-
tion between the two molecules. However, as discussed earlier, the fumaramide 
linking element also has other conformations available to it and these alternate 
conformations may be influencing binding site selection. 
Large DNA. The high resolution denaturing gel studies show a difference in 
DNA recognition by P7E·Fe(II) and BEDF·Fe(II). The amount of information 
available from the experiments on restriction fragments is limited by the small 
number of unique DNA sequences which they contain. In order to better com-
pare the specificities of these two molecules, double strand cleavage experiments 
were carried out on intact linearized pBR322. BED·Fe(II) was included in these 
studies to compare the complete series of octaamide compounds. Cleavage re-
actions were carried out as described earlier and final concentration, conditions 
and reaction times are given in the gel figure legends. 
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Figure 3.10 Autoradiogram of a 1% non-denaturing agarose gel with 32 P-
endlabeled pBR322 labeled at both ends of the Sty I site. The reactions were 
100 JLM in total DNA base pairs (final concentration). The iron chelates of the 
compounds were allowed to equilibrate with the DNA for one hour at 65°C. 
Cleavage was initiated by the addition of DTT to a final concentration of 5 mM 
and allowed to proceed for 2 hours at 37°C. 
Lane 1 is an intact DNA control lane incubated under reaction conditions. Lane 
2 contains the molecular weight marker standards. Lane 3 is a DNA cleavage 
reaction with P7E·Fe(II) at 0.8 JLM; Lane 4 is a DNA cleavage reaction with 
BEDF·Fe(II) at 0.2 JLM; Lane 5 is a DNA cleavage reaction with BED·Fe(II) at 
0.2 JLM; Lane 6 is a DNA cleavage reaction with BED·Fe(II) at 0.4 JLM. 
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Figure 3.11 Histogram analysis of the double strand cleavage of pBR322 by BEDF-Fe(II), P7E-Fe(II), and 
BED -Fe(II) from figure 3.10. Arrows represent the amount of cleavage produced at each site. 
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Each of the molecules produces a discrete banding pattern·. These patterns 
were quantitated and converted into histogram form (fig. 3.11). The binding site 
assignments were based on the assignments for P7E·Fe(ll) described earlier. Two 
regions on pBR322 are cleaved by all of the octaamide compounds. One site con-
tains the longest run of A·T DNA on pBR322 with 15 consecutive A·T residues 
(3235 on pBR322). The other is a sequence containing a stretch of nine con-
secutive A·T residues with only one base interupting the run of polypyrimidines 
(4245 on pBR322). The two additional cleavage sites observed with BEDF·Fe(ll) 
and P7E·Fe(II) include the longest polypyrimidine run of consecutive A·T base 
pairs on pBR322, seven at 3080, and the second longest tun of A·T DNA on 
pBR322, ten base pairs at 4325. Importantly, the sites on the 167 bp fragment 
do not show up in this assay. This means that while the sites observed on the 
167 bp fragment are strong with respect to other sites on that fragment, they 
are weak compared to these sites. 
Table 3.2: Binding Sites for the Octaamide Compounds on pBR322 
Site Sequence P7E BEDF BED 
3080 GGTGGTTTTTTTGTTTGCAA M M 
3235 GATCCTTTTAAATTAAAAAT s s s 
4245 TGTATTTAGAAAAATAAACA M M w 
4325 TTAACCTATAAAAATAGGCG M w 
S strong; M moderate; W weak. 
The strong similarity in the cleavage patterns between P7E·Fe(II) and 
BEDF·Fe(II) demonstrates that the N-methylpyrrolecarboxamide can be effi.-
ciently replaced by a structurally simpler linking element to produce a molecule 
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which maintains the sequence specificity of a poly-N-methylpyrrolecarboxamide. 
Because the same sites are cleaved by both molecules, it suggests that amide 
orientation is not important for the recognition of the highest affinity sites. 
In these experiments, P7E·Fe(II) was used at 0.8 J.LM and both BED·Fe(II) 
and BEDF·Fe(II) were used at 0.2 J.LM . These concentrations were chosen be-
cause they produce approximately the same amount of cleavage at the high-
est affinity site. The higher cleavage efficiency observed with BED·Fe(II) and 
BEDF·Fe(II) may be due to a higher affinity for these compounds to the DNA. 
The higher affinity could arise from the linking elements permitting the poly-N-
methylpyrrolecarboxamide subunits to more closely match the DNA recognition 
pattern. An alternative explanation for the higher cleavage efficiency is that 
the incorporation of two EDTA·Fe(II) cleaving functionalities into the dimers 
increases the likelihood of double strand cleavage in a single binding event and 
thereby makes double strand cleavage more efficient. 
Specificity. These results show that BED·Fe(II) is much more specific than 
either P7E·Fe(II) or BEDF·Fe(II) in the double strand cleavage assay and 
that specificity decreases in the series of octaamide compounds BED·Fe(II) ~ 
BEDF·Fe(II) 2: P7E·Fe(II). This was an unexpected result because the high reso-
lution gel studies with BED·Fe(II) showed both monomeric and dimeric binding; 
this should produce lower sequence specificity than dimeric binding alone. Map-
ping the cleavage sites for BED·Fe(II) from the double strand studies shows that 
none of the sites studied in the high resolution work were observed in the double 
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strand assay and; therefore, they were ·not BED·Fe(II)'s highest affinity sites. 
This is consistent with monomeric binding as a weaker binding mode which is 
not employed by BED·Fe(II) at its highest affinity sites. 
BEDF·Fe(II) and P7E·Fe(II) are two octaamides which recognize the same 
sites on pBR322 with approximately the same affinities while using different 
poly-N-methylpyrrolecarboxamide orientations. BED·Fe(II) is also a poly-N-
methylpyrrolecarboxamide compound similar in structure to BEDF·Fe(II); how-
ever, it is more specific in its cleavage of pBR322 than either of the other oc-
taamide compounds. This increase in specificity may result from the flexibility 
that the heptanedioic acid linking element provides BED·Fe(II). 
P7E·Fe(II) and BEDF·Fe(II) are rigid molecules which require simultaneous 
recognition of the DNA by all of their amides. Furthermore, all of the amides 
are rigidly set at fixed distances. Therefore, BEDF·Fe(II) and P7E·Fe(II) have 
very little freedom in the way they align their amides with the DNA base pairs. 
Because heptanedioic acid is a long flexible tether and monomeric binding has 
been documented for BED·Fe(II), it can be assumed that heptanedioic acid is 
a long enough linker to allow independent recognition of the DNA by the two 
tripyrrole subunits. This provides BED·Fe(II) with a large degree of freedom 
in the spacing between the two polypyrrole subunits. Biophysical studies have 
shown that polypyrrole compounds alter DNA structure and have provided ev-
idence of cooperative binding.33 • 34• 51 • 99 BED·Fe(II) has the flexibility for one 
subunit to bind and alter the DNA conformation and allow the second subunit 
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to make adjustments and bind cooperatively. This binding mechanism superim-
poses the effects of cooperativity and anti-cooperativity on the normal sequence 
specificity of the tri-N -methylpyrrolecarboxamide monomers, amplifying the dif-
ferences in binding energy. for different sites. P7E·Fe(II) and BEDF·Fe(II) with 
their rigid structures and fixed amide distances probably do not have the flexi-
bility required for cooperative DNA recognition. The increased specificity in the 
series of the poly-N -methylpyrrolecarboxamide octaamides could result from 
the flexible linking element in BED·Fe(II) allowing its two subunits to bind to 
DNA independently with allostery while the rigid structure of P7E·Fe(II) and 
BEDF·Fe(II) precludes this type of interaction. 
This result presents a new strategy for DNA recognition: oligomerization of 
poly-N-methylpyrrolecarboxamide subunits with flexible tethers. This approach 
would allow the sequence specificity of the individual subunits to be enhanced 
by cooperative binding interactions. By utilizing allosteric binding, this strategy 
in effect makes the specificity of the whole greater than the sum of the parts. 
Recent studies in our group have focused on amino acid linking elements 
for two di-N-methylpyrrolecarboxamide subunits. 104 This work found that {3-
alanine was a more effective tether than either glycine or ')'-amino butyric acid. 
Incorporation of {3-alanine into the dimers resulted in solely dimeric binding 
demonstrating that a rigid linker is not required for dimeric binding. These 




(P4)sE·Fe(II) . . The knowledge that .8-alanine is a flexible amino acid link-
ing element promoting dimeric binding and efficient DNA recognition makes 
possible the design of an oligomer of N-methylpyrrolecarboxamides capable of 
recognizing very long stretches of A·T containing DNA (fig. 3.12). This ap-
proach resulted in a new sequence-specific DNA binding molecule, tris(tetra-N-
methylpyrrolecarboxamide)bis(.B-alaninyl)-EDTA 36 ((P4)sE) (fig. 3.13) . This 
pentadecaamide contains three tetra-N-methylpyrrolecarboxamide subunits cou-
pled by .3-alanine and according to "the n + 1 rule should bind 16 base pairs of 
DNA. Attachment of EDTA to the amino terminus of the trimer allows the use 
of the affinity cleaving method to determine the binding site size and sequence 
through analysis of cleavage patterns on 32P-endlabeled DNA restriction frag-
ments. As a point of reference, the frequency at which a 16 A·T base pair stretch 
occurs is equivalent to that of a unique 8 base pair site (table 2.6) . Consequently, 
molecules of this type may have the specificity needed to operate on very large 
DNA. 
Synthesis. The synthesis of (P4)sE employed a highly convergent synthetic 
route utilizing tetra-N-methylpyrrolecarboxamide nitro ester 37 as the common 
intermediate for all three tetra-N-methylpyrrolecarboxamide subunits (scheme 
3.2). As described previously, tetra-N-methylpyrrolecarboxamide nitro ester 37 
can be converted to tetra-N-methylpyrrolecarboxamide nitro dimethyl amine 
38. Reduction of the terminal nitro group followed by acylation vvith the 
imidazolide of t-boc .8-alanine 39 afforded tetra-N-methylpyrrolecarboxamide 
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Figure 3.12 Model for ,a-alanine linked trimer recognition of double helical DNA. 
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dimethyl amino t-boc .8-alanine -40. The primary amine was then depro-
tected with TFA in CH2Cl2 to yield tetra-N-methylpyrrolecarboxamide dimethyl 
amino .8-alanine 41. Reduction of the terminal nitro group of tetra-N-
methylpyrrolecarboxamide nitro ester 37 followed by acylation with the imi-
dazolide of t-boc .8-alanine produced tetra-N-methylpyrrolecarboxamide methyl 
ester t-boc .8-alanine 42. Hydrolysis of the methyl ester with sodium hydroxide 
afforded tetra-N-methylpyrrolecarboxamide acid t-boc .8-alanine 43. Conden-
sation of tetra-N-methylpyrrolecarboxamide dimethyl amino .8-alanine 41 and 
tetra-N-methylpyrrolecarboxamide acid t-boc .8-alanine 43 using dicyclohexyl-
carbodiimide and N-hydroxybenzotriazole produced the t-boc protected tetra-N-
methylpyrrolecarboxamide .8-alanine dimer 44 which was deprotected with TFA 
in CH2Cl2 to afford tetra-N-methylpyrrolecarboxamide .8-alanine dimer 45. The 
tetra-N-methylpyrrolecarboxamide acid EDTA triethyl ester 24 is available from 
tetra-N-methylpyrrolecarboxamide nitro ester as previously described. Coupling 
24 with the tetra-N-methylpyrrolecarboxamide dimer 45 produced the triethyl 
ester of the final compound, (P4) 3E-3E 46. Hydrolysis of the ethyl esters with 
lithium hydroxide afforded the final compound, (P4}3E 36, a molecule with a 
molecular weight of 2154. 
DNA recognition by (P4}3E was examined by both MPE·Fe(II) footprinting 
and affinity cleaving on a 32P-endlabeled restriction fragments from plasmid 
SV-CAT: a 205 bp fragment, Xba I-H£nd III (5174-129 on SV40 and six base 
pairs of the pUC 18 polylinker region). MPE·Fe(II) footprinting reactions were 
R':t-boc (44), H (45) 
R:Me (37), H (22) 
R:Me (42), H (43) 
R":Et (46), H (36) 
Scheme 3.2 Synthesis of (P4hE 
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carried out ·as described earlier using the indium chelate of (P4)sE. The indium 
chelate was formed by mixing (P4)sE with 2 equivalents of indium(III) chloride. 
Indium has been shown to effectively sequester the EDTA chelator and prevent 
affinity cleaving under redox conditions. 104 The affinity cleaving reactions were 
carried out as described earlier. The final reaction conditions and concentrations 
for both the footprinting and affinity cleaving reactions are given in the figure 
legends. 
Densitometric analysis of the footprinting data for (P4)sE·In(III) is consis-
tent with the occupation a 16 bp stretch of A·T DNA (fig. 3.14, 3.15). Analysis 
of the affinity cleaving data (fig. 3.14, 3.15) reveals two major cleavage loci 
flanking a 16 base pair A·T site. According to the n + 1 rule, a functional 
pentadecaamide should recognize 16 base pairs of DNA. The observation of only 
two cleavage loci with affinity cleaving and the footprinting data demonstrate 
that (P4)sE is binding to the DNA with a single binding mode. These pat-
terns define a 16 bp region of A·T DNA which is assigned as the binding site 
of (P4)sE. The observation of exclusive 16 base pair binding in the absence of 
possible monomeric (6 bp) or dimeric (11 bp) sites demonstrates that the {3-
alanine linker is an efficient replacement for the N-methylpyrrolecarboxamide 
and verifies that a rigid tether is not required to assure simultaneous binding 
of all subunits. N-methylpyrrolecarboxamide compounds are known to bind B-
form DNA in solution. 17• 18• 7 • 20-22 If the (P4)sE-DNA complex is in the B-form, 
then this synthetic organic molecule is recognizing a turn and a half of the DNA 
helix. 
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Figure 3.14 Autoradiogram of high resolution denaturing gel electrophoresis 
of 32 P-endlabeled 205 bp SV-CAT restriction fragment (Xba I-Hind III). The 
reactions were 100 J.LM in total DNA base pairs (final concentration). For the 
affinity cleaving reactions, the (P4)sE·Fe(II) was allowed to equilibrate with the 
DNA for one hour at 65°C. Cleavage was initiated by the addition of DTT 
to a final concentration of 3 mM and allowed to proceed 2 hours at 37°C. For 
the footprinting reactions, the (P4)sE·In(III) was allowed to equilibrate with the 
DNA for one hour at 65°C. Cleavage was initiated by the addition ofMPE·Fe(II) 
at 3 J.LM and DTT to a final concentration of 3 mM and was allowed to proceed 
15 min. at 37°C. 
Odd numbered lanes are 51-labeled DNA. Even numbered lanes are 3'-labeled 
DNA. Lanes 1 and 2 are intact DNA control lanes incubated under reaction con-
ditions. Lanes 3 and 4 are chemical sequencing lanes containing the products 
of Maxam-Gilbert G reactions. Lanes 5 and 6 are MPE·Fe(II) DNA cleav-
age reactions; Lanes 7 and 8 are MPE·Fe(II) DNA cleavage reactions with 
(P4) 3 E ·In(III) at 1 J.LM; Lanes 9 and 10 are MPE·Fe(II) DNA cleavage reactions 
with (P4)3 E·In(III) at 0.3 J,LM; Lanes 11 and 12 are DNA cleavage reactions 
with (P4)sE·Fe(II) at 1 J.LM; Lanes 13 and 14 are DNA cleavage reactions with 
(P4)sE·Fe(II) at 0.3 J.LM. 
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G MPE·Fe(II)/(P4 hE-In(III) (P4 hE·Fe(II) 
1 2 3 4 5 6 7 8 9 10 11 12 13 14 
.__ 
. . 
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32p5'- TCCG CCC A TTCTC CGCC CCA TGGCTG AC 
3'- AG GC G GG T A A GAG GC GG G G T A CC GA CTG 
CAGAGGCCGAGGCCGCCTCGGCCTCTGA~~ 
GTCTCCGGCTCCGGCGGAGCCGGAGACTC-~ 
!llll !l !J 
32p5'- TC CG C CCA TTCTC CG CCC CA TGG CTG ACT A A TTTTTTTT A TTT AT C A G A GG CC GAG G CC GC C TC G GCC TC TGA G-3' 
3CAGGCGGGTAAGAGGCGGGGTACCG'fff'TTAAAAAAAATAAATAI''CTCCGGCTCCGGCGGAGCCGGAGACT~· 
Figure 3.15 (Upper) Histograms of the MPE-Fe(II) DNA cleavage inhibition patterns for (P4hE-In(III) on the 205 
bp SV-C.AT fragment. Bars represent the amount of MPE-Fe(II) cleavage inhibition produced by (P4}3E-In(III). 
Boxes define binding site location and size. (Lower) Histograms of the DNA cleavage patterns for (P4}3E-Fe(II) on 
the 205 bp SV-CAT fragment. Arrows represent the amount of cleavage resulting in the removal of the indicated 
base. Boxes define binding site location and size based on the asymmetric cleavage model. 
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Large DNA. The high resolution studies have demonstrated that (P4)sE·Fe(II) 
recognizes a 16 bp binding site as predicted by the n + 1 rule. No evidence of 
competing monomeric or dimeric binding modes was observed on this restriction 
fragment. To determine whether this specificity can be extended to the cleavage 
of large pieces of DNA, double strand cleavage experiments were carried out on 
the SV-CAT plasmid. This plasmid was chosen because it includes base pairs 
5174-129 of SV40. This region contains the 17 bp run of A·T DNA studied in the 
high resolution assays and the plasmid itself has another 18 bp run of consecutive 
A·T DNA ensuring that there are high affinity sites for (P4)sE·Fe(II) on the 
plasmid. Cleavage reactions were carried out as described earlier for double 
strand cleavage and final concentration, conditions, and reaction times are given 
in the gel figure legends. 
By inspection, it is apparent that P9E·Fe(II) digestion of SV-CAT (fig. 3.16 
lanes 3 and 4, 6 and 7) produces far fewer bands that (P4)sE·Fe(II) (fig. 3.16 
lanes 5, 8). This contradicts the expectation that a pentadecaamide should be 
more specific than a decaamide. It indicates that (P4)sE·Fe(II) is recognizing 
DNA either with a low sequence specificity or more likely monomeric and dimeric 
binding modes are interfering with its ability to recognize DNA effectively. 
Reaction conditions were varied over a wide range in an effort to overcome 
the low specificity of double strand cleavage. Pre-equilibration was carried out 
·over a time range of 2-24 hours and a temperature range of 20°C to 90°C. 
Cleavage reactions were run from 1 to 16 hours at temperatures from 20°C 
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Figure 3.16 Photograph of a 1% non-denaturing agarose gel with SV-CAT 
DNA stained with ethidium bromide and visualized by fluorescence. The re-
actions were 100 J.LM in total DNA base pairs (final concentration). The 
(P4) 3 E·Fe(IT) was allowed to equilibrate with the DNA for two hours at 65°C. 
Cleavage was initiated by the addition of DTT to a final concentration of 5 mM 
and allowed to proceed for 2 hours at 65°C. 
Lanes 1-5 contain SV-CAT linearized with BamH I; Lanes 6-10 contain SV-CAT 
linearized with EcoR V; Lanes 1 and 10 are intact DNA control lanes incubated 
under reaction conditions; Lanes 2 and 9 contain the molecular weight marker 
standards; Lanes 3 and 6 are the DNA cleavage reactions with P9E·Fe(II) at 0.1 
J.LM; Lanes 4 and 7 are the DNA cleavage reactions with P9E·Fe(IT) at 0.05 J.LM; 
Lanes 5 and 8 are the DNA cleavage reactions with (P4)sE·Fe(II) at 0.1 J.LM. 
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to 65° C. Because organic solvents have been shown to facilitate triple strand 
formation, 105 reactions were run in 40% ethylene glycol. Finally, different DNA 
substrates, pBR322 and SV40, were used. None of these modifications had any 
appreciable effect on the number of bands which were produced in the reaction. 
In summary, trimerization of tetra-N-methylpyrrolecarboxamide subunits 
with ,8-alanine produces a molecule which is capable of recognizing 16 base pairs 
of A·T DNA, more than a turn and a half of the DNA helix, and, with the attach-
ment of EDTA, is capable of efficient DNA cleavage at these sites. Furthermore, 
this work demonstrates the generality of the N-methylpyrrolecarboxamide as 
an A·T DNA recognition element and the feasibility of linking multiple DNA-
binding subunits together, combining the specificity of the individual subunits 
to produce a molecule of very high sequence specificity. Because double strand 
cleavage experiments showed many more cleavage sites than would be expected, 
the linking element still requires optimization. It may be that a longer linker is 
needed to allow independent binding of the subunits. A longer linking element 
may, as in the case of BED·Fe(II), promote more effective recognition of DNA 
by each of the polypyrrole subunits. 
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Chapter 4 
A Comparison of Three Footprinting Reagents 
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DNA footprinting is a powerful direct method for determining the binding 
sites of proteins and small molecules on heterogeneous DNA.41- 44• 46 • 93 • 10 6 This 
technique is based on a sequence specific DNA binding molecule's ability to pro-
tect an endlabeled DNA fragment from cleavage at its binding site. The binding 
site is visualized as a region of diminished cleavage on an autoradiogram of a high 
resolution denaturing gel (fig. 4.1). The two most commonly used reagents for 
DNA footprinting are the enzyme DNase I and the small molecule MPE·Fe(II); 
however, neither reagent is completely sequence neutral. DNase I cleaves at 
every base, but the amount of cleavage varies greatly from base to base, appar-
ently sensitive to small changes in DNA structure.107 This property can lead 
to large regions of the DNA which are very inefficiently cleaved. Regions with 
low cleavage do not produce a good signal in footprinting experiments, mak-
ing assignment of the exact positions of the binding sites difficult. MPE·Fe(II) 
is a synthetic organic molecule with lower sequence specificity than D N ase I. 
MPE·Fe(II) cleaves DNA significantly at every base, but it cleaves preferentially 
in G·C regions. This results in regions of enhanced and diminished cleavage. 
This uneven baseline also complicates binding site assignment. Conceptually, 
then, the ability to cleave DNA in a completely sequence neutral manner would 
facilitate binding site determination. 
Polyamines are thought to recognize DNA sequence neutrally binding as 
polycations to the polyanionic DNA. 108 • 109 Therefore, attachment of a cleav-
ing functionality to a polyamine may produce a DNA-cleaving polyamine useful 
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Figure 4.1 lllustration of MPE·Fe(II) footprinting on a high resolution dena-
turing gel with native and ligand protected segments of double helical DNA. 
for DNA footprinting. In addition, such a compound should allow the pos-
sible sequence and conformational specificities of polyamines to be studied at 
the nucleotide level. To explore this approach, EDTA was attached to the 
polyamine spermine to produce the bifunctional DNA binding/cleaving molecule 
spermidine-EDTA (SE) (fig. 4.2) . 
Recent work by Tullius has shown that a system containing EDTA·Fe(II) and 
ascorbate produces very even DNA cleavage and can be used to footprint 
proteins. 106 Because EDTA·Fe(II) is negatively charged, it should not bind 
polyanionic DNA.11° Cleavage of DNA then requires remote generation of a 
reactive species which must diffuse to the DNA. MPE·Fe(II) rec~gnizes DNA by 
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intercalating its aromatic methidium residue between the base pairs. SE·Fe(II) 
should bind DNA as a polycation electrostatically attracted to the DNA phos-
phate backbone. To explore the relationship between the way in which the DNA 
cleaving species is delivered to the DNA and the detection of a small molecule's 
binding site, a footprinting comparison of three reagents, MPE·Fe(II), SE·Fe(II), 
and EDTA·Fe(II) was undertaken (fig. 4.2). These compounds are thought to 
cleave DNA via the same reactive species generated from an EDTA·Fe(II) moi-
ety in the presence of 02 and reducing agent but recognize DNA by different 
mechanisms. 
Synthesis of Spermidine-EDTA. The synthesis of spermidine-EDTA 47 was 
carried out as shown in scheme 4.1. EDTA-triethyl ester 16 was activated with 
carbonyl diimidizole and condensed with spermine. The amines were protected 
with t-boc groups using di-tert-butyl dicarbonate and the protected spermidine-
EDTA 48 was isolated by chromatography on silica gel. The ethyl esters were 
removed by treatment with 7 equivalents of lithium hydroxide (2.3 eq./ester) fol-
lowed by t-boc removal with trifiouroacetic acid. Spermidine-EDTA was isolated 
as the TFA salt. 
DNA Cleavage by MPE·Fe(II), SE·Fe(II), and EDTA·Fe(II). The cleav-
age patterns produced by partial digestion of a 517 bp (EcoR I-Rsa I) endlabeled 
fragment from pBR322 with MPE·Fe(II), SE·Fe(II) and EDTA·Fe(II) were ex-
amined by high resolution denaturing gel electrophoresis. The reactions were 
carried out by equilibrating the cleaving agent (1:50, MPE·Fe(II)/bp or 1:2, 
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Figure 4.2 Footprinting reagents (left to right) SE-Fe, MPE-Fe, EDTA-Fe. 
1) EDTA triethyl ester imidazolide 
2) t-BOC anhydride 
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SE·Fe(II) or EDTA·Fe(II)/bp) with the DNA for 15 minutes at 37° C. Cleavage 
was initiated by the addition of reducing agent (3 mM DTT or 1 mM ascorbate, 
final concentration) and the reactions were allowed to continue for 15 minutes 
at 37°C. The reaction mixtures were frozen, lyophilized, and resuspended in 
formamide loading buffer. After heat denaturation, they were run on 8% high 
I 
resolution denaturing polyacrylamide gels. The gels were dried and exposed to 
photographic film to produce the autoradiograms shown in figures 4.3 and 4.4. 
The significant features to note in figure 4.3 lanes 3-5, 14-16 and figure 4.4 lanes 
3-5, 14-16 are the very even cleavage patterns produced by SE·Fe(II) and by 
EDTA·Fe(II) with ascorbate and the regions of enhanced and diminished cleav-
age seen with MPE·Fe(II). These features are quantitated by scanning the gel 
and plotting distance scanned versus absorbance. The densitometry traces for 
figure 4.3 lanes 14-16 and 20-11 are shown in figure 4.5. Traces B and C show the 
very even cleavage pattern seen with SE·Fe(II) and EDTA·Fe(II) respectively. 
Trace A demonstrates the uneven cleavage pattern seen with MPE·Fe(II). It is 
also important to note the lack of cleavage seen with EDTA·Fe(II) and DTT 
(fig. 4.4 lane 5, 8, 11, 16, 19 22). 
Foot printing P 5. The footprinting reactions were run by equilibrating the 
DNA with an appropriate concentration of P5 (see fig. 4.3 and 4.4 for final P5 
concentrations) for 1 h at 37°C. The cleavage reactions were carried out as de-
scribed above. The addition of P5 produces regions of diminished cleavage. The 
assigned P 5 binding sites and cleavage inhibition patterns for both concentra-
tions of P5 are shown in histogram form (fig. 4.6) and a table of P5 binding 
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Figure 4.3 Autoradiogram of high resolution denaturing gel electrophoresis of 
32P-endlabeled 517 bp pBR322 restriction fragment (EcoR l-Rsa I). The reac-
tions were 100 J.tM in DNA base pairs (final concentration). In the footprinting 
. 
lanes, P5 was allowed to equilibrate with the DNA one hour at 37°C. MPE·Fe(II) 
was then allowed to equilibrate with the DNA for 15 minutes. Cleavage was ini-
tiated by th~ addition of sodium acrobate to a final concentration of 1 mM and 
allowed to proceed for 15 minutes at 37°C. 
Lanes 1-11 contain 5'-endlabeled DNA. Lanes 12-22 contain 3'-endlabeled DNA. 
Lanes 1 and 12 are intact DNA control lanes after incubat1on under reaction 
conditions. Lanes 2 and 13 are chemical sequencing lanes containing the prod-
ucts of Maxam-Gilbert G reactions. Lanes 3, 6, 9, 14, 17, and 20 contain 1:50 
MPE·Fe(II)/bp. Lanes 4, 7, 10, 15, 18, and 21 contain 1:2 SE·Fe(II)/bp. Lanes 
5, 8, 11, 16, 19, and 22 contain 1:2 EDTA·Fe(II)/bp . Lanes 6-8 and 17-19 contain 
1:30 P5/bp. Lanes 9-11 and 20-22 contain 1:2 P5/bp. 
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Figure 4.4 Autoradiogram of high resolution denaturing gel electrophoresis of 
32P-endlabeled 517 bp pBR322 restriction fragment (EcoR I-Rsa I). The reac-
tions were 100 J.LM in DNA base pairs (final concentration). In the footprinting 
lanes, P5 was allowed to equilibrate with the DNA one hour at 37°C. MPE·Fe(II) 
was then allowed to equilibrate with the DNA for 15 minutes. Cleavage was ini-
tiated by the addition of dithiothreitol to a final concentration of 3 mM and 
allowed to proceed for 15 minutes at 37°C. 
Lanes 1-11 contain 51-endlabeled DNA. Lanes 12-22 contain 3'-endlabeled DNA. 
Lanes 1 and 12 are intact DNA control lanes after incubation under reaction 
conditions. Lanes 2 and 13 are chemical sequencing lanes containing the prod-
ucts of Maxam-Gilbert G reactions. Lanes 3, 6, 9, 14, 17, and 20 contain 1:50 
MPE·Fe(II)/bp. Lanes 4, 7, 10, 15, 18, and 21 contain 1:2 SE·Fe(II)/bp. Lanes 
5, 8, 11, 16, 19, and 22 contain 1:2 EDTA·Fe(II)/bp. Lanes 6-8 and 17-19 contain 
1:30 P5/bp. Lanes 9-11 and 20-22 contain 1:2 P5/bp. 
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Figure 4.5 Densitometry plots of distance scanned versus absorbance for the autoradiogram shown in figure 4.3. 
{A) Trace of MPKFe(II) control {fig. 4.3 lane 14). {B) Trace of SE·Fe(II) control (fig. 4.3 lane 15). (C) Trace of 
EDTA-Fe(II) control {fig. 4.3 lane 16). {D) Trace of MPE·Fe{II) footprinting of P5 (1:2) (fig. 4.3 lane 20). (E) 
Trace of SKFe(II) footprinting of P5 (1:2) {fig. 4.3 lane 21). (F) Trace of EDTA-Fe(II) footprinting of P5 {1:2) 
























Figure 4.6 Histograms showing binding sites derived from P5 footprinting. Bars indicate cleavage inhibition and 
asterisks indicate cleavage enhancement. Boxes indicate binding site and size. (A) MPE-Fe(II) footprinting with 
1:30 P5/bp. (B) EDTA-Fe(II) and SE-Fe(II) footprinting with 1:30 P5/bp. (C) MPE-Fe(II) footprinting with 1:2 
P5/bp. (D) EDTA-Fe(II) and SE-Fe(II) footprinting with 1:2 P5/bp. 
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Figure 4.7 Autoradiogram of high resolution denaturing gel electrophoresis of 
32P-endlabeled 517 bp pBR322 restriction fragment ( EcoR I-Rsa I). The reac-
tions were 100 JLM in DNA base pairs (final concentration). In the foot printing 
lanes, P5 was allowed to equilibrate with the DNA one hour at 37°C. MPE·Fe(II) 
was then allowed to equilibrate with the DNA for 15 minutes at 37°C. There-
actions were cooled to 0°C and cleavage was initiated by the addition of dithio-
threitol to a final concentration of 3 mM. 
Lanes 1-10 contain 3'-endlabeled DNA. Lane 1 is an intact DNA control lane 
after incubation under reaction conditions at 37°C. Lane 2 is a chemical se-
quencing lane containing the products of Maxam-Gilbert G reactions. Lanes 
3-10 contain 1:50 MPE·Fe(II)/bp. Lanes 4, 6, 8, and 10 contain 1:2 P5/bp. 
Lanes 3 and 4 are cleavage at 4°C for 4 hours. Lanes 5 and 6 are cleavage at 
20°C for 1 hour. Lanes 7 and 8 are cleavage at 37°C for 15 minutes. Lanes 9 
and 10 are cleavage at 55°C for 5 minutes. 
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Figure 4.8 Densitometry plots of distance scanned versus absorbance for the 
autoradiogram shown in figure 4.7. (A) Trace of MPE·Fe(II) footprinting of P5 
(1:2) at 4°C (fig. 4.7 lane 4). (B) Trace of MPE·Fe(II) footprinting of P5 (1:2) 
at 20°C (fig. 4.7 lane 6). (C) Trace of MPE·Fe(II) footprinting of P5 (1:2) at 
37°C (fig. 4.7 lane 8). (D) Trace of MPE·Fe(II) footprinting of P5 (1:2) at 55° C 
(fig. 4.7 lane 10). 
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sites is given in table 4.1. With a P5:bp ratio of 1:2, extensive DNA cleavage 
is observed in three regions with MPE·Fe(II). Examination of the densitometry 
(fig. 4.5) shows no MPE·Fe(II) enhancement between the first two wells at the 
left, but obvious enhancement at three central sites. SE·Fe(II) and EDTA·Fe(II) 
detect all sites equivalently and give approximately the same amount of cleavage 
between each footprinting well. Varying the cleavage temperature from 4° C to 
55°C did not eliminate the regions of enhanced cleavage seen with MPE·Fe(II) 
(fig. 4.7 and 4.8). 
Figure 4.9 The structure of P 5. 
Cleavage Patterns. With EDTA·Fe(II) and 1 mM sodium ascorbate, very 
even DNA cleavage is observed. This is consistent with equal cleavage at each 
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base and demonstrates that all of the sugars of DNA are equivalently accessible 
to the oxidative DNA cleaving species. Using a thiol reducing agent which can 
efficiently scavange radicals, EDTA·Fe(ll) cleavage is inhibited. Cleavage inhi-
bition is also seen with reactions containing acetate buffers or organic solvents. 
These results are consistent with the proposal that the active DNA cleaving 
species for the EDTA·Fe(II) containing compounds is a diffusible species such 
as hydroxyl radical which, in the case of EDTA·Fe(II), it is generated remotely 
and can be intercepted before reaching the DNA. 
Because EDTA·Fe(II) generates its reactive species remotely, it is not in-
teracting with the DNA and; therefore, it must be independent of the DNA se-
quence. In other words, the cleavage pattern EDTA·Fe(II) produces is the same 
as that produced by a molecule which binds DNA sequence neutrally. Conse-
quently, deviations from the even cleavage pattern observed with EDTA·Fe(II) 
with another EDTA·Fe(II) DNA cleaving compound must result from an uneven 
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distribution of that cleaving molecule along the DNA. 
With SE·Fe(II), a cleavage pattern equivalent to that of EDTA·Fe(II) with 
ascorbate is observed with either 3 mM DTT or 1 mM sodium ascorbate as the 
reductant. Because SE·Fe(II) is not inhibited by DTT, the cleaving species must 
be generated near the DNA verifying that SE·Fe(II) binds to the DNA. Because 
the even cleavage pattern is the same pattern observed by the non-DNA binding 
molecule EDTA·Fe(II), SE·Fe(II) interacts with the DNA sequence neutrally 
to single base pair resolution. This provides evidence that polyamines bind 
heterogeneous . DNA sequence neutrally at the nucleotide level. 
The uneven cleavage pattern seen with MPE·Fe(II) has been observed 
before.41- 43• 46 However, it is now possible to conclude that this pattern is 
due to variations in the binding constant of MPE·Fe(II) along the heterogeneous 
DNA polymer and is not a reflection of varying reactivity of the sugar back-
bone based on the even DNA cleavage pattern seen with both SE·Fe(II) and 
EDTA·Fe(II). The highest amounts of cleavage are seen in G·C regions and the 
lowest are found in A· T containing regions consistent with the known preference 
of intercalators for G·C base pairs. 111 
Foot printing. Footprinting of P 5 at two concentrations showed cleavage inhi-
bition at the same sites with each footprinting reagent. The sites observed are 
listed in table 4.1. They show that P5 binds to a 7 bp site as predicted from 
the n+1 rule. 112 This rule states that poly-N-methylpyrrolecarboxamides with 
n amides will bind n+1 base pairs. All the sites at low P5 binding density (1:30) 
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are exclusively A·T sites, but at higher binding density (1:-2), sites containing G-
C base pairs are observed. Polypyrrole compounds are known to prefer A·T rich 
DNA and their mode of DNA binding has been observed in a crystal structure 
0f netropsin bound to DNA. 36- 38 The fit of netropsin to DNA is this structure is 
very tight and it is not readily apparent how such an interaction could adjust to 
include a 2-amino group of guanine protruding into the minor groove. Because 
sites containing guanine are seen only at high concentrations, they must have a 
lower affinity and it may be that at the G·C containing sites P5 does not fit as 
deeply into the minor groove allowing room for the guanine 2-amino group. 
Although each footprinting reagent shows the same P 5 binding sites, there 
are some important differences between the different footprinting reagents. With 
sodium ascorbate as the reductant, SE·Fe(IT) and EDTA·Fe(IT) are equivalent. 
They both show very even control cleavage patterns and very well defined in-
hibition wells in the footprinting lanes. This allows the footprints to be easily 
interpreted. EDTA·Fe(II) has an advantage over other footprinting reagents be-
cause it does not bind to the DNA and consequently does not alter the structure 
of DNA. The disadvantage of generating radicals remotely from the DNA is that 
they have a much greater opportunity to react with substrates other than the 
DNA including the DNA ligand being footprinted. SE·Fe(II) on the other hand 
binds to DNA electrostatically and it does not appear to alter the DNA struc-
ture. Because SE·Fe(II) binds to DNA it is not noticeably inhibited by thiol 
reducing agents, organic buffers, or organic solvents such as methanol which are 
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sometimes used to overcome limited aqueous solubility of the small molecule 
being footprinted. By generating its DNA cleaving species near DNA, SE·Fe(II) 
is more likely to react with the DNA making it compatible with a wider range 
of reaction conditions than EDTA·Fe(II). 
MPE·Fe(II) cleaves DNA at very low MPE·Fe(II):bp ratios and this min-
imizes the overall effect of intercalation on the DNA structure. However, at 
the sites that cleavage occurs, MPE·Fe(II) is either intercalated or partially 
intercalated.67 This means that while MPE·Fe(II) does not change the global 
structure of the DNA, it has disrupted the local structure in the region in which 
it is reporting. MPE·Fe(II) also recognizes the 3° structure of DNA. This at-
tribute is both an advantage and a disadvantage. It is a disadvantage in the 
respect that uneven cleavage in the control lane makes it difficult to assign foot-
prints. If the molecule being footprinted disrupts the 3° structure of DNA, the 
altered enhancement/inhibition patterns compound the difficulty of footprint 
interpretation. On the other hand, 3° structure recognition is an advantage 
because it allows those regions of DNA which are being altered by the DNA 
ligand to be determined. An example of this effect is seen in the three regions 
of enhanced cleavage observed on the 517 bp fragment. 
Cleavage Enhancement. A comparison of the gelscans (fig. 4.5) from the foot-
printing experiment on the 517 bp fragment shows greatly increased cleavage in 
three regions of DNA by MPE·Fe(II) with the addition of a high binding density 
of P5 (1:2). The ability of a bifunctional DNA binding/cleaving molecule such 
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as DNase I or MPE·Fe(II) to cut DNA is governed by two characteristics of the 
molecule; the binding affinity for a particular site and the efficiency of cleavage 
at that site. Without additional information, these two factors cannot be dis-
tinguished. Comparison of DNA cleavage with MPE·Fe(II) and EDTA·Fe(II) or 
SE·Fe(II) suggests that increased cleavage in the enhanced regions is due to an 
increased binding of MPE· Fe(II) and not simply an increase in the reactivity of 
those sugars to oxidative degradation. 
The increased binding of MPE·Fe(II) can be explained two ways. P5 and 
MPE·Fe(II) both compete for the minor groove of DNA. One explanation for the 
enhanced cleavage is that the sites which show higher cleavage are the only sites 
where MPE·Fe(II) efficiently competes with P5 for the minor groove. However, 
the region between the first two P5 binding sites shown in figure 4.5 does not 
show cleavage enhancement and enhancement is not seen on other regions of the 
517 bp fragment or with other DNA fragments at the same P 5 concentration. 
This argues that enhanced cleavage is not merely a result of competition for the 
minor groove of DNA. A more likely possibility is that this region of enhanced 
cleavage results from a structural change induced by P5 which increases the 
binding affinity for MPE·Fe(II) to this region. 
There are many examples in the literature of polypyrrole compounds bind-
ing to DNA and altering its structure. Kineoplast DNA has been shown to exist 
in a kinked form and the binding of distamycin A removes those kinks. 35 In 
another example, both distamycin A and netropsin have been shown to greatly 
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lengthen DNA isolated from certain sources, but not from others.33 • 34 These 
studies also found a cooperative binding interaction between ethidium bromide 
and the poly-N-methylpyrrolecarboxamide compounds. Before we discuss the 
enhanced cleavage on this fragment, it should be noted that this region is just 
upstream of the -35 consensus region for the ,8-lactamase promoter113 and in-
cludes a portion of the region indicated as the site of photo-cleavage of super-
coiled pBR322 by A-tris( diphenylphenanthroline)cobalt(III) and attributed to Z 
DNA.114 Because of its location, the structure of this region of DNA may be 
significant in the regulation of the ,8-lactamase gene. 
The most obvious feature of this region is the inverted repeat of the primary 
structure (fig. 4.6). With an inverted repeat, the possibility of a cruciform struc-
ture arises. These structures have been mapped on supercoiled pBR322 but this 
particular site has . not been seen.115- 118 To probe the possibility of cruciform 
formation or other modified DNA structure including single stranded and Z-form 
regions, the small molecule probes Os04 and diethyl pyrocarbonate and the en-
zyme S1 nuclease were used;
115 • 116• 119- 121 however, none of the reagents showed 
any reactivity indicative of non-Watson-Crick DNA in the presence of P5 or P5 
and ethidium. The reactivity of the DNA to dimethyl sulfate was also exam-
ined to probe possible structural alterations but revealed no unusual reactivity. 
Finally, MPE·Fe(II) footprinting of P5 on another DNA fragment containing an 
inverted repeat was carried. out and no cleavage enhancement was observed. It 
is also important to remember that no cleavage enhancement or inhibition is 
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seen in these regions with SE·Fe(II) or EDTA·Fe(II), therefore the sugars must 
be equivalently accessible to the oxidative cleaving species in both the modified 
and unmodified forms. No indications of single stranded regions or any modi-
fied double stranded structure were detected by the small molecule or enzyme 
probes. The reactivity of the base sugars to cleavage mediated by SE·Fe(II) 
and EDTA·Fe(II) is as expected for double stranded Watson-Crick DNA. These 
results do not completely rule out radical DNA structures, but they suggest 
more modest DNA structural alterations such as local unwinding or conversion 
to another double stranded form with a higher affinity for MPE·Fe(II). 
One structure consistent with these results is a junction between two forms 
of DNA. For instance, G·C regions of DNA are known to prefer the A-form and 
polypyrrole compounds are known to convert double stranded DNA to the B-
form.17-22 If P5 binding converts the A·T regions to B-form and the G·C regions 
remain A-form, the junction region between A and B form DNA may be less 
tightly stacked making intercalation more favorable. 122 It is also known that 
distamycin A removes bends from kineoplast DNA causing it to run slower in an 
acrylamide gel, but in the gel demonstrating this effect, distamycin A also causes 
another fragment to run faster (see ref. 35 fig. 5). Because distamycin causes 
only one fragment to run faster, this result is consistent with a sequence specific 
distamycin A induced bending of the DNA. If P5 bends the DNA adjacent to its 
binding site in the enhanced sequence, then the region of the bend may increase 
base pair separation in the minor groove of DNA allowing more exothermic 
intercalation by MPE·Fe(II). 
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With bent DNA, the degree of apparent bending has been found to be 
temperature dependent. 123 • 124 To investigate the effect of temperature on the 
efficiency of enhanced cleavage, footprinting of P5 was carried out at four tem-
peratures, 4°C, 20°C, 37°C, and 55°C (fig. 4.7). Comparison of the densitometry 
scans for these lanes shows that they are very similar although not identical for 
the entire temperature range. The important observation is that P 5 demon-
strates substantial enhanced cleavage between 4°C and 55°C (fig. 4.8). There-
fore, P5 binding not only induces a structural change in an adjacent unbound 
region, but stabiliZes that structural change over a 50°C temperature range. 
This work has demonstrated that attachment of EDTA·Fe(II) to spermine 
creates a molecule, SE·Fe(ll), which binds and cleaves DNA sequence neutrally. 
This lack of specificity provides evidence that at the nucleotide level polyamines 
recognize heterogeneous DNA independent of sequence. The lack of sequence 
specificity allows SE·Fe(II) to be used as a footprinting reagent. Comparison 
of SE·Fe(II) with two other small molecule footprinting reagents, EDTA·Fe(ll) 
and MPE·Fe(II), found that both EDTA·Fe(II) and SE·Fe(II) produce an even 
cleavage pattern with well defined cleavage inhibition wells that facilitate bind-
ing site assignment. Because SE·Fe(II) is bound to the DNA and is not inhibited 
by thiols, organic solvents or buffer components in contrast to EDTA·Fe(II), it is 
compatible with a wider range of reaction conditions and, therefore, it is poten-
tially a more useful footprinting reagent. MPE·Fe(II) produces a non-uniform 
cleavage pattern which results from an uneven binding affinity along the DNA 
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polymer. In the presence of a penta-N-methylpyrrolecarboxamide compound, 
MPE·Fe(II) shows regions of enhanced cleavage. These regions are most likely 
due to changes induced in the DNA structure by the binding of the penta-N-
methylpyrrolecarboxamide molecule, possibly a change in either DNA form or 





MATERIALS AND METHODS 
Nuclear magnetic resonance spectra were recorded on a a Varian Asso-
ciates EM-390 (1H=90.0), JEOL JNM-GX 400 (1H=399.65) or Bruker WM 
(1 H=500.12) and are reported in parts per million downfield from tetramethyl-
silane. Infrared spectra were recorded on a Beckman 4210 or a Shimadzu IR-
435 spectrophotometer. Ultraviolet-visible spectra were recorded on a Beckman 
Model25 spectrophotometer, a Cary Model219 spectrophotometer or a Hewlett-
Packard Model 8451A spectrophotometer. Mass spectra were recorded using 
FAB techniques at the Midwest Center for Mass Spectrometry at the University 
of Nebraska. Agarose gels stained with ethidium bromide were photographed 
with Polaroid type 55 film and the negatives were scanned at 485 nm, with a 
Cary 219 spectrophotometer interfaced to an Apple II computer or on an LKB 
Ultroscan XL densitometer. Autoradiography of polyacrylamide gels or agarose 
gels with radiolabelled DNA was carried out at -70°C on Kodak X-Omat AR 
film. 
Reagent grade chemicals were used without further purification unless oth-
erwise stated. Chromatography was performed using EM Reagents Silica Gel 
(230-400 mesh). N,N-dimethylformamide (DMF) was dried over 4A molecular 
seives. N,N'-carbonyldiimidazole was sublimed under reduced pressure prior to 
use. Ferrous ammonium sulfate was a Baker Analyzed Reagent. Dithiothreitol 
(DTT) was purchased from Boehring Mannheim. All non-aqueous reactions were 
run under argon with rigorous exclusion of water unless otherwise noted. All 
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water used in biological reactions and dilutions was deionized and distilled using 
a Corning Mega-Pure system. Aqueous (a32P) dATP and dCTP, triethylammo-
nium salts, 3000 Ci/mmol, were from Amersham and aqueous (132P)ATP, 5000-
9000 Ci/mmol, was from ICN. Nucleotide triphosphates were from Pharmacia. 
All enzymes were from Boehring Mannheim except the Klenow fragment of DNA 
polymerase I which was from New England Biolabs. Plasmid pBR322 125 • 126 was 
grown in Escherichia coli, strain HBlOl, and isolated by standard procedures. 127 
Calf thymus DNA from Sigma was sonicated, deproteinized, and extensively 
dialyzed. 71 A-phage DNA was from Boehring Mannheim. Plasmid SV-CAT was 
generously provided by Nevis Fregien. 
N-Methyl-4-nitropyrrole-2-carboxylic Acid 15. The monopyrrole ni-
tro acid 15 was prepared by a modification of the procedure of Bialer et al. 90 
A solution of 150 gm (1.37 mol) N-methylpyrrole-2-carboxylic acid in 900 mL 
acetic anhydride was stirred by means of an overhead stirrer and cooled to -25°C 
with a dry ice/acetone bath. A solution of 120 mL nitric acid at 0°C and 350 mL 
acetic anhydride at 0°C was prepared. This solution was added dropwise to the 
reaction mixture maintaining the reaction temperature at -25°C. The solution 
was stirred at -25°C for an additional hour and then poured onto 1300 mL of 
ice and water and stirred 1.5 h. After stirring, it was placed in a -20°C freezer 
for 12 h. The crystalline precipitate was collected and recrystallized from 1:1 
acetic acid:water ( v /v) to give 105 g ( 45 %) monopyrrole nitro acid 15. 1 H NMR 
(DMSO-d6 ) 6 3.9 (s, 3H), 7.25 (d, J=2 Hz, 1H), 8.25 (d, J=2 Hz, lH). 
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N-Methyl-4-nitropyrrole-2-carboxylic acid methyl ester 49. To so-
lution of 16 g (0.09 mol) monopyrrole nitro acid 15 in 160 rnL methanol, 16 rnL 
sulfuric acid was added and the solution was refluxed 17 h. The solution was 
then cooled and the volume was reduced under vacuum. The white crystalline 
product was filtered off to give 15.5 g (90%) monopyrrole nitro methyl ester 
49.90 1 H NMR (CDC13 ) 8 3.85 (s, 3H), 4.0 (s, 3H), 7.35 (d, J=1.5 Hz, 1H), 
7.55 (d, J=l.5 Hz, 1H). 
N-Methyl-4-(N-methyl-4-nitropyrrole-2-carboxylamide)-pyrrole-2-
carboxylic acid methyl ester 50. A solution of 15 g (0.08 mol) monopyrrole 
nitroester 49 in 130 ml DMF was reduced over 5% palladium on charcoal (1.5 g) 
at atmospheric pressure. The solution was filtered through Celite to remove the 
catalyst and 20 rnL triethylamine (0.14 mol) was added. A mixture of 15 g N-
methyl-4-nitropyrrole-2-carboxylic acid chloride (0.09 ·mol) was added in 20 mL 
DMF with stirring. (N-methyl-4-nitropyrrole-2-carboxylic acid chloride was pre-
pared by refluxing the monopyrrole acid in thionyl chloride until clear ( ...... 1 h) 
and removing excess thionyl chloride under vacuum.) The mixture stirred 12 h, 
700 rnL ice and water was added and the product was filtered off. After washing 
with water twice and diethyl ether, the light-green product was dried yielding 
24 g (95%) of the dipyrrole nitro ester 50.90 1 H NMR (DMSO-d6 ) 8 3.75 (s, 
3H), 3.85 (s, 3H), 4.0 (s, 3H), 6.9 (d, J=l.5 Hz, 1H), 7.5 (d, J=1.5 Hz, 1H), 7.6 
(d, J=2.0 Hz, 1H), 8.2 (d, J=l.5 Hz, 1H), 10.3 (s, 1H). 
4-Nitro-tri-N-methylpyrrole-2-carboxylic acid methyl ester 14. A 
solution of 16.7 g (0.055 mol) dipyrrole nitro ester 50 in 500 mL DMF was 
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hydrogenated over 5% palladium on charcoal (1 g) at atmospheric pressure. 
The solution was filtered through Celite to remove the catalyst and 15 mL 
(0.11 mol) triethylamine was added. A solution of 11.1 g (0.065 mol) N-methyl-4-
nitropyrrple-2-carboxylic acid chloride in 15 mL DMF was added. The reaction 
mixture stirred 12 h. A mixture of 600 mL ice and water was added and the 
product was filtered off. After washing with water twice and once with cold 
methanol, the light-green product was dried yielding 22 g (93%) of the tripyrrole 
nitro ester 14.90 1 H NMR (DMSO-d6 ) 8 3.75 (s, 3H), 3.83 (s, 3H), 3.85 (s, 3H), 
4.0 (s, 3H), 6.9 (d, J=l.5 Hz, 1H), 7.05 (d, J=l.5 Hz, 1H), 7.25 (d, J=l.5 Hz, 
1H), 7.5 (d, J=l.5 Hz, 1H), 7.6 (d, J=l.5 Hz, 1H), 8.2 (d, J=l.5 Hz, 1H), 10 (s, 
1H) , 10.35 ( s, 1H). 
4-Nitro-tri-N-methylpyrrole-2-carboxylic acid 21. To a suspension 
of 2 g ( 4. 7 mMol) tripyrrole nitro ester 14 in 135 mL ethanol, a solution of 1.5 g 
(37.5 mMol) sodium hydroxide in 125 mL water was added and the mixture was 
refluxed for 3.5 h. The solution was cooled and concentrated to 150 mL under 
vacuum. After acidification with 6 N HCl, the product was filtered off, washed 
twice with water and once with cold methanol to give 1.9 g (95%) tripyrrole 
nitro acid 21.90 1H NMR (DMSO-d6 ) 8 3.84 (s, 3H), 3.87 (s, 3H), 3.97 (s, 3H), 
6.85 (d, J=1.5 Hz, 1H), 7.1 (d, J=1.5 Hz, 1H), 7.25 (d, J=1.5 Hz, 1H), 7.26 (d, 
J=1.5 Hz, lH), 7.45 (d, J=l.5 Hz, 1H), 7.65 (d, J=1.5 Hz, lH), 8.2 (d, J=1.5 
Hz, 1H), 9.95 (s, lH), 10.35 (s, 1H). 
4-Nitro-tri-N-methy lpyrrole-2-carboxamide dimethy lpropy lamine 
53. A solution of 2.5 g (6.0 mMol) tripyrrole nitro acid 51, 0.68 g (6.6 mMol) 
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3-dimethylaminopropylamine and 0.89 g (6.6 mMol) N-hydroxybenzotriazole in 
10 mL DMF was cooled to 0°C, 1.36 g (6.6 mMol) dicyclohexylcarbodiimide 
was added and the solution was allowed to warm to 25°C and stir for 12 h. The 
DMF was removed under high vacuum, the residue was triturated twice with 
diethyl ether and then flash chromatographed on silica gel (concentrated aqueous 
ammonia:methanol, 3:97, v /v) to give 2.1 g (70%) tripyrrole nitro amine 53. 70 
IR (KBr) 3130, 2950, 1638, 1580, 1500, 1308, 1250 cm- 1 ; 1 H NMR (DMSO-d6 ) 
8 1.6 (m, 2H), 2.15 (s, 6H), 2.28 (t, J=6 Hz, 2H), 3.2 (m, 2H), 3.80 (s, 3H), 3.85 
(s, 3H), 3.95 (s, 3H), 6.85 (d, J=l.5 Hz, lH), 7.05 (d, J=1.5 Hz, 1H), 7.20 (d, 
J=1H), 7.27 (d, J=l.5 Hz, lH), 7.6 (d, J=l.5 Hz, lH), 8.05 (t, J=4 Hz, lH), 
8.15 (d, J=l.5 Hz, 1H), 9.95 (s, lH), 10.35 (s, lH). 
EDTA triethylester 16-. After suspending 10 g (0.034 mol) EDTA in 
dry ethanol, 1.5 mL sulfuric acid was added with stirring and the mixture was 
refluxed 24 h. A 50 mL saturated aqueous sodium bicarbonate solution was 
added and the reaction mixture was extracted with 250 mL dichloromethane. 
The organic layer was washed three times with saturated sodium bicarbonate, 
twice with water, dried over anhydrous sodium sulfate and concentrated to give 
11 g (80%) crude EDTA-tetraethylester. The triethyl ester 16 was prepared 
according to the procedure of Hay and Nolan.91 The 1.5 g (3.7 mMol) of the 
crude tetraester and 0.63 g (3.7 mol) cupric chloride dihydrate was dissolved 
in 100 mL water. A solution of 0.16 g (4.0 mMol) sodium hydroxide in 5 mL 
water was added with stirring at a rate to maintain the pH of the solution just 
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below 5. The solution was then bubbled-with H2 S and filtered. The filtrate was 
concentrated under vacuum and purified by flash chromatography on silica gel 
(methanol:dichloromethane, 1:9, v /v) to give 0.89 g (64%) of the triethylester 
16.70 1H NMR (CDC13 ) 6 1.3 (t, J=7 Hz, 9H), 2.74 (s, 4H), 3.3 (s, 2H), 3.4 (s, 
2H), 3.5 (s, 4H), 4.1 (q, J=7 Hz, 6H). 
EDTA triethylester-linker 17. To a solution of 5 g (0.013 mol) EDTA 
triethylester 16 and 1.52 g (0.13 mol) N-hydroxysuccinimide in 100 mL dioxane 
was added with stirring 2. 7 g (0.013 mol) of dicyclohexylcarbodiimide in 20 mL 
dioxane. The solution was stirred for 12 h, filtered and the filtrate concentrated. 
The filtrate was then dissolved in 100 mL dimethoxyethane and added with 
stirring to a solution of 2 g (0.02 mol) 4-aminobutyric acid and 1.68 g (0.02 
mol) sodium bicarbonate in 100 mL water. After stirring 12 h. the solution was 
concentrated under vacuum and purified by flash chromatography on silica gel 
(methanol:dichloromethane, 1:9, v/v) to give 4 g (65%) 17.70 1 H NMR (DMSO-
d6) 6 1.19 (t, J=7 Hz, 9H), 1.63 (m, 2H), 2.2 (t, J=6 Hz, 2H), 2.7 (t, J=6 Hz, 
2H), 3.1 (m, 2H), 3.19 (s, 2H), 3.45 (s, 2H), 3.53 (s, 4H), 4.08 (m, 6H), 8.0 (t, 
J=5 Hz, 1H). 
Distamycin-EDTA triethylester 18. A solution of 200 mg (0.40 mMol) 
tripyrrole nitro amine 53 in 5 mL DMF was hydrogenated over 5% palladium 
on charcoal (60 mg) at atmospheric pressure. The solution was filtered throuth 
Celite to remove the catalyst. Activated EDTA-triethylester-linker 17 in 20 mL 
DMF was prepared by adding 80 mg N,N'-carbonyldiimidazole and allowing 
-188-
the solution to stir 1 h. The reduced tripyrrole nitro amine was added and the 
solution stirred 12 h. The reaction mixture was concentrated under high vacuum, 
triturated three times with diethyl ether and purified by flash chromatography 
on silica gel (concentrated aqueous ammonia:methanol, 2:98, v /v) to give 300 
mg (82%) 18. 1 H NMR (DMSO-d6 ) 8 1.19 (t, J=7 Hz, 9H), 1.60 (m, 2H), 1.75 
(m, 2H), 2.13 (m, 2H), 2.2 (t, J=7 Hz, 2H), 2.26 (t, J=7 Hz, 2H), 2.7 (m, 4H), 
3.1 (s, 2H), 3.2 (s, 2H), 3.45 (s, 2H), 3.55 (s, 4H), 3.84 (s, 3H), 3.88 (s, 3H), 3.90 
(s, 3H), 4.08 (q, J=7 Hz, 6H), 6.80 (d, J=2 Hz, 1H), 6.86 (d, J=2 Hz, 1H), 7.16 
(d, J=2 Hz, 1H), 7.18 (d, J=2 Hz, 1H), 7.22 (d, J=2 Hz, 1H), 8.00 (t, J=5 Hz, 
1H), 8.05 (t, J=5 Hz, 1H), 9.80 (s, 1H), 9.88 (s, 1H), 10.37 (s, 1H). 
Distamycin-EDTA 1. A solution of 39 mg (1.6 mMol) lithium hydroxide 
in 10 mL water was added with stirring to a solution of 70.5 mg (0.08 mMol) 
distamycin-EDTA triethylester 18 in 10 mL ethanol. The solution stirred 12 h 
and was concentrated under vacuum. The residue was purified by flash chro-
matography on silica gel (concentrated aqueous ammonia: methanol, 3:97, v /v) 
to give 55 mg (85%) distamycin-EDTA 1 . 70 1 H NMR (DMSO-d6 ) 8 1. 73 (~, 
2H), 1.85 (m, 2H), 2.3 (t, J=7 Hz, 2H), 2.72 (s, 6H), 3.05 (t, J=7 Hz, 2H), 3.13 
(m, 2H), 3.22 (m, 2H), 3.40 (t, J=6 Hz, 2H), 3.45 (t, J=6 Hz, 2H), 3.80 (s, 3H), 
3.82 (s, 3H), 3.83 (s, 3H), 3.93 (s, 4H), 4.04 (s, 2H), 4.17 (s, 2H), 6.91 (s, 1H), 
6.93 (s, 1H), 7.05 (s, 1H), 7.18 (s, 1H), 7.22 (s, 1H), 7.26 (s, 1H), 8.25 (t, .J=5 Hz, 
1H), 8.86 (t, J=5 Hz, 1H), 9.95_ (s, 1H), 9.97 (s, 1H), 10.15 (s, 1H); UV (H2 0) 
Amax 238 nm, 305 nm. 
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4-Nitro-tetra-N-methylpyrrole-2-carboxylic acid methyl ester 37. 
A solution of 8 g (19 mMol) tripyrrole nitro ester 14 in 150 mL DMF was 
hydrogenated over 5% palladium on charcoal (1 g) at 52 psi hydrogen on a Parr 
rocker. The solution was filtered through Celite to remove the catalyst and 10 
mL (136 mMol) triethylamine was added. A solution of 3.8 g (22 mMol) N-
methyl-4-nitropyrrole-2-carboxylic acid chloride in 10 mL DMF was added and 
the reaction mixture stirred 12 h. After stirring, 600 mL ice and water was added 
and the product was filtered off. The product was washed twice with water, once 
with cold methanol and dried yielding 7.9 g (77%) of the tetrapyrrole nitro ester 
37. IR (KBr) 2950, 1700, 1660, 1580, 1440, 1400, 1305, 1245, 1105 cm- 1 ; 1H 
NMR (DMSO-d6 ) 6 3.79 (s, 3H), 3.84 (s, 3H), 3.86 (s, 3H), 3.87 (s, 3H), 3.97 
(s, 3H), 6.91 (d, J=2 Hz, 1H), 7.06 (d, J=2 Hz, 1H), 7.08 (d, J=2 Hz, 1H), 7.25 
(d, J=2 Hz, 1H), 7.28 (d, J=2 Hz, 1H), 7.47 (d, J=2 Hz, 1H), 7.60 (d, J=2 Hz, 
1H), 8.18 (d, J=2 Hz, 1H), 9.93 (s, 1H), 9.99 (s, 1H), 10.28 (s, 1H). 
4-Nitro-tetra-N-methylpyrrole-2-carboxylic acid 22. To a suspen-
sion of 730 mg (1.3 mMol) tetrapyrrole nitro ester 37 in 25 mL ethanol a solution 
of 0.5 g (12.5 mMol) sodium hydroxide in 25 mL water was added and the mix-
ture was refl.uxed for 4 h. The solution was then cooled and concentrated to ,..,.,35 
mL under vacuum. After acidification with 6 N HCl, the product was filtered 
off, washed three times with water and once with diethyl ether to give 630 mg 
(89%) tetrapyrrole nitro acid 22. IR (KBr) 2950, 1645, 1580, 1540, 1430, 1400, 
1305, 1245, 1110 cm- 1 ; 1 H NMR (DMSO-d6 ) 6 3.83 (s, 3H), 3.86 (s, 3H), 3.88 
-190-
(s, 3H), 3.97 (s, 3H), 6.87 (s, 1H), 7.06 (s, 1H), 7.07 (s, 1H), 7.25 (s, 1H), 7.28 
(s, 1H), 7.43 (s, 1H), 7.60 (s, 1H), 8.80 (s, 1H), 9.90 (s, 1H), 9.99 (s, 1H), 10.29 
(s, 1H); m/e 573 (M+H+). 
4-Nitro-tetra-N-methylpyrrole-2-carboxamide dimethylpropylamine 
38. A solution of 500 mg (0.93 mMol) tetrapyrrole nitro acid 22, 250 mg (1.9 
mMol) N-hydroxybenzotriazole and 170 mg (1.7 mmol) 3-dimethylaminopropyl-
amine in 5 mL DMF was cooled to 0°C and 230 mg (1.1 mMol) dicyclohexyl-
carbodiimide was added with stirring. After stirring 1 hat 0°C, the solution was 
allowed to warm to 25°C and stir for 12 h. The DMF was removed under high 
vacuum, the residue was triturated twice with diethyl ether and then purified 
by flash chromatography on silica gel (concentrated aqueous ammonia:methanol, 
2:98, v /v) to give 520 mg (90%) tetrapyrrole nitro amine 38. IR (KBr) 2950, 
1630, 1580, 1530, 1465, 1430, 1308, 1255 cm- 1 ; 1H NMR (DMSO-d6 ) 6 1.60 (m, 
2H), 2.20 (m, 2H), 2.30 (t, J=7 Hz, 2H), 3.2 (m, 2H), 3.80 (s, 3H), 3.85 (s, 3H), 
3.88 (s, 3H), 3.95 (s, 3H), 6.85 (s, 1H), 7.07 (m, 2H), 7.20 (s, 1H), 7.27 (s, 1H), 
7.31 (s, 1H), 8.05 (t, J=7 Hz, 1H), 8.1 (s, 1H), 9.92 (s,. 1H), 9.97 (s, 1H), 10.03 
(s, 1H), 10.35 (s, 1H); m/e 621 (M+H+). 
Tetra-N-methylpyrrolecarboxamide-EDTA triethylester 19. A so-
lution of 240 mg (0.39 mMol) tetrapyrrole nitro amine 38 in 5 mL DMF was 
hydrogenated over 5% palladium on charcoal (60 mg) at atmopheric pressure. 
The sol~tion was filtered through Celite to remove the catalyst. Activated 
EDTA triethylester-linker was prepared by dissolving 210 mg (0.46 mMol) EDTA 
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triethylester-linker 17 in 2 mL DMF, adding 80 mg (0.49 mMol) N,N1-carbonyl-
diimidazole and allowing the solution to stir 1 h. The reduced tetrapyrrole nitro 
amine was added to the activated EDTA triethylester-linker and the solution 
stirred 12 h. The reaction mixture was concentrated under high vacuum, trit-
urated three times with diethyl ether and purified by flash chromatography on 
silica gel (concentrated aqueous ammonia:methanol, 3:97, vjv) to give 307 mg 
(77%) 19. IR (KBr) 2943, 1738, 1649, 1582, 1539, 1533, 1465, 1434, 1403, 1256, 
1204 cm- 1 ; 1 H NMR (DMSO-d6 ) 6 1.18 (m, 9H), 1.62 (m, 2H), 1.72 (m, 2H), 
2.15 (s, 6H), 2.25 (m, 4H), 2.70 (m, 2H), 2.73 (m, 2H), 3.14 (m, 2H), 3.19 (m, 
4H), 3.46 (s, 2H), 3.51 (s, 4H), 3.80 (s, 3H), 3.84 (s, 3H), 3.85 (s, 3H), 3.86 (s, 
3H), 4.06 (m, 6H), 6.83 (s, 1H), 6.88 (s, 1H), 7.05 (s, 1H), 7.16 (s , 1H), 7.18 (s, 
1H), 7.24 (s, 2H), 8.00 (t, J=5 Hz, 1H), 8.06 (t, J=5 Hz, 1H), 9.80 (s, 1H), 9.88 
(s, 1H), 9.90 (s, 1H), 9.93 (s, 1H); m/e 1034 (M+H+). 
Tetra-N-methylpyrrolecarboxamide EDTA 2. A solution of 47 mg 
(2.0 mMol) lithium hydroxide in 15 mL water was added with stirring to a 
solution of 101 mg (0.10 mMol) tetra-N-methylpyrrolecarboxamide-EDTA tri-
ethylester 19 in 10 mL ethanol. The solution stirred 12 h and was concentrated 
under vacuum. The residue was purified by flash chromatography on silica gel 
(concentrated aqueous ammonia:methanol, 3:97, vjv) to give 77 mg (83%) 2. 
IR (KBr) 2950, 1620, 1580, 1540, 1460, 1435, 1400, 1260, 1200, 1100 cm- 1 ; 1 H 
NMR (DMSO-d6 +TFA) 6 i.75 (m, 2H), 1.86 (m, 2H), 2.28 (m, 2H), 2.80 (s , 
6H), 3.09 (m, 2H), 3.16 (m, 4H), 3.27 (m, 4H), 3.73 (s, 4H), 3.85 (m, 14H), 4.04 
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(s, 2H), 6.89 (s, 1H) , 6.95 (s , 1H), 7.08 (s, 1H), 7.16 (s, 1H), 7.18 (s, 1H), 7.23 
(s, 2H), 8.17 (m, 1H), 8.43 (m, 1H), 9.85 (s, 1H), 9.91 (s, 1H), 9.94 (s, 1H); UV 
(H20) Amax 238 nm, 310 nm; m/e 951 (M+H+). 
4-Nitro-penta-N-methylpyrrole-2-carboxylic acid methyl ester 54. 
A solution of 12.2 g (22 mMol) tetrapyrrole nitro ester 37 in 350 mL DMF was 
hydrogenated over 5% palladium on charcoal (2 g) at 52 psi hydrogen on a Parr 
rocker. The solution was filtered through Celite to remove the catalyst and 10 
mL triethylamine was added. A solution of 4. 7 g N-methyl-4-nitropyrrole-2-
carboxylic acid chloride (27 mMol) in 10 mL DMF was added and the reaction 
mixture stirred 12 h . After stirring, 750 mL ice and water was added and the 
product was filtered off. The product was washed three times with water, once 
with cold methanol and dried yielding 13.5 g (90%) of the pentapyrrole nitro 
ester 54. ffi (KBr) 2950, 1770, 1660, 1590, 1520, 1440, 1390, 1305, 1250, 1100 
cm- 1 ; 1 H NMR (DMSO-d6 ) 8 3.78 (s, 3H), 3.85 (s, 9H), 4.02 (s, 3H), 6.91 (s, 
1H), 7.10 (s, 3H), 7.45 (s, 1H), 7.60 (s, 1H), 8.14 (s, 1H), 9.86 (m, 3H), 10.20 (s, 
1H); m/e 673 (M+H+). 
4-Nitro-penta-N-methylpyrrole-2-carboxylic acid 55. To a suspen-
sion of 5 g (7.4 mMol) pentapyrrole nitro ester 54 in 200 mL ethanol, a solution 
of 4 g (100 mMol) sodium hydroxide in 200 mL water was added and the mixture 
was refluxed for 4 h. The solution was cooled and reduced in volume to 250 mL 
under vacuum. After acidification with 6 N HCl, the product was filtered off, 
washed three times with water and once with diethyl ether to give 4. 77 g (97%) 
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pentapyrrole nitro acid 55. IR (KBr) 2950, 1650, 1590, 1520, 1435, 1395, 1305, 
1250, 1105 cm- 1 ; 1 H NMR (DMSO-d6 ) 8 3.85 (s, 12H), 4.00 (s, 3H), 6.88 (s, 
1H), 7.10 (s, 3H), 7.30 (m, 3H), 7.45 (s, 1H), 7.61 (s, 1H), 8.20 (s, 1H), 9.90 (s, 
1H), 9.95 (s, 1H), 10.00 (s, 1H), 10.30 (s , 1H). 
4-Nitro-penta-N -methy lpyrrole-2-car boxamide dimethy lpropy lamine 
56. A solution of 1 g (1.5 mMol) pentapyrrole nitro acid 55, 0.41 g (3.0 mMol) 
N-hydroxybenzotriazole and 0.19 g (1.9 mMol) 3-dimethylaminopropylamine in 
175 mL DMF was cooled to 0°C and 0.47 g (2.3 mMol) dicyclohexylcarbodiimide 
was added with stirring. After stirring 1 h at 0°C, the solution was allowed to 
warm to 25°C and stir for 12 h. The DMF was removed under high vacuum, 
the residue was triturated three times with <_iiethyl ether and then flash chro-
matographed on silica gel (concentrated aqueous ammonia:methanol, 3.5:96.5, 
vjv) to give 0.9 g (80%) pentapyrrole nitro amine 56.71 IR (KBr) 2945, 1627, 
1580, 1530, 1465, 1435, 1307, 1260, 1110 cm- 1 ; 1 H NMR (DMSO-d6 ) 8 1.65 (m, 
2H), 2.20 (s, 6H), 2.30 (t, J=7 Hz, 2H), 3.2 (m, 2H), 3.83 (s, 3H), 3.90 (s, 3H), 
3.91 (s, 3H), 3.92 (s, 3H), 4.00 (s, 3H) , 6.85 (s, 1H), 7.10 (m, 3H), 7.20 (m, 3H), 
7.27 (m, 2H), 7.31 (s, 1H), 8.10 (t, J=7 Hz, 1H), 8.20 (s, 1H), 9.92 (s, 1H), 9.97 
(s, 1H), 10.03 (s, 1H); mje 743 (M+H+). 
Penta-N-methylpyrrolecarboxamide-EDTA triethyl ester 20. A 
solution of 1 g (1.35 mMol) nitro amine 56 in 20 mL DMF was hydrogenated over 
5% palladium on charcoal (200 mg) at atmospheric pressure. The mixture was 
filtered through Celite to remove the catalyst. Activated EDTA triethylester-
linker was prepared by dissolving 620 mg (1.5 mMol) EDTA triethylester-linker 
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17 in 5 mL DMF and adding 240 mg (1.5 mMol) N,N'-carbonyldiirnidazole 
and allowing the solution to stir 1 h. The reduced nitro compound was added 
and the solution stirred 12 h. The reaction mixture was concentrated under 
high vacuum, triturated three times with diethyl ether and purified by flash 
chromatography on silica gel (concentrated aqueous ammonia:methanol, 4:96, 
v/v) to give 0.6 g (40%) 20. 71 IR (KBr) 2960, 1725, 1650, 1585, 1540, 1470, 
1440, 1410, 1260, 1210, 1110 cm- 1 ; 1 H NMR (DMSO-d6 ) 6 1.20 (t, J=7 Hz, 
6H), 1.65 (m, 2H), 1.74 (m, 2H), 2.15 (s, 6H), 2.20 (m, 2H), 3.20 (m, 2H), 3.22 
(s, 2H), 3.45 (s, 2H), 3.50 (s, 4H), 3.80 (s, 3H), 3.87 (m, 20H), 4.07 (m, 6H), 6.80 
(s, 2H), 7.70 (m, 3H), 7.20 (s, 2H), 7.25 (s, 3H), 8.10 (t, J=7 Hz, 1H), 9.90 (s, 
2H), 9.95 (s, 1H); m/e 1156 (M+). 
Penta-N-methylpyrrolecarboxamide-EDTA 3. A solution of 25 mg 
(1.0 mMol) lithium hydroxide in 8 mL water was added with stirring to a solu-
tion of 57.5 mg (0.05 mMol) penta-N-methylpyrrolecarboxamide-EDTA triethyl 
ester 20 in 8 mL ethanol. The solution was stirred 12 h and concentrated 
under va<;uum. The residue was purified by flash chromatography on silica gel 
(concentrated aqueous ammonia:methanol, 3:97, v/v) to give 43 mg (80%) 3. 71 
IR (KBr) 2950, 1730, 1640, 1570, 1438, 1430, 1400, 1252, 1205 cm- 1 ; 1 H NMR 
(DMSO-d6 +TFA) 6 1.77 (m, 2H), 1.92 (m, 2H), 2.33 (t, J=7 Hz, 2H), 2.75 (s, 
6H), 3.08 (m, 2H), 3.20 (m, 2H), 3.24 (m, 2H), 3.30 (m, 2H), 3.35 (m, 2H), 3.80 
(s, 4H), 3.87 (m, 15H), 3.98 (s, 2H), 4.10 (s, 2H), 6.95 (m, 2H), 7.10 (m, 3H), 
7.20 (s, 1H), 7.22 (s, 1H), 7.32 (s, 3H), 8.20 (s, 1H), 8.65 (s, 1H), 9.97 (m, 4H), 
10.05 (s, 1H); UV (H20) Amax 239 nm, 313 nm; m/e 1072 (M+H+). 
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Tri-N-methylpyrrolecarboxylic acid-EDTA triethylester 23. A so-
lution of 125 mg (0.30 mMol) tripyrrole nitro acid 21 in 2 mL DMF was hy-
drogenated at atmospheric pressure over 5% palladium on charcoal (10 mg). 
The mixture was filtered through Celite to remove the catalyst. A solution of 
118 mg (0.26 mMol) EDTA triethylester-linker 17 and 45.5 mg (0.28 mMol) 
N,N'-carbonyldiimidazolein 4 mL DMF was allowed to stir 1 h. After 1 h, 
the reduced nitro acid was added and the solution stirred 12 h. The re-
action was concentrated under vacuum and triturated three times with di-
ethyl ether. The reaction mixture was loaded onto a flash silica gel column 
(methanol:dichloromethane, 1:9, v /v) and impurities were removed with a sol-
vent gradient (methanol:dichloromethane, 1:9 to 1:3, v /v). The product was 
stripped from the column with methanol to give 114 mg (53%) of 23. IR (KBr) 
3100, 2940, 1730, 1650, 1570 (broad), 1435, 1400, 1200, 1020 cm- 1 ; 1 H NMR 
(DMSO-d6 ) 8 1.19 (m, 9H), 1.71 (m, 2H), 2.25 (t, J=7 Hz, 2H), 2.70 (m, 2H), 
2.72 (m, 2H), 3.22 (m, 2H), 3.19 (s, 2H), 3.45 (s, 2H), 3.50 (s, 4H), 3.85 (s, 9H), 
4.06 (m, 6H), 6.43 (s, 1H), 6.68 (s, 1H), 6.98 (s, 1H), 7.03 (s, 1H), 7.18 (s, 1H), 
7.23 (s, 1H), 8.03 (t, J=S Hz, 1H), 9.67 (s, 1H), 9.90 (s, 3H); m/e 828 (M+H+). 
Hexa-N-methylpyrrolecarboxamide-EDTA triethyl ester 25. A 
solution of 21 mg (0.042 mMol) tripyrrole nitro amine 53 in 2 mL DMF was 
hydrogenated over 5% palladium on charcoal (10 mg) at atmospheric pressure. 
The solution was filtered through Celite to remove the catalyst. To the solution 
of reduced tripyrrole nitro amine 11.4 mg (0.084 mMol) N-hydroxybenzotriazole 
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and 35 mg (0.042 mMol) 23 was added with stirring. After the initial reactants 
dissolved, 10.5 mg (0.051 mMol) dicyclohexylcarbodiimide was added and the 
solution stirred 12 h. The DMF was removed under high vacuum, the residue 
was triturated with diethyl ether and then flash chromatographed (concentrated 
aqueous ammonia:(methanol:dichloromethane, 1:1, v /v), 1.5:98.5, v /v) to give 
16 mg (30%) 25. IR (KBr) 3100, 2950, 1734, 1653, 1576, 1558, 1540, 1436, 1256, 
1204, 1026 cm- 1 ; 1 H NMR (DMSO-d6 ) 6 1.18 (m, 9H), 1.62 (m, 2H), 1.75 (m, 
2H), 2.14 (s, 6H), 2.23 (m, 4H), 2.70 (m, 2H), 2.73 (m, 2H), 3.14 (m, 2H), 3.17 
(m, 2H), 3.19 (s, 2H), 3.46 (s, 2H), 3.51 (s, 4H), 3.80 (s, 3H), 3.84 (s, 3H), 3.85 
(s, 3H), 3.87 (s, 9H), 4.06 (m, 6H), 6.83 (s, 1H), 6.88 (s, 1H), 7.06 (s, 1H), 7.09 
(s, 3H), 7.16 (s, 1H), 7.18 (s, 1H), 7.25 (s, 3H), 8.00 (t, J=5 Hz, 1H), 8.06 (t, 
J=5 Hz, 1H), 9.80 (s, 1H), 9.88 (s, 1H), 9.89 (s, 1H), 9.94 (s, 2H); m/e 1278 
(M+H+). 
Hexa-N-methylpyrrolecarboxamide-EDTA 4. A solution of 2.3 mg 
(0.10 mMol) lithium hydroxide in 0.48 mL water was added with stirring to a 
solution of 6 mg (0.005 mMol) hexa-N-methylpyrrolecarboxamide-EDTA triethyl 
ester 25 in 0.48 mL ethanol. The solution was stirred 12 hand was concentrated 
under vacuum. The residue was purified by flash chromatography on silica gel 
(concentrated aqueous ammonia:methanol, 2.5:97.5, v /v) to give 4.41 mg (78%) 
4. ffi (KBr) 3020, 2930, 2850, 1730, 1640, 1585, 1465, 1435, 1405, 1260, 1205, 
1100 cm- 1 ; 1 H NMR (DMSO-d6 +TFA) 8 1.75 (m, 2H), 1.85 (m, 2H), 2.29 (t, 
J=7 Hz, 2H), 2.80 (m, 6H), 3.09 (m, 2H), 3.17 (m, 4H), 3.26 (m, 2H), 3.31 (m, 
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2H), 3.74 (s, 4H), 3.85 (m, 18H), 3.91 (s, 2H), 4.07 (s, 2H), 6.89 (s, 1H), 6.96 (s, 
1H), 7.09 (s, 2H), 7.11 (s, 2H), 7.16 (s, 1H), 7.17 (s, 1H), 7.23 (s, 4H), 8.16 (t, 
J=5 Hz, 1H), 8.41 (t, J=5 Hz, 1H), 9.82 (s, 1H), 9.90 (s, 2H), 9.94 (s, 3H); UV 
(H20) Amax 240 nm, 314 nm; m/e 1195 (M+H+). 
Hepta-N-methylpyrrolecarboxamide-EDTA triethyl ester 26. A 
solution of 14.2 mg (0.023 mMol) tetrapyrrole nitro amine 38 in 2 mL DMF was 
hydrogenated over 5% palladium on charcoal (10 mg) at atmospheric pressure. 
The solution was filtered through Celite to remove the catalyst. To the solution 
of reduced tetrapyrrole nitro amine 6.2 mg (0.046 mMol) N-hydroxybenzotriazole 
and 19 mg (0.023 mMol) 23 was added with stirring. After the initial reactants 
dissolved, 5. 7 mg (0.028 mMol) dicyclohexylcarbodiimide was added and the 
solution stirred 12 h. The DMF was removed under high vacuum, the residue 
was triturated with diethyl ether and then flash chromatographed (concentrated 
aqueous ammonia:(ethyl acetate:ethanol, 3:2, v /v), 4.4:95.6, v /v) to give 8.2 mg 
(27%) 26. IR (KBr) 3020, 2920, 2850, 1735, 1645, 1580, 1540, 1480, 1435, 1405, 
1260, 1200, 1105, 1020 cm- 1 ; 1 H NMR (DMSO-d6 ) 8 1.18 (m, 9H), 1.62 (m, 
2H), 1.71 (m, 2H), 2.18 (s, 6H), 2.23 (t, J=6 Hz, 2H), 2.30 (m, 2H), 2.70 (m, 
4H), 3.12 (m, 2H), 3.18 (s, 2H), 3.46 (s, 2H), 3.80 (s, 3H), 3.83 (s, 3H), 3.86 (s, 
. 15H), 4.06 (m, 6H), 6.83 (s, 1H), 6.88 (s, 1H), 7.06 (s, 1H), 7.07 (s, 1H), 7.09 (s, 
3H), 7.16 (s, 1H), 7.18 (s, 1H), 7.24 (s, 5H), 8.00 (t, J=7 Hz, 1H), 8.09 (broad 
s, 1H), 9.81 (s, 1H), 9.91 (s, 1H), 9.95 (s, 4H); m/e 1400 (M+). 
Hepta-N-methylpyrrolecarboxamide-EDTA 5. A solution of 0.48 
mg (0.021 mMol) lithium hydroxide in 1.5 mL water was added with stirring 
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to a solution of 2.8 mg (0.002 mMol) hepta-N-methylpyrrolecarboxamide-EDTA 
triethyl ester 26 in 2 mL ethanol. The solution was stirred 12 h and was 
concentrated under vacuum. The residue was purified by flash chromatography 
on silica gel (concentrated aqueous ammonia:methanol, 2.5:97.5, vfv) to give 
1.98 mg (75%) 5. IR (KBr) 3020, 2930, 2850, 1730, 1640, 1580, 1540, 1460, 
1435, 1400, 1260, 1205, 1105 cm- 1 ; 1 H NMR (DMSO-d6 +TFA) 8 1.75 (m, 2H), 
1.85 (m, 2H), 2.29 (t, J=7 Hz, 2H), 2.80 (m, 6H), 3.09 (m, 2H), 3.17 (m, 4H), 
3.27 (m, 2H), 3.31 (m, 2H), 3.74 (s, 4H), 3.85 (m, 20H), 3.91 (s, 2H) , 4.07 (s, 
2H), 6.83 (s, 1H), 6.88 (s, 1H), 7.06 (s, 1H), 7.08 (s, 1H), 7.09 (s, 3H), 7.16 (s, 
1H), 7.19 (s, 1H), 7.25 (s, 5H), 8.16 (t, J=6 Hz, 1H), 8.41 (t, J=6 Hz, 1H), 9.82 
(s, 1H), 9.90 (s, 2H), 9.94 (s, 4H); UV (H20) Amax 242 nm, 314 nm; mfe 1317 
(M+H+). 
Tetra-N-methylpyrrolecarboxylic acid-EDTA triethylester 24. A 
solution of 58 mg (0.108 mMol) tetrapyrrole nitro acid 22 with 0.039 mL (0.28 
mMol) triethylamine in 2 mL DMF was hydrogenated at atmospheric pressure 
over 5% palladium on charcoal (10 mg). The mixture was filtered through Celite 
to remove the catalyst. A solution of 55 mg (0.119 mMol) EDTA triethylester-
linker 17 and 22 mg (0.136 mMol) N,N'-carbonyldiimidazole in 1 mL DMF was 
allowed to stir 1 h. After 1 h, the reduced nitro acid was added and the solution 
stirred 12 h. The reaction was concentrated under vacuum and triturated three 
times with diethyl ether. The reaction mixture was loaded onto a flash silica gel 
column (methanol:dichloromethane, 1:9, v fv) and impurities were removed with 
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a solvent gradient (methanol:dichloromethane, 1:9 to 1:3, v /v). The product 
was stripped from the column with methanol to give 53 mg (56%) of 24. IR 
(KBr) 3100, 3010, 2930, 2850, 1730, 1650, 1580, 1545, 1435, 1400, 1235, 1200, 
1100, 1060, 1020 cm- 1 ; 1 H NMR (DMSO-d6 ) o 1.17 (m, 9H), 1.72 (p, J=7 Hz, 
2H), 2.24 (t, J=7 Hz, 2H), 2.70 (d, J=5 Hz, 2H), 2.73 (d, J=5 Hz, 2H), 3.13 (q, 
J=6 Hz, 2H), 3.19 (s, 2H), 3.46 (s, 2H), 3.51 (s, 4H), 3.83 (s, 9H), 3.86 (s, 3H), 
4.06 (m, 6H), 6.42 (s, 1H), 6.88 (s, 1H), 6.99 (s, 1H), 7.05 (s, 2H), 7.17 (s, 1H), 
7.23 (s, 1H), 7.25 (s, 1H), 8.02 (t, J=7 Hz, 1H), 9.68 (s, 1H), 9.85 (s, 1H), 9.92 
(s, 2H); m/e 950 (M+H+). 
Octa-N-methylpyrrolecarboxamide-EDTA triethyl ester 27. A so-
lution of 5.4 mg (0.0087 mMol) tetrapyrrole nitro amine 38 in 2 mL DMF 
was hydrogenated over 5% palladium on charcoal (1.5 mg) at atmospheric 
pressure. The solution was filtered through Celite to remove the catalyst. 
To the solution of reduced tetrapyrrole nitro amine 2.3 mg (0.017 mMol) N-
hydroxybenzotriazole, 1.9 mg (0.0092 mMol) dicyclohexylcarbodiimide and 8 mg 
(0.0084 mMol) tetra-N-methylpyrrolecarboxylic acid-EDTA triethylester 24 was 
added with stirring. After the solution stirred 12 h, the DMF was removed under 
high vacuum, and the residue was triturated with diethyl ether and then flash 
chromatographed (concentrated aqueous ammonia: ( methanol:dichloromethane, 
1:1, v jv), 1:33, v /v) to give 4.4 mg (34%) 27. IR (KBr) 3020, 2920, 2850, 1735, 
1645, 1585, 1540, 1435, 1400, 1260, 1205, 1105 cm- 1 ; 1 H NMR (DMSO-d6 ) o 
1.17 ·(m, 9H), 1.61 (p, J=7 Hz, 2H), 1.71 (p, J=7 Hz, 2H), 2.14 (s, 6H), 2.24 (t, 
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J=6 Hz, 4H), 2.68 (d, J=9 Hz, 2H), 2.71 (d, J=8 Hz, 2H), 3.14 (m, 2H), 3.19 
(s, 2H), 3.51 (s, 2H), 3.60 (s, 4H), 3.80 (s, 3H), 3.84 (s, 3H), 3.87 (m, 18H), 4.07 
(m, 6H), 6.83 (s, 1H), 6.89 (s, 1H), 7.09 (m, 14H), 7.16 (s, 1H), 7.19 (s, 1H), 
7.25 (m, 14H), 8.01 (t, J=5 Hz, 1H), 8.07 (t, J=5 Hz, 1H), 9.81 (s, 1H), 9.89 (s, 
1H), 9.90 (s, 1H), 9.96 (s, 5H); mje 1523 (M+H+) . 
Octa-N-methylpyrrolecarboxamide-EDTA 6. A solution of 1.0 mg 
(0.042 mMol) lithium hydroxide in 1 mL water was added with stirring to a solu-
tion of 3.4 mg (0.0022 mMol) octa-N-methylpyrrolecarboxamide-EDTA triethyl 
ester 27 in 1 mL ethanol. The solution was stirred 12 h and was concentrated 
under vacuum. The residue was purified by flash chromatography on silica gel 
(concentrated aqueous ammonia:methanol, 3:97, v/v) to give 2.60 mg (82%) 6. 
m (KBr) 3010, 2930, 2850, 1735, 1640, 1580, 1540, 1460, 1435, 1400, 1260, 1205, 
1105 cm- 1 ; 1 H NMR (DMSO-d6 +TFA) 8 1.75 (p, J=6 Hz, 2H), 1.85 (p, J=7 
Hz, 2H), 2.29 (t, J=7 Hz, 2H), 2.80 (d, J=5 Hz, 6H), 3.09 (m, 2H), 3.18 (m, 
4H) , 3.25 (m, 2H), 3.31 (m, 2H), 3.76 (s, 4H), 3.83 (s, 3H), 3.85 (s, 3H), 3.88 (m, 
18H), 3.92 (s, 2H), 4.07 (s, 2H), 6.89 (s, 1H) , 6.97 (s, 1H), 7.10 (s, 2H), 7.12 (s, 
4H), 7.17 (s, 1H), 7.18 (s, 1H), 7.24 (s, 6H), 8.17 (t, J=6 Hz, 1H), 8.41 (t, J=6 
Hz, 1H), 9.83 (s, 1H), 9.91 (s, 1H), 9.92 (s, 1H), 9.96 (s, 5H); UV (H20) Amax 
242 nm, 314 nm; m/e 1439 (M+H+). 
Nona-N-methylpyrrolecarboxamide-EDTA triethyl ester 28. A 
solution of 6.6 mg (0.0089 mMol) pentapyrrole nitro amine 56 in 2 mL DMF 
was hydrogenated over 5% palladium on charcoal (1 mg) at atmospheric pres-
sure. The solution was filtered through Celite to remove the catalyst. To 
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the solution of reduced pentapyrrole nitro amine 2.3 mg (0.017 mMol) N-
hydroxybenzotriazole, 1.9 mg (0.0092 mMol) dicyclohexylcarbodiimide and 8 mg 
(0.0084 m.Mol) tetra-N-methylpyrrolecarboxylic acid-EDTA triethylester 24 was 
added with stirring. After the solution stirred l2 h, the DMF was removed under 
high vacuum, and the residue was triturated with diethyl ether and then flash 
chromatographed (concentrated aqueous ammonia: ( methanol:dichloromethane, 
1:1, v/v), 1:33, v/v) to give 4.0 mg (29%) 28. IR (KBr) 3010, 2920, 2850, 1730, 
1645, 1580, 1540, 1435, 1400, 1260, 1200, 1105, 1020 cm- 1 ; 1H NMR (DMSO-
d6) o 1.21 (m, 9H), 1.66 (p, J=7 Hz, 2H), 1.76 (p, J=7 Hz, 2H), 2.18 (s, 6H), 
2.29 (m, 4H), 2.72 (d, J=4 Hz, 2H), 2.75 (d, J=4 Hz, 2H), 3.21 (m, 6H), 3.21 (s, 
6H), 3.45 (s, 2H), 3.52 (s, 4H), 3.83 (s, 3H), 3.87 (s, 3H), 3.90 (m, 21H), 4.08 
(m, 6H), 6.84 (d, J=2 Hz, 1H), 6.91 (d, J=2 Hz, 1H), 7.09 (d, J=2 Hz, 1H), 7.11 
(d, J=2 Hz, 1H), 7.13 (s, 5H), 7.23 (m, 7H), 8.06 (t, J=5 Hz, 1H), 8.22 (s, 1H), 
9.78 (s, 1H), 9.86 (s, 1H), 9.88 (s, 1H), 9.93 (s, 6H). 
Nona-N-methylpyrrolecarboxamide-EDTA 7. To 4 mg (0.0024 
m.Mol) of nona-N-methylpyrrolecarboxamide-EDTA triethyl ester 28 and 0.5 
mg (0.021 m.Mol) lithium hydroxide were added 2 mL of ethanol and 1 mL wa-
ter. The solution was stirred 12 h and was concentrated under vacuum. The 
residue was purified by flash chromatography on silica gel (concentrated aqueous 
ammonia:methanol, 1:33, v /v) to give 3.5 mg (92%) 7. IR (KBr) 3010, 2950, 
2850,1730,1620,1585,1550,1465,1435,1405,1260,1205, 1110cm-1 ; 1 HNMR 
(DMSO-d6+TFA) 8 1.75 (p, J=7 Hz, 2H), 1.85 (p, J=7 Hz, 2H), 2.29 (t, J=7 
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Hz, 2H), 2.80 (d, J=4 Hz, 6H), 3.10 (m, 2H), 3.19 (m, 4H), 3.26 (m, 2H), 3.31 
(m, 2H), 3. 77 (s, 4H), 3.83 (s, 3H), 3.85 (s, 3H), 3.87 (s, 3H), 3.89 (m, 18H), 3.92 
(s, 2H), 4.08 (s, 2H), 6.90 (s, 1H), 6.97 (s, 1H), 7.10 (s, 2H), 7.12 (s, 5H), 7.17 
(s, 1H), 7.18 (s, 1H), 7.24 (s, 7H), 8.17: (t, J=6 Hz, 1H), 8.42 (t, J=6 Hz, 1H), 
9.84 (s, 1H), 9.92 (s, 2H), 9.96 (s, 6H); UV (H20) Amax 241 nm, 314 nm. 
4-Nitro-di-N-methylpyrrole-2-carboxylic acid 51. To a suspension 
of 2 g (6.5 mMol) dipyrrole nitro ester 50 in 80 mL ethanol, a solution of 1.5 
g (37.5 mMol) sodium hydroxide in 80 mL water was added and the mixture 
was refluxed for 3.5 h. The solution was cooled and concentrated to ......- 100 mL 
under vacuum. After acidification with 6 N HCl, the product was filtered off and 
washed four times with water and dried to give 1.99 g (104%) dipyrrole nitro 
acid 51. 1 H NMR (DMSO-d6 ) 6 3.83 (s, 3H), 3.94 (s, 3H), 6.83 (d, J=2 Hz, 
lH), 7.41 (s, 1H), 7.56 (d, J=2 Hz, 1H), 8.16 (d, J=2 Hz, 1H), 10.24 (s, lH). 
4-Nitro-di-N -methy lpyrrole-2-car boxamide dimethy lpropy !amine 
52. To a solution of 78 mg (0.27 mMol) dipyrrole nitro acid 21, 29.9 
mg (0.29 mMol) 3-dimethylaminopropylamine and 71.9 mg (0.53 mMol) N-
hydroxybenzotriazole in 2 mL DMF was added 60.4 mg (0.29 mMol) dicyclo-
hexylcarbodiimide and the solution was allowed to stir for 12 h. The DMF 
was removed under high vacuum, the residue was triturated twice with diethyl 
ether and then flash chromatographed on silica gel (concentrated aqueous am-
monia: methanol, 3:97, v /v) to give 84 mg (84%) dipyrrole nitro amine 52. IR 
(KBr) 3130, 2950, 1638, 1580, 1500, 1308, 1250 cm- 1 ; 1H NMR (DMSO-d6 ) 6 
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1.62 (m, 2H), 2.15 (s, 6H), 2.26 (t, J=7 Hz, 2H), 3.20 (t, J=7 Hz, 2H), 3.81 (s, 
3H), 3.96 (s, 3H), 6.82 (d, J=2 Hz, 1H), 7.20 (d, J=2H), 7.57 (d, J=2 Hz, 1H), 
8.11 (t, J=5 Hz, 1H), 8.16 (d, J=2 Hz, 1H), 10.35 (s, 1H); m/e 377 (M+H+). 
4-Acetamide-di-N -:methy lpyrrole-2-carboxamide dime thy lpropy 1-
amine 8. A solution of 200 mg (0.51 mMol) nitro di-N-methylpyrrolecarbox-
amide dimethylpropylamine 52 in 5 ml DMF was hydrogenated at atmospheric 
pressure over 5% palladium on charcoal (40 mg). The catalyst was filtered off 
and 300 J.LL ( 4.08 mMol) triethylamine followed by 100 J.LL (1.15 mMol) acetyl 
chloride was added. The reaction mixture was stirred overnight and then con-
centrated under high vacuum. The residue was triturated with diethyl ether and 
flash chromatographed (concentrated aqueous ammonia:methanol, 2:98, v /v) to 
give 175 mg (88%) 8. IR (KBr) 3100, 2940, 1640, 1580, 1530, 1435, 1400, 1260, 
1205, 1095 cm- 1 ; 1 H NMR (DMSO-d6 ) 6 1.61 (p, J=7 Hz, 2H), 1.97 (s, 3H), 
2.13 (s, 6H), 2.23 (t, J=7 Hz, 2H), 3.17 (t, J=6 Hz, 2H), 3.80 (s, 3H), 3.82 (s , 
3H), 6.81 (s, 1H), 6.83 (s, 1H), 7.14 (s, 1H), 7.18 (s, 1H), 8.06 (t, J=5 Hz, 1H), 
9.81 (s, lH), 9.84 (s, lH); UV (H20) Amax 235 nm (21,600), 296 nm (22,800); 
m/e 389 (M+H+) . 
4-Acetamide-tri-N-methylpyrrole-2-carboxamide dimethylpropyl-
amine 9. A solution of 300 mg (0.60 mMol) tri-N-methylpyrrolecarboxamide 
dimethylpropylamine 53 in 2 mL DMF at atmospheric pressure over 5% palla-
dium on charcoal (50 mg), the catalyst was filtered off and acetic acid imidazolide 
(prepared by adding 300 mg (1.85 mMol) carbonyldiimidazole to 105 J.LL (1.8 
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mMol) acetic acid in 2 mL DMF and stirring 2H) was added. The reaction mix-
ture was stirred overnight and concentrated under high vacuum. The residue 
was triturated with diethyl ether and after flash chromatography (concentrated 
aqueous ammon~a:methanol, 2:98, v /v) gave 230 mg (75%) 9. IR (KBr) 3100, 
2930, 1640, 1580, 1530, 1435, 1400, 1260, 1200, 1100 cm- 1 ; 1 H NMR (DMSO-
d6) 6 1.87 (t, J=7.0 Hz, 2H), 2.78 (s, 3H), 3.06 (t, J=7 Hz, 2H), 3.25 (q, J=6.0 
Hz, 2H), 3.82 (s, 3H), 3.83 (s, 3H), 3.85 (s, 3H), 6.88 (s, 1H), 6.94 (s, 1H), 7.06 
(s, 1H), 7.15 (s, 1H), 7.19 (s, 1H), 7.24 (s, 1H), 8.18 (t, J=5 Hz, 1H), 9.86 (s, 
lH), 9.92 (s, 2H); UV (H20) -Xmax 237 nm (28,000), 303 nm (33,000); m/e 511 
(M+H+). 
4-Acetamide-tetra-N -me thy lpyrrole-2-carboxamide dimethy lpropy 1-
amine 10. A solution of 100 mg (0.16 mMol) tetra-N-methylpyrrolecarbox-
amide dimethylpropylamine 38 in 5 mL DMF at atmospheric pressure over 
5% palladium on charcoal (20 mg). The catalyst was filtered off and 134 J.LL 
(1.82 mMol) triethylamine followed by 40 J.LL (0.46 mMol) acetyl chloride was 
added. The reaction mixture was stirred overnight and then concentrated under 
high vacuum. The residue was triturated with diethyl ether and flash chro-
matographed (concentrated aqueous ammonia:methanol, 2.6:97.4, vjv) to give 
67 mg (66%) 10. IR (KBr) 2910, 1730, 1640, 1580, 1545, 1535, 1435, 1400, 1255, 
1200, 1100 cm- 1 ; 1 H NMR (DMSO-d6 ) 6 1.86 (p, J=7.7 Hz, 2H), 2.77 (s, 6H), 
3.08 (t, J=1.7 2H), 3.25 (q, J=6.0 Hz, 2H), 3.82 (s, 3H), 3.84 (s, 3H), 3.85 (s, 
3H), 3.86 (s, 3H), 6.88 (s, 1H), 6.95 (s, 1H), 7.08 (s, 2H), 7.15 (s, 1H), 7.19 (s, 
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1H), 7.24 (s, 2H), 8.18 (t, J=7 Hz, 1H), 9.92 (s, 1H), 9.93 (s, 1H), 9.95 (s, 1H); 
UV (H20) Amax 238 nm (30,000), 308 nm (40,000); m/e 633 (M+H+). 
4-Acetamide-penta-N-methylpyrrole-2-carboxamide dimethylpropyl-
am~e 11. A solution of 155mg (0.21 mMol) penta-N-methylpyrrolecarbox-
amide dimethylpropylamine 56 in 30 mL DMF at atmospheric pressure over 
5% palladium on charcoal (36 mg). The catalyst was filtered off and 300 J.LL 
(4.08 mMol) triethylamine followed by 40 J.LL (0.46 mMol) acetyl chloride was 
added. The reaction mixture was stirred overnight and then concentrated under 
high vacuum. The residue was triturated with diethyl ether and flash chro-
matographed (concentrated aqueous ammonia:methanol, 2.5:97.5, v/v) to give 
95 mg (62%) 11. IR (KBr) 3100, 3010, 2920, 2850, 1730, 1640, 1580, 1545, 1435, 
1400, 1255, 1200, 1100 cm- 1 ; 1 H NMR (DMSO-d6 ) 6 1.86 (m, 2H), 1.98 (s, 2H), 
2.77 (s, 6H), 3.06 (t, J=7 Hz, 2H),3.25 (m, 2H), 3.78 (s, 3H), 3.82 (s, 3H), 3.84 
(s, 3H), 3.89 (s, 3H), 6.88 (s, 1H), 6.95 (s, 1H), 7.08 (s, 2H), 7.09 (s, 1H), 7.15 (s, 
H), 7.19 (s, H), 7.24 (s, 3H), 8.18 (t, J=7 Hz, 1H), 9.86 (s, 1H), 9.93 (s, 2H), 9.96 
(s, 2H); UV (H20) Amax 238 nm (35,000), 310 nm (46,000); m/e 755 (M+H+). 
4-Acetamide-tri-N-methylpyrrole-2-carboxylic acid methyl ester 
29. A solution of 100 mg (0.234 mMol) 4-nitro-tri-N-methylpyrrolecarboxylic 
acid methyl ester 14 in 4 mL DMF at atmospheric pressure over 5% palladium 
on charcoal (20 mg) at 37°C for 3 h. The catalyst was filtered off through a 
Celite plug. To the stirring reaction mixture 130 J.LL (94 mg, 4 eq) triethylamine 
followed by 40 J.LL ( 44 mg, 2 eq) acety 1 chloride was added. After removing 
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the solvent under high vacuum and trituration with diethyl ether, the reaction 
mixture was purified by flash chromatography on silica gel to provide 60 mg 
(0.11 mMol, 99% based on recovered starting material) 29. IR (KBr) 3100, 
2950, 1710, 1650, 1580, 1435, 1405, 1250, 1200, 1100 cm- 1 ; 1 H NMR (DMSO-
da) 8 1.97 (s, 3H), 3.83 (m, 9H), 6.83 (m, 2H), 7.04 (s,- 1H), 7.15 (s, 1H), 7.23 
(s, 1H), 7.24 (s, 1H), 9.80 (s, 1H), 9.89 (s, 2H). 
4-Acetamide-tri-N-methylpyrrole-2-carboxylic acid 30. A solution 
of 200 mg (0.45 mMol) 4-acetamide-tri-N-methylpyrrolecarboxylic acid methyl 
ester 29 and 55 mg (1.38 mMol) sodium hydroxide in 5 mL water and 5 mL 
ethanol was re:fluxed for 4 h. The ethanol was removed under reduced pressure. 
The solution was cooled in an ice bath and 0. 75 mL (1.50 mMol) 2 N HCl was 
added. The precipitate was filtered off and washed once with water, twice with 
ether and dried to afford 167 mg (87%) 30. IR (KBr) 3100, 2930, 2850, 1640, 
1580, 1435, 1400, 1235, 1205, 1110 cm- 1 ; 1 H NMR (DMSO-d6 ) 8 1.97 (s, 3H), 
3.82 (s, 3H), 3.83 (s, 3H), 3.84 (s, 3H), 6.85 (s, 2H), 7.05 (s, 1H), 7.16 (s, 1H), 
7.24 (s, 1H), 7.44 (s, 1H), 9.84 (s, 1H), 9.91 (s, 2H); m/e 427 (M+H+). 
4-Acetamide-hexa-N-methylpyrrole-2-carboxamide dimethylpropyl-
amine 12. A solution of 35 mg (0. 70 mMol) tri-N-methylpyrrolecarboxamide 
dimethylpropylamine 53 in 5 mL DMF at atmospheric pressure over 5% pal-
ladium on charcoal (10 mg). The catalyst was filtered off through a Celite 
plug and 30 mg (0.07 mMol) 4-acetamide-tri-N-methylpyrrole-2-carboxylic acid 
30, 16 mg (0.078 mMol) dicyclohexylcarbodiimide and 19 mg (0.141 mMol) N-
hydroxybenzotriazole were added. The reaction mixture was stirred overnight 
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and then concentrated under high vacuum. The residue was triturated with 
diethyl ether and flash chromatographed (concentrated aqueous ammonia:( ethyl 
acetate:ethanol, 3:2, v jv), 6:94, v /v) to give 31 mg (50%) 12. ffi (KBr) 3010, 
2920,2850,1730,1640,1580,1540,1435,1400,1255,1200, 1100cm- 1 ; 1 HN11R 
(DMSO-d6) o 1.83 (m, 2H), 1.98 (s, 3H), 3.00 (m, 2H), 3.26 (m, 2H), 3.81 (s, 
3H), 3.84 (s, 3H), 3.86 (s, 3H), 3.87 (s, 9H), 6.88 (s, 1H), 6.94 (s, 1H), 7.08 (s, 
2H), 7.10 (s, 2H), 7.15 (s, 1H), 7.19 (s, 1H), 7.25 (s, 4H), 8.17 (t, J=5 Hz, 1H) , 
9.85 (s, 1H), 9.93 (s, 2H), 9.96(s, 2H); UV (H20) Amax 240 nm (38,000), 314 nm 
(53,000); m/e 877 (M+H+) . 
4-Acetamide-hepta-N -methy lpyrrole-2-carboxarnide dimethy lpropy 1-
amine 13. A solution of 60 mg (0.097 mMol) tetra-N-methylpyrrolecarbox-
amide dimethylpropylamine 38 in 2 mL DMF at atmospheric pressure over 5% 
palladium on charcoal (15 mg) . The catalyst was filtered off through a Celite 
plug and 46.9 mg (0.109 mMol) 4-acetamide-tri-N-methylpyrrole-2-carboxylic 
acid 30, 25 mg (0.121 mMol) dicyclohexylcarbodiimide and 33 mg (0.244 mMol) 
N-hydroxybenzotriazole were added. The reaction mixture was stirred overnight 
and then concentrated under high vacuum. The residue was triturated with di-
ethyl ether and flash chromatographed in (concentrated aqueous ammonia:(ethyl 
acetate:ethanol, 3:2, v/v), 7:93, v/v) to give 66.2 mg (68%) 13. IR (KBr) 3020, 
2910,2850,1735,1645,1580,1545,1435,1400,1260,1200, 1100cm- 1 ; 1 HNMR 
(D11SO-d6) o 1.85 (m, 2H), 1.98 (s, 2H), 2.81 (s, 6H), 3.07 (t, J=2 Hz, 2H) , 3.25 
(t, J=6 Hz, 2H), 3.82 (s, 3H) , 3.84 (s, 3H), 3.86 (s, 3H), 3.87 (s, 12H) , 6.88 
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(s, 1H), 6.96 (s, 1H), 7.08 (s, 2H), 7.10 (s, 3H), 7.15 (s, 1H), 7.19 (s, 1H), 7.26 
(s, 5H), 8.18 (t, J=7 Hz, 1H), 9.84 (s, 1H), 9.92 (s, 2H), 9.94 (s, 4H); m/e 999 
(M+H+) . 
Tri-N-methylpyrrolecarboxamide-4-N02 -t-boc amine 33. To a solu-
tion of 1 g (1.85 mMol) tripyrrole nitro amine 3271 in 4 mL DMF was added 0.48 
gm (2.2 mMol) di-tert-butyl-dicarbonate. The reaction was allowed to proceed 
3 hand then was concentrated under high vacuum. The residue was triturated 
three times with anhydrous diethyl ether and flash chromatography on silica gel 
(concentrated aqueous ammonia:methanol, 1:500, v /v) to afford 0.87g (75%) 33. 
1H NMR (DMSO-d6 ) 6 1.36 (s, 9H), 1.50 (m, 2H), 1.60 (m, 2H), 2.12 (s, 3H), 
2.27 (m, 4H), 2.93 (m, 2H), 3.17 (m, 2H), 3.77 (s, 3H), 3.85 (s, 3H), 3.98 (s, 3H), 
6.79 (t , J=5 Hz, 1H), 6.82 (s, 1H), 7.02 (s, 1H), 7.18 (s, 1H), 7.27 (s, 1H), 7.59 
(s, 1H), 8.03 (t, J=5 Hz, 1H), 8.19 (s, 1H), 9.93 (s, 1H), 10.28 (s, 1H); m/e 642 
(M+H+) . 
Bisdistamycin t-boc amine fumaramide 34. A solution of 150 mg (0.23 
mMol) 33 in 1 mL DMF was hydrogenated at atmospheric pressure over 5% pal-
ladium on charcoal (30 mg). After hydrogenation, the catalyst was filtered off 
through a plug of Celite, 13.6 mg (0.117 mMol) fumaric acid, 57 mg (0.276 mMol) 
dicyclohexylcarbodiimide and 50 mg (0.37 mMol) N-hydroxybenzotriazole were 
added and the reaction was allowed to continue for 24 h. The solvent was 
removed under vacuum and the residue was triturated with diethyl ether. Chro-
matography was attempted (concentrated aqueous ammonia:methanol, 6.5:93 .5, 
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v /v) but produced mixed fractions. The solids were taken up in solvent (con-
centrated aqueous ammonia:methanol, 1:250, v /v) and 45 mg pure product 
precipitated on standing. The supernatant was purified by flash chromatogra-
phy on silica gel ((concentrated aqueous ammonia:methanol, 1:250, v jv) then 
(concentrated aqueous ammonia:(ethyl acetate:ethanol, 3:2, vjv), 1:50, vjv)) to 
yield 32 mg 34. The total yield from the reaction was 77mg (50%) 34. 1 H NMR 
(DMSO-de) 6 1.36 (s, 9H), 1.52 (m, 2H), 1.62 (m, 2H), 2.14 (s, 3H), 2.30 (m, 
4H) 2.93 (m, 2H), 3.18 (q, J=6 Hz, 2H), 3.80 (s, 3H), 3.85 (s, 3H), 3.88 (s, 3H), 
6.80 (broads, 1H), 6.85 (s, 1H), 6.96 (s, 1H), 7.05 (s, 1H), 7.09 (s, 1H), 7.18 (s, 
1H), 7.25 (s, 1H), 7.35 (s, 1H), 8.04 (broads, 1H), 9.90 (s, 1H), 9.99 (s, 1H), 
10.50 (s, 1H). 
Bisdistamycin amine fumaramide 57. To a solution of 35 mg (0.027 
m.Mol) 34 in 0.75 mL CH2 Cl2 was added 0.5 mL TFA. The reaction was allowed 
to stir for 10 min and was precipitated with 3 mL anhydrous diethyl ether. The 
solid was filtered off, washed with anhydrous ether and dried under vacuum. It 
was then purified by flash chromatography on silica gel (concentrated aqueous 
ammonia:methanol, 3:25, v /v) to afford 24 mg (82%) 57. 1 H NMR (DMSO-d6 ) 
8 1.59 (m, 2H), 2.11 (s, 3H), 2.30 (m, 4H), 3.18 (q, J=8 Hz, 2H), 3.23 (q, J=5 
Hz, 2H), 3.80 (s, 3H), 3.85 (s, 3H), 3.88 (s, 3H), 6.84 (s, 1H), 6.98 (s, 1H), 7.05 
(s, 1H), 7.10 (s, 1H), 7.20 (s, 1H), 7.27 (s, 1H), 7.34 (s, 1H), 8.04 (t, J=1H), 9.91 
(s, 1H), 9.99 (s, 1H), 10.51 (s, 1H); m/e 1104 (M+H+). 
Bis-EDTA-Distamycin Fumaramide-Hexa Ethyl Ester 35. A solu-
tion of 92 mg (0.24 mMol) EDTA triethylester in 5 mL DMF was activated as 
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the imidazolide by the addition of 40 mg (0.25 mMol) N,N'-carbonyldiimidazole 
and stirring 2 h. After this time, the activated EDTA triethylester was added to 
a solution of 36.25 mg (0.0329 rnMol) 57 in 2 mL DMF and the coupling reac-
tion was allowed to proceed for 12 h. The reaction was then concentrated under 
vacuum and triturated three times with diethyl ether. The sample was flash 
chromatagraphed twice ( (concentrated aqueous ammonia: (ethyl acetate:ethanol, 
3:2, v/v), 3:97, v/v) then (concentrated aqueous ammonia:methanol, 1:99, v/v)) 
to produce 24 mg (40%) 35. 1 H NMR (DMSO-d6 ) 8 1.18 (t, J=7 Hz, 9H), 1.56 
(m, 2H), 1.62 (m, 2H), 2.13 (s, 3H), 2.30 (m, 4H), 2.71 (m, 4H), 3.12 (q, J=6 
Hz, 2H), 3.17 (m, 4H), 3.50 (s, 2H), 3.59 (s, 4H), 3.80 (s, 3H), 3.85 (s, 3H), 3.88 
(s, 3H), 4.05 (q, J=7 Hz, 6H), 6.84 (s, 1H), 6.96 (s, 1H), 7.08 (s, 1H), 7.10 (s, 
1H), 7.20 (s, 1H), 7.27 (s, 1H), 7.36 (s, 1H), 7.99 (t, J=7 Hz, 1H), 8.05 (t, J=7 
Hz, 1H), 9.90 (s, 1H), 9.99 (s, 1H), 10.50 (s, 1H); m/e 1820 (M+H+). 
Bis-EDTA-Distamycin Fumaramide 31. A solution of 16.8 mg (0.0092 
mMol) bis-EDTA-distamycin fumaramide-hexa ethyl ester 35 in 1 mL ethanol 
and 1 mL water was hydrolyzed by the addition of 4 mg (0.167 mMol) lithium 
hydroxide. The hydrolysis reaction was allowed to proceed for 12 h when the 
reaction was concentrated under vacuum. The compound was purified by flash 
chromatography on silica gel (concentrated aqueous arnmonia:methanol, 3:97, 
v /v) to yield 16.2 mg (106%) 31. IR (KBr) 3010, 2920, 2850, 1735, 1640, 1600, 
1440, 1400, 1260, 1200, 1140, 1100 cm- 1 ; 1 H NMR (DMSO-d6) 8 1-.90 (m, 4H), 
2.85 (s, 3H), 3.13 (m, 2H), 3.22 (m, 2H), 3.28 (m, 2H), 3.32 (m, 2H), 3.40 (m, 
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2H), 3.46 (m, 2H), 3.85 (s, 3H), 3.90 (s, 3H), 3.93 (s, 3H), 3.95 (s, 4H), 4.00 (s, 
2H), 4.10 (s, 2H), 6.96 (s, 1H), 7.00 (s, 1H), 7.11 (s, 2H), 7.18 (s, 1H), 7.37 (s, 
1H), 8.13 (broads, 1H) 8.50 (m, 1H), 9.98 (s, 1H), 10.03 (s, 1H), 10.54 (s, 1H); 
UV (H20) Amax 241 nm, 310 nm; m/e 1652 (M+H+). 
t-Boc .8-alanine 39. A solution of 6.23 g (70 mMol) .8-alanine and 2.5 
g (70 mMol) sodium hydroxide in 210 mL dioxane:water (2:1, v /v) was cooled 
to 0°C in an ice water bath. Solid t-boc anhydride (16.8 g, 77 mMol) was 
added and allowed to stir at 0°C for 0.5 h and then room temperature for 1 
h. The solution was rotovapped at 35° C until distillation had .nearly stopped 
and 300 mL ethyl acetate was added. The pH of the solution was adjusted to 
pH 3 with 2 M potassium bisulfate. The mixture was shaken and the organic 
phase was separated. The aqueous layer was extracted two more times with 
ethyl acetate (200 mL) and the organic layers were combined. After washing 
once with water, the combined organic layers were dried over anhydrous sodium 
sulfate, the solvent was removed by rotoevaporation and the resulting solid was 
dried under high vacuum to yield 11.33 g (87%) t-boc .8-alanine 39. 1 H NMR 
(DMSO-d6 ) 6 1.37 (s, 9H), 2.34 (t, J=7 Hz, 2H), 3.12 (q, J=7 Hz, 2H), 6.79 (br 
s, 1H); m/e 190 (M+H+). 
t-Boc .8-alaniny 1-tetra-N-methy lpyrrolecar boxamide dimethy lpropy 1-
amine 40. A solution of 138 mg (0.22 mMol) 4-nitro-tetra-N-methylpyrrole-2-
carboxamide dimethylpropylamine in 5 mL DMF was hydrogenated at atmo-
spheric pressure over 5% palladium on charcoal (40 mg). The t-boc .8-alanine 
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im.idazolide was prepared by dissolving 62.5 mg (0.33 mMol) t-boc ,0-alanine in 
2 mL DMF, adding 60 mg (0.37 mMol) N,N'-carbonyldiimidazole and stirring 
1 h. The hydrogenated 4-nitro-tetra-N-methylpyrrole-2-carboxamide dimethyl-
propylamine was filtered through celite to remove · catalyst, and added to the 
t-boc ,0-alanine imidazolide and stirred 12 h. The solvent was removed under 
high vacuum and the residue was triturated twice with diethyl ether and was 
purified by flash chromatography on silica gel (concentrated aqueous ammo-
nia:methanol, 2:98, v/v) to afford 114 mg (68%) 40. 1 H NMR (CD3 CN) 8 1.40 
(s, 9H), 1.67 (m, 2H), 2.23 (s, 6H), 2.37 (t, J=7 Hz, 2H), 2.44 (t, J=7 Hz, 2H), 
3.32 (m, 4H), 3.86 (s, 3H), 3.87 (s, 3H), 3.89 (s, 6H), 5.48 (broad s, 1H), 6.61 
(s, 1H), 6 .76 (s, 1H) , 6.89 (s, 1H), 6.91 (s, 1H), 7.14 (s, 1H), 7.21 (s, 3H), 7.53 
(broad s, lH), 8.30 (s, 1H), 8.40 (s, 2H), 8.44 (s, 1H). 
t-Boc ,0-alaninyl-tetra-N-methylpyrrolecarboxamidecarboxylic acid 
methyl ester 42. A solution of 138 mg (0.25 mMol) 4-nitro-tetra-N-
methylpyrrole-2-carboxylic acid methyl ester in 5 mL DMF was hydrogenated 
over 5% palladium on charcoal ( 40 mg) at atmospheric pressure. t-Boc ,0-alanine 
was activated as the im.idazolide by dissolving 70 mg (0.37 mMol) t-boc ,0-alanine 
in 1 mL DMF and adding 67 mg (0.41 mMol) N,N'-carbonyldiimidazole and stir-
ring for 1 h. The hydrogenation mixture was filtered through Celite to remove 
the catalyst, added to the activated acid and the solution was allowed to stir 
12 h. The solvent was removed under high vacuum, the residue was triturated 
with diethyl ether three times and purified by flash chromatography on silica 
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gel (methanol:dichloromethane, 1:9, vjv) to . give 66 mg (38%) 42. IH NMR 
(DMSO-da) o 1.38 (s, 9H), 2.40 (t, J=7 Hz, 2H), 3.19 (q, J=7 Hz, 2H), 3.74 (s, 
3H), 3.84 (s, 6H), 3.85 (s, 3H), 3.86 (s, 3H), 6.81 (t, J=S Hz, 1H), 6.88 (d, J=l.7 
Hz, 1H), 6.91 (d, J=l.3 Hz, 1H), 7.05 (s, 1H), 7.08 (d, J=1.7 Hz, 1H), 7.16 (s, 
1H), 7.24 (s, 2H), 7.47 (d, J=1.7 Hz, 1H), 9.84 (s, 1H), 9.88 (s, 1H), 9.90 (s, 1H), 
9.93 (s, 1H). 
t-Boc ,B-alaninyl-tetra-N-methylpyrrolecarboxamidecarboxylic acid 
43. A suspension of 54 mg (0.078 mMol) t-boc ,8-alaninyl-tetra-N-methyl-
pyrrolecarboxamidecarboxylic acid methyl ester 42 in 5 mL water and 5 mL 
ethanol was added 11.4 mg (0.29 mMol) sodium hydroxide and the mixture was 
refluxed for 3 h. At this time an additional 7 mg (0.18 mMol) sodium hydroxide 
was added and the solution was refluxed for another hour. After one hour, the 
solution was clear and the ethanol was rotovapped off. The solution was cooled 
in an ice bath and 0.6 mL 1 N HCL (0.6 mMol) was added in 5 mL ice cold 
water. The resulting mixture was lyophilized and washed three times with one 
mL water. The solid was isolated after each washing by centrifugation. The 43 
mg resulting solid was purified by flash chromatography on silica gel with (con-
centrated aqueous ammonia:(methanol:dichloromethane, 1:1, v /v), 1:33, v /v) to 
afford 19 mg (36%) 43. 1 H NMR (DMSO-d6 ) o 1.38 (s, 9H), 2.40 (t, J=7 Hz, 
2H), 3.20 (q, J=7 Hz, 2H), 3.84 (s, 3H), 3.85 (s, 3H), 3.86 (s, 3H), 6.82 (t, J=1H), 
6.89 (d, J=2 Hz, 1H), 7.06 (m, 2H), 7.11 (d, J=2 Hz, 1H), 7.25 (s, 1H), 7.69 
(d, J=2 Hz, 1H), 9.86 (s, 1H), 9.92 (s, 1H), 9.96 (s, 1H), 10.02 (s, 1H); m/e 677 
(M+H+) . 
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.8-a1aniny 1-tetra-N-methy 1pyrro1ecarboxamide dimethy 1propy 1amine 
41. A solution of 94 mg (0.136 mMol) 40 in 6 mL CH2 Cl2 and 3 mL TFA was 
stirred for 10 min and the product was precipitated by the addition of 40 mL 
diethyl ether. The precipitate was purified by flash chromatography on silica 
gel with (concentrated aqueous ammonia:methanol, 11:89, vjv) to give 7·3 mg 
(81%) 41. 1 H NMR (DMSO-d6 ) 8 1.61 (p, J=7 Hz, 2H), 2.14 (s, 6H), 2.25 (t, 
J=7 Hz, 2H), 2.42 (t, J=7 Hz, 2H), 2.89 (t, J=7 Hz, 2H), 3.19 (q, J=6 Hz, 2H), 
3.80 (s, 3H), 3.84 (s, 3H), 3.85 (s, 3H), 3.86 (s, 3H), 6.83 ( d, J =2 Hz, 1H), 6.89 
(d, J=2 Hz, 1H), 7.06 (m, 2H), 7.18 (m, 2H), 7.24 (m, 2H), 8.06 (t, J=5 Hz, 
1H), 9.89 (t, J=5 Hz, 1H), 9.89 (s, 1H), 9.90 (s, 1H), 9.94 (s, 1H), 9.99 (s, 1H). 
t-Boc .8-a1anine-tetra-N-methy 1pyrro1ecarboxamide-.B-a1aniny 1-tetra-
N-methy1pyrro1ecarboxamide-dimeth1y propy1amine 44. A solution of 
13.7 mg (0.021 mMol) .8-alaninyl-tetra-N-methylpyrrolecarboxam.ide dimethyl 
propyl amine 41, 15 mg (0.022 mMol) t-boc .8-alaninyl-tetra-N-methylpyrrolecar-
boxamide carboxylic acid 43, 5 mg (0.024 mMol) dicyclohexylcarbodiimide, and 
6 mg (0.044 mMol) N-hydroxybenzotriazole in 5 mL DMF were stirred for 24 
h. The DMF was removed under high vacuum and the residue was triturated 
twice with diethyl ether. After flash chromatography on silica gel (concentrated 
aqueous ammonia:methanol, 1:39, vjv), the fractions were allowed to stand and 
product precipitated. Combining this product with that isolated from the su-
pernatant gave 26 mg (94%) 44. 1H NMR (DMSO-d6 ) 8 1.38 (m, 9H), 2.40 (t, 
J=7 Hz, 4H), 3.20 (t, J=6 Hz, 4H), 3.80 (s, 3H), 3.82 (s, 3H), 3.83 (s, 3H), 3.85 
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(s, 3H), 6.84 (t, J=5 Hz, 1H), 6.86 (s, 2H), 6.89 (s, 2H), 7.06 (s, 4H), 7.16 (s, 
1H), 7.18 (s, 1H), 7.20 (s, 2H), 7.23 (s, 4H), 8.09 (t, J=5 Hz, 1H), 8.10 (t, J=5 
Hz, 1H), 9.87 (s, 1H), 9.92 (s, 5H), 9.94 (s, 2H); m/e 1322 (M+H+) . 
.B-alanine-tetra-N-methy lpyrrolecar boxamide-,B-alaniny 1-tetra-N -me thy 1-
pyrrolecarboxamide-dimethly propylamine 45. A solution of 5.1 mg 
(0.0042 mMol) 44 in 1 mL TFA:CH2Cl2 (2:1, v /v) was stirred for 15 min. 
and precipitated with anhydrous diethyl ether. The solid was triturated with 
(concentrated aqueous ammonia:methanol, 1:10, v/v) and washed with water 
and dried under high vacuum to afford 4.4 mg (93%) 45. 1 H NMR (DMSO-d6 ) 
8 1.60 (p, J=6 Hz, 2H), 2.14 (s, 6H), 2.23 (t, J=7 Hz, 2H), 2.32 (m, 4H), 2.81 
(t, J=2H), 3.25 (m, 4H), 3.80 (s, 3H), 3.82 (s, 3H), 3.85 (m, 18H), 6.83 (s, 1H), 
6.86 (s, 1H), 6.89 (s, 2H), 7.06 (s, 4H), 7.16 (s, 1H), 7.18 (s, 1H), 7.20 (s, 2H), 
7.25 (s, 4H), 8.07 (t, J=3 Hz, 2H), 9.91 (m, 8H). 
(P4)sE triethyl ester 46. To a solution of 4.4 mg (0.0036 mMol) 45 
in 0.5 mL DMF and 0.25 mL CH2Ch was added 3.6 mg (0.0038 mMol) 24, 
0.91 mg (0.0044 mMol) dicyclohexylcarbodiimide and 1.0 mg (0.007 4 mMol) 
N-hydroxybenzotriazole. The mixture was allowed to stir 12 h. At this time, 
it was concentrated under vacuum and triturated with anhydrous diethyl ether 
once. The chromatography column was equilibrated with (concentrated aqueous 
ammonia:(methanol:dichloromethane, 1:1, v /v), 1:99, v /v) and the solvent was 
changed to 1:1 methanol:CH2Ch. The crude reaction mixture was loaded onto 
the column in 1:1 methanol:CH2Cl2 (v /v) and three column volumes of solvent 
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were run through the column. The solvent system was changed to ( concen-
trated aqueous ammonia:(methanol:dichloromethane, 1:1, v /v), 1:99, v /v) and 
the product was collected to afford 3.6 mg (46%) 46. 1 H NMR (DMSO-d6 ) 8 
1.22 (m, 9H), 1.75 (p, J=7 Hz, 2H), 1.89 (p, J=7 Hz, 2H), 2.26 (s, 6H), 2.34 (t, 
J=7 Hz, 2H), 2.40 (t, J=7 Hz, 2H), 2.59 (t, J=6 Hz, 4H), 2.76 (broads, 4H), 
3.51 (s, 2H), 3.66 (s, 4H), 3.86 (m, 24H), 4.12 (m, 6H), 6.70 (m, 2.5H),128 6.88 
(m, 5.5H),128 7.17 (m, 9H); 128 m/e 2153 (M+H+). 
(P4)sE 36. To a solution of 1.8 mg (0.00084 mMol) of 46 in 0.6 mL ethanol 
was added 0.5 mg (0.021 mMol) lithium hydroxide in 0.4 mL water. The reaction 
was allowed to stir for 16 h at which time it was concentrated to dryness. The 
sample was then neutralized at 0°C with HCl and lyophilized to afford 36. 
During the preparation of the NMR sample, a hydrolysis mixture of (P4)sE 
was taken up in 1:1 methanol/water. This solution was cooled and precipi-
tate formed. The sample was then neutralized with 1 p.L of TFA and copious 
precipitate formed. This precipitate was isolated and used for the NMR sam-
ple. Subsequent studies on the solubility of (P4)sE found that it was easily 
soluble in basic water but only sparingly soluble in methanol, neutral water, wa-
ter/pyridine, or water/pyridine/DMF. IR (KBr) 3010, 2920, 2850, 1730, 1645, 
1635, 1600, 1580, 1490, 1450, 1385, 1250, 1200, 1140 cm- 1 ; 1 H NMR (DMSO-
d6+TFA) 8 1.74 (m, 2H), 1.85 (m, 2H), 2.29 (t, J=7 Hz, 2H), 2.58 (m, 4H), 2.80 
(d, J=5 Hz, 6H), 3.08 (m, 2H), 3.17 (m, 4H), 3.29 (m, 4H), 3.46 (m, 4H), 3.75 
(s, 4H), 3.85 (m, 38H), 4.07 (s, 2H), 6.87 (s, 2H), 6.90 (s, 2H), 6.96 (s, 1H), 7.07 
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(m, 6H), 7.19 (m, 6H), 7.20 (s, 6H), 8.08 (t, 1H), 8.16 (t , 1H), 8.40 (t, 1H) , 9.82 
(s, 1H), 9.91 (m, llH); UV (HzO) Amax 240 nm, 312 nm. 
Protected Spermidine-EDTA 48. The imidazolide of EDTA triethyl 
ester 16 was prepared by adding 0.8 g ( 4.9 mMol) carbonyl diimidazole to a 
solution of 1.84 g ( 4.9 mMol) EDTA triethyl ester 16 in 12 mL DMF and stirring 
2 h. The EDTA triethyl ester imidazolide was added to a solution of 1 g ( 4.9 
mMol) spermine in 20 mL DMF and stirred 12 h. At this time, 3.5 g (16 mMol) 
di-tert-butyl dicarbonate was added and the solution was heated to 37°C and 
stirred for 4 h. After the DMF was distilled off under vacuum, the residue 
was taken up in 200 mL diethyl ether and was extracted three times with 150 
mL water, once with saturated sodium chloride and then dried over sodium 
sulfate. After the removing the solvent under reduced pressure, the resulting 
oil was dissolved (acetonitrile/dichloromethane, 2:3, v /v), loaded on a silica gel 
column, and washed with 975 mL of the solvent system. The solvent system 
was changed (ethanol/ethyl acetate, 1:20, v jv) and the protected compound 
was eluted from the column to give 1.3 g (31%) 48. 1H NMR (DMSO-d6 ) 6 
1.18 (m, 9H), 1.38 (m, 27H), 1.57 (m, 4H), 2.69 (q, 2H, J=6Hz), 2.73 (m, 2H) , 
2.88 (q, 2H, J=6Hz), 3.1 (m, 10H), 3.17 (s, 2H), 3.45 (s, 2H), 3.51 (s, 4H), 4.07 
(m, 6H), 6.76 (broads, IH), 7.99 (t, IH, J=5Hz). Analysis for C41H1aNaOa. 
Calculated C, 57.19; H, 9.00; N, 9.76. Found: C, 57.19; H, 8.86; N, 9.95. Exact 
Mass (pos. ion, FAB) for C41H11NaOi3 : calculated 861.5548; found 861.5531. 
Spermidine EDTA 47. A solution of 60 mg (0.07 mMol) 48 in 5 mL 
denatured ethanol was hydrolyzed by the addition of 12 mg (0.5 mMol) lithium 
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hydroxide in 5 mL water and heating to 70° C for 3 h. The reaction mixture was 
dried under vacuum and taken up in 5 mL dichloromethane. To this solution, · 
1.5 mL TFA was added and the solution was stirred 12 min. The product was 
precipitated with diethyl ether and collected on a glass frit. After washing with 
diethyl ether and drying, 62 mg (85%) 47 was obtained as the TFA salt. 1H 
NMR (DMSO-da+TFA) o 1.62 (broads, 4H), 1.76 (t, 2H, J=7Hz), 1.88 (m, 2H), 
2.91 (m, 10H), 3.25 (m, 4H), 3.32 (m, 2H), 3.78 (s, 4H), 3.87 (s, 2H), 4.00 (s, 
2H), 7.90 (broads, 3H), 8.51 (t, 1H, J=5Hz), 8.65 (broads, 2H), 8.76 (broads, 




Prepare 2 L VB minimal media (1 Leach in two 2 L flasks) 
per 1 L: 
2 g Casamino acids 
20 mL 50X V-B salts 
50 mL autoclaved thymine (1 mg/m.L) 
H2 0 to give ......,980 mL total volume 
Autoclave on wet cycle, allow to cool to r.t., add: 
20 mL Sterile (autoclaved) 20% (w/v) D-glucose 
2 mL Ampicillin (25 mg/mL, filtered sterile 0.45 J.LM) 
1 mL Thiamine·HCl (1 mg/mL, filtered sterile 0.45 J.LM) 
Inoculate 1 L of VB minimal w /4 mL of an overnight culture of bacteria in 
L-broth and 50 J.Lg/mL ampicillin (to keep selective pressure on, increases the 
yield of plasmid). Shake at 37°C at 200 rpm. 
Amplify when O.D.590nrn = 0.6-0.9 (best to amplify at higher O.D.) Amplify by 
adding 2 mL Chloromycetin sodium succinate (100 mg/mL) per 1 L of broth 
(final concentration = 200 J.Lg/mL) 
-219...:. 
Chloromycetin sodium succinate = Chloroamphenical (Cm) and the 100 
mgj mL solution is made by adding 10 mL of sterile H2 0 ( vz"a syringe) to a 
1 g vial of Cm and shaking until it has completely dissolved. 
Amplify for 12-17 hours at 37°C with shaking. 
Harvest Cells: 
Chill 2 L flasks on ice bath with frequent agitation 
Load chilled cells into 500 mL bottles, balance with double pan balance. 
Spin at 5000 rpm, 4°C for 201 , discard supernatants and wipe bottles dry. 
Lysis: 
Resuspend cell pellet in 4-6 mL of: 
25% Sucrose 
50 mM Tris pH 8 (less volume is better) 
Transfer resuspended cells to a 70Ti (polycarbonate) tube and add: 
1.6 mL lysozyme (5 mg/mL prepared just before use) 
-Let sit 51 on ice with occasional stirring 
5 mL 0.5 M EDTA pH 8 
-Let sit 51 on ice with occasional stirring 





Tris pH 8 
EDTA pH 8 
Solution to almost fill tube- (air bubble good for agitation) 
Shake vigorously (!!) until the lysates "clear" 
looks like shampoo that's been shaken, usually 20-30 sec is 0 .K. 
try to avoid clumping of lysates 
Balance tubes to ±0.01 g, load into Ti70 rotor 
Spin 30 K rpm, 4°C for 301 
Pour off supernatants into 50 mL polypropylene centrifuge tube 
** avoid gluey junk near cell debris ** 
Add 350 A of 2 mgjmL RNase A (DNase free as in Maniatis), incubate 20' at 
37°C 
Add 1/3 volume ( rv6-7 mL) of 3o% PEG 8000/1.5M NaCl to each tube, shake 
to mix and incubate 30'-8 h on ice (long time = better yield) . 
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Centrifuge PEG/NaCl mixture: 20' at 6 K rpm, 4°C, pitch supernatants 
Resuspend pellet in 2-5 mL cold lOX TE using a glass rod 
100 mM Tris pH 8 
10 mM EDTA pH 8 
CsCl spins: 
Set up 1st CsCl isopycnic banding run: 
(use lx40 mL quick seal tube per 500 mL of original broth) 
59.52 g CsCl (ultrapure) 
+ Pellets in lOX TE 
+ 3.2 mL ethidium bromide (10 mg/mL) 
+ lX TE buffer to give a final weight of : 124.00 g 
This equals 80 mL of 48% (w/w) CsCl and has a p ,...,1.55 
Stir to dissolve CsCl 
Load into VTi50 quickseal tubes, balance to ±0.01 g and seal 
Run in VTi50 rotor at 42 K rpm, l7°C for 20 h 
Vent tube at top with an 18 GA needle and pull lower (plasmid) band (using 
UV illumination) by puncturing quick seal tube ,....,1 em below band with an 18 
GA needle and 10 mL syringe. Keep needle bevel up and protect DNA from 
excessive exposure to UV light. 
Transfer bands into VTi65 tubes, fill tubes with CsCl filling solution (p = 1.55, 
400 J.Lg/mL ethidium bromide) 
Balance tubes to ±0.01 g, seal and load into VTi65.2 Rotor 
Spin at 55 K rpm, 17°C for 12 h 
Extract plasmid (lower) band as before, but use a 3 mL syringe 
Extract ethidium bromide with 1X TE saturated isoamyl alcohol 
about 12-15 extractions of 1 volume each are needed 
(DNA is in bottom layer) 
check for EtBr removal with UV light 
Dialyze plasmid vs. lX Reaction Buffer pH 7.9, 40 mM Tris acetate, 5 mM 
sodium acetate at 4°C . 
High Resolution DNA Studies 
Preparation of Specifically Labeled DNA Fragments. Endlabeling was 
carried out similarly for each fragment . The following is a description of the 
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procedure for the labeling and isolation of the 167bp and 517bp fragments from 
pBR322. Super helical pBR322 plasmid DNA was digested with the restric-
tion endonuclease EcoR I, then labeled at the 3' end with (a32P)dATP using 
the Klenow fragment of DNA polymerase I. A second digest with restriction 
endonuclease Rsa I yielded the 3' labeled 167bp and 517bp fragments. These re-
striction fragments were isolated by polyacrylamide gel electrophoresis. Cleavage 
of pBR322 with EcoR I and successive treatment with calf alkaline phosphatase, 
(--y32P)ATP and T4 polynucleotide kinase, and Rsa I yielded the 5' labeled frag-
ments. Guanine specific chemical cleavage lanes were carried out as according 
to Maxam and Gilbert.129 The specific reaction procedures and conditions are 
outlined in the following description. 
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167/517 3' and 5' labelling of pBR322 
EcoR I Digest of 15 J..Lg pBR322 
100 A pBR322 (150 J..Lg/ml) 
20 A lOx EcoR I buffer 
78 ADD H20 
2 A Eco R I ( 20 f..L /A) 
200 A at 37°C, >3 h 
MINIGEL (1% agarose, 80V, 40-60 min) 
1 A digest 
Standard 
2 A pBR322 (150 J..Lg/ml) 
10 ADD H2 0 1 A Ficolloading buffer 
2 ADD H20 
4 A load in 1 lane 
20 A 20% NaOAc, vort 
600 A EtOH, invert 5x 
spin 20' 
pull supers 
4 A Ficol loading buffer 
16 A load 4 A/lane 
Phenol Extract (2x) 
200 A Phenol (saturated with lx reaction buffer) 
vort 
spin 20sec 
discard LOWER layer 
Ether Extract (3x) 
900 A Ether 
vort 
spin 20sec 
discard UPPER layer 
EtOH ppt. (2X) 
EtOH Wash 
200 A 70% EtOH (cold) 
spin 3' 
pull supers 
vac 3-10 min 
200 A 0.3M NaOAc, vort 




CAPing for 5' labelling 
15 J.Lg EcoR I'd pBR322 
80 A DD H20 
10 A lOx CAP Buffer 
10 A CAP (1 J.L/ A) 
100 A 37°C, 30 min 
Phenol Extract (2x) 
100 A Phenol (saturated with lx reaction buffer) 
vort 
spin 20sec 
discard LOWER layer 
Chloroform Extract (lx, optional) 
10 A 20% NaOAc, vort 
300 A EtOH, invert 5x 
spin 20' 
pull supers 
100 A 24:1 CHC13 i-Amyl Alcohol 
vort 
spin 20sec 
discard LOWER layer 
Ether Extract (3x) 
900 A Ether 
vort 
spin 20sec 
discard UPPER layer 
EtOH ppt. (2x) 
70% EtOH wash 
200 A 70% EtOH (cold) 
spin 31 
vac 3-10 min 
100 A 0.3M NaOAc, vort 




15 f..Lg EcoR I'd pBR322 
21). DD H20 
5 ). lOx Hae III buffer 
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End Labelling 31 and -5' 
51 Labelling 
15 f..Lg EcoR I'd & CAP'd pBR322 
34). DD H2 0 
5 ). lOx Kinase buff 
5 ). 66 mM DTT (10 mg/ml) 
5). dTTP (10 mM) 
5 ). 66 mM DTT (10 mg/ml) 
ca 4 ). "Y-32P dATP 
10 ). alpha-32PdATP 
4 ). 5 u/). polymerase 
50 ). 25°C, 20 min 
1 ). dATP (10 mM) 
1 ). dTTP (10 mM) 
1 ). dGTP (10 mM) 
1 ). dCTP (10 mM) 
52 ). 25°C, 10 min 
10 ). 20% NaOAc, vort 
300 ). EtOH, invert 5x 
spin 201 
pull supers 
2 ). Kinase (NBL, 2 f..L /).) 
50 ). 37°C, 45 min 
EtOH ppt. (2x) 
70% EtOH wash 
200 ). 70% EtOH (cold) 
spin 3' 
vac 3-10 min 
RSA Digest 
15 f,.Lg labelled DNA 
32). DD H20 
5 ). lOx RSA buffer 
100 ). 0.3M NaOAc, vort 
300). EtOH, invert 5x 
spin 20' 
pull supers 
5). 66 mM DTT (10 mg/ml) 
7.5 ). RSA (10 f..L/ ).) 
50 ). 37°C, 1-3 h 
10 A 20% NaOAc, vort 




EtOH ppt. (2x) 
70% EtOH wash 
200 A 70% EtOH (cold) 
spin 3' 
vac 3-10 min 
100 A 0.3 M N aOAc, vort 
300 A EtO H, invert 5x 
spin 20' 
pull supers 
Prep Acrylamide Gel (5%, 1:30) 
Plug (10%, 1:30) 
2.5 g Acrylamide 
85 mg Bisacrylamide 
30 mg Ammonia Persulfate 
5 ml5x TBE 
to 25 ml with DD H20 
stir ca 1/2 h 
millipore filter 
40 A TEMED 
GEL (5%, 1:30) 
4.0 g Aery lamide 
136 mg Bisacrylamide 
48 mg Ammonia Persulfate 
16 ml5x TBE 
to 80 ml with DD H20 
stir ca. 1/2 h 
millipore filter 
40 A TEMED, let stand couple hours at least 
load labelled nucleotides and electrophorese at 240 V 




500 A 100 mM Na Cacodylate (pH 8.0) 
100 A 100 mM MgCl2 
50 A Stop Buffer, vort 




10 A 100 mM EDTA 
390 ADD H2 0 
1000 A 
Stop Buffer 
94 A 4N NaOAc 
18 A Thioethanol 
126 A DD H20 
2 A tRNA (2 mg/ml) 
250 A 
G-Reaction 
200 A Start Buffer 
1.5 A CT (1 mM bp) 
5 A 32P labelled DNA 
206 A 
cool to 0°C 
1 A Dimethyl Sulfate 
20°C, 8 min 
100 A 70% EtOH 
spin 3' 
pull supers 
250 A 0.3 M NaOAc, vort 




100 A 1 M Piperidine (99 A Piperidine + 900 A DD H20) 
90°C, 30 min 
freeze, lyophilize 
10 ADD H20 
freeze, lyophilize 
10 .X DD H20 
freeze, lyophilize 
resuspend in formamide loading buffer (at ca. 0.3mR/A) 
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Affinity Cleavage Reactions. The concentration of each poly-N-methyl-
pyrrolecarboxamide-EDTA compound was determined spectroscopically using 
the extinction coefficients measured for the acetyl compounds (table 5.1). The 
extinction, co.efficients for P8E and P9E were estimated from the series of acetyl 
compounds containing two to seven N-methylpyrrolecarboxamide units. The 
extinction coefficients for BEDF and (P4)sE were estimated as a linear combi-
nation of the extinction coefficients for the monomers. This assumption is sup-
ported by the extinction coefficients measured for the netropsin dimers.100 · 102 
Each oligopeptide-EDTA·Fe(II) molecule was prepared fresh by mixing at high 
concentration (1-10 m.M) with 1-2 equivalents of Fe(NH4)2(S04)2·6H20 and 
dilluting to the appropriate concentration. 
Table 5.1: Extinction Coefficients for Affinity Cleaving Compounds 
































The cleavage reactions were run with >5000 cpm of 32P endlabeled restric-
tion fragment made up to a total concentration of 100 JLM in base pairs (final 
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conc-entration) with sonicated calf thymus DNA. To 9 f.l-L of DNA/buffer solu-
tion, 3 f.l-L of oligopeptide-EDTA·Fe(II) complex was added. Each oligopeptide-
EDTA·Fe(II) complex was then allowed to equilibrate with the buffered DNA 
solution. Equilibration was typically carried out for 1-2 hours at 25°C-65°C. 
Cleavage was initiated by the addition of 3 f.J-L of a 25 mM dithiothreitol (DTT) 
solution to the reaction mixture to give a total reaction volume of 15 f.l-1 and a 
final concentration of 5 mM DTT. The reaction buffer was prepared to 40 mM 
Tris base and 5 mM sodium acetate and then adjusted to pH 7.9 with acetic 
acid. The reactions were typically run for 1-2 hours at 25°C-37°C and were 
terminated by freezing. 
Footprinting Reactions. The footprinting reactions were run in a buffer 
of pH 7.4 containing 10 mM Tris and 50 mM NaCl and were made up to a final 
DNA concentration of 100 f.J-M (in base pairs) with ·sonicated calf thymus DNA. 
The footprinting reagents (MPE·Fe(II), EDTA·Fe(IT), SE·Fe(II)) were prepared 
by mixing at 1 mM with one equivalent of Fe(NH4 )2(S04 )2·6Hz0 and diluting 
immediately. To a 6 f..LL solution of DNA and buffer, 3 f.l-L of the molecule to 
be footprinted at an appropriate concentration was added. This solution was 
allowed to equilibrate at 37°C for 1 h. Next, 3 f.J-L of footprinting reagent (10 
f..LM MPE·Fe(IT) or 250 f..LM SE·Fe(il) or EDTA·Fe(II)) was added and allowed 
to equilibrate for 15 min at 37°C. The cleavage reaction was initiated by the 
addition of 3 f.l-L of 15 mM DTT or 5 mM sodium ascorbate .to give final concen-
trations of 3 mM DTT and 1 mM sodium ascorbate, respectively. Footprinting 
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reactions were allowed to continue for 15 min at 37°C and were terminated by 
freezing. 
The MPE·Fe(II) footprinting reactions were also run at different tempera-
tures. To compensate for the effect of the temperature change on the rate of 
cleavage, cleavage times were varied as follows: 4°C, 4 hours; 20°C, 1 hour; 
37°C, 15 min; 55°C, 3 min. 
(P4) 3 E·In(ITI) Footprinting. The (P4) 3 E·In(III) was prepared by mixing 
(P4)sE which had been dissolved in '"""PH 11 DDW at a concentration of 1 mM 
with two equivalents of InCls in '"""PH 3 DDW. The (P4)sE solution was basified 
with NaOH and the InCls solution was acidified with HCL The (P4) 3 E·In(III) 
was diluted to the appropriate concentration and equilibrated with the DNA 
for one hour at 65°C. The MPE·Fe(II) for these reactions was prepared by mix-
ing MPE at 2 mM with 1.9 equivalents of Fe(NH4 )2 (S04 )2·6H2 0 and diluting 
immediately. 
After equilibration, the samples were cooled to room temperature and 3 
mM DTT (final concentration) and 1:30 MPE·Fe(TI) to base DNA pairs (3.3 
J.LM final concentration) were added. The samples were vortexed and allowed to 
react at 37°C for 13 min. These conditions were optimized for a 205 bp DNA 
fragment and may overdigest a larger fragment. Cleavage was terminated by 
freezing. 
High Resolution Gels. The lyophilized reactions were suspended in 4 J.LL Of 
IX TBE, 80% (vol/vol) formamide at pH 8.3 containing bromophenol blue and 
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xylene cylanol tracking dyes. Recrystalization of the formamide is important to 
remove any traces of formic acid which may cause depurination upon heat de-
naturation. Storing the TBE/formamide loading buffer for extended periods of 
time results in the formation of trace formic acid, however, the dyejformamide 
mixture alone appears to be stable when frozen. Gel buffer (TBE) consisted of 
89 mM Tris base, 89 mM boric acid and 2 mM Na2 EDTA, pH 8.3. The gels were 
either 0.4 mm thick, 40 em long or wedge-shaped 0.2-0.6 mm thick, 40 em long 
and were 5-8% polyacrylamide (1:20 crosslinked), 50% urea. The gels were pre-
electrophoresed for 0.5 hour and then the samples were heat denatured at 90° C 
for 90 s, cooled to 0°C, loaded onto the gel, and electrophoresed at 1300-2000 
V. Gels were typically run until either the bromophenol blue or xylene cylanol 
tracking dye reached the bottom of the gel. The gels could be dried using a BIO-
RAD Model 483 Slab Gel Dryer. They were then exposed to Kodak X-Omat 
photographic film at -70°C with a duPont Cronex Lighting Plus intensification 
screen for 8-12 hours. The gels were subsequently re-exposed at -70°C without 
an intensification screen (dried gels could be exposed at room temperature). 
The time for the second exposure was determined by assuming the intensifica-
tion screen decreased the exposure time by lOx. The gel was scanned and the 
data were recorded as a plot of absorbance versus distance scanned, quantitated 
and converted into histogram form. 
Double Strand Cleavage 
DNA Preparation. 10 J.LgS of pBR322 was linearized with Sty I. This enzyme 
recognizes an asymmetrical site on pBR322 at 1369, 5'-88**gg-3'. Both ends 
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of the linearized plasmid were labeled with hot CTP and one end was selectively 
labeled with hot ATP using the 3' endlabeling techniques described earlier. The 
DNA was purified on a 0. 7% low melt agarose gel containing 0.25 J.Lg/mL ethid-
ium bromide (EtBr) run at I5 rnA (""'25 V) at 4°C ovemight. The DNA was 
visualized by UV fluorescence of the EtBr and the bands were excized. To each 
of the samples, 800A of IX TE buffer was added and the sample was heated for 
5 minutes at 65°C with vortexing at 3 minutes. The DNA was isolated from 
the agarose by extraction with: 500A phenol (centrifuging at least IO minutes to 
separate the phases); 250A phenol and 250A CHC13 /i-amyl alchohol (24:I v/v); 
500A CHC13 . After these extractions, the sample was transfered to a 2.2 mL 
ependorf tube and extracted 5 times with anhydrous butanol to remove EtBr 
and to concentrate the sample. It was then transfered to a 1.5 mL ependorf 
tube and extracted once with anhydrous butanol and lyophilized (extracting 
once with CHC13 before lyophilization helps remove excess butanol). The DNA 
was resuspended with 50 .A DDW and precipitated with 25 A, 7.5 M ammonium 
acetate and I50A ethanol. After precipitation, the sample was washed once 
with 70% ethanol, dried, resuspended in IX reaction buffer and the yield was 
determined by scintilation counting. 
Agarose Gels. The DNA cleaving reactions were carried out as described for 
the high resolution gels. Equilibration was typically carried out at 65°C for I 
hour. The reactions were initiated by the addition of a DTT solution and carried 
out at 37°C for 2 hours. The activity loaded per lane was ""'5000 cpm for the 
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pBR322 labeled at one end and ----10,000 cpm for DNA labeled at both ends. 
The final reaction volumes were typically 15 >.. and to this reaction mixture was 
added 2 >.. lOX ficol loading buffer. lOX Ficol loading buffer was made up as 
follows: 
0.25% BPB 40 mg 
0.25% XC 40 mg 
25% ficol 3. 75 gm 
to 15 mL 
The samples were loaded onto a vertical 4 mm, 1% agarose gel and elec-
trophoresed at 120 V until the bromophenol blue tracking dye reached the bot-
tom of the gel. The gels were dried on a gel drier at 60° C and were exposed to 
Kodak X-Omat photographic film without an intensification screen overnight. 
Time course studies were run at lOX scale and aliquots were quenched by 
freezing in dry ice. Loading buffer was added to the sample, the sample was 
thawed and immediately loaded onto the gel. The equilibration studies were run 
by preparing a large scale reaction mixture and aliquoting it into each of the 
reaction tubes to ensure that each reaction mixture was identical. 
The gels with non-radioactive DNA were run under the same reaction con-
ditions with 0.25 J.Lg of DNA per reaction and a final reaction volume of 10 >... 
The DNA was visualized by staining with ethidium bromide (0.25 J.Lg/m.L) and 
the gel was photographed with Polaroid type 55 positive/negative film. 
The molecular weight marker lane for the radiolabeled DNA was produced 
by four individual digestions of double labeled pBR322. The general digestion 
procedure is outlined in table 5.2. 
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Table 5.2 
10 .X .X phage (1 p;g) in TE pH 8.0 
10 .X both endlabeled hot pBR322 
7 .X 9 .X to 100 .X diluted mercaptoethanol 
10 .X lOX RE buffer 
70 .X DDW 
2 .X Restriction Enzyme 
109 .X Total Volume 
After digestion, the reactions were ethanol precipitated once, counted and com-
bined to produce the molecular weight marker lane. The enzymes used in these 
digestions and the molecular weights of the radiolabeled fragments produced 
with each enzyme upon digestion of Sty I linearized pBR 322 are given in table 
5.3. 
Table 5.3 
EcoR I 1371; 2992 
BamH I 994; 3369 
Xmn I 662; 1769 
Pvu I 1897; 2466 
The autoradiograms were scanned with an LKB densitometer and quanti-
tated with the accompanying data analysis software. The molecular weights of 
the DNA fragments from the cleavage reactions were determined by comparison 
of the mobility of the bands observed with the mobility of the molecular weight 
standard. To obtain greater accuracy in molecular weight determination, some 
cleavage reactions were spiked with the molecular weight standard. This allowed 
direct comparison of the mobilities of the reaction fragments with the molecu-
lar weight standard and avoided error introduced by lane to lane variations in 
electrophoretic mobility. 
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Because each cleavage site produces two fragments of DNA which sum to 
4365, the cleavage of double labeled pBR322 should produce a symmetrical band-
ing pattern. The bands resulting from cleavage at each site can then be paired by 
their integration because equal amounts of each fragment should be produced. 
For any given difference in the length of two DNA fragments, the relative dif-
ference in migration will be greater for smaller fragments. Therefore, the lower 
molecular weight bands were considered to be more accurate. The degree to 
which the bands in the molecular weight standard deviate from a straight line 
provides a limit for the accuracy of molecular weight assignment by this pro-
cedure. Therefore, binding site assignments were checked by determining the 
correlation coefficient of the line produced by plotting the observed band migra-
tion vs. the log of the assigned molecular weight and comparing that result to 
the correlation coefficient determined for the molecular weight marker lane . 
.X-phage Gels The DNA cleavage reactions were run as described earlier for 
the high resolution gels with 0.25 J,Lg of DNA per reaction and a final reaction 
volume of 10 ). ( ,..,..100 J,LM in base pairs). Resuspending precipitated .X-phage 
DNA was very difficult. It required high temperatures and alot of vortexing. 
It may be easier to remove EDTA from the DNA by dialysis. After EDTA 
removal, the concentration of the DNA was determined by UV absorbance at 
260 nm using the relationship 1A=45.45 J,LgjmL. Equilibration was typically 
carried out at 65°C for 2 hours . The reactions were initiated by the addition 
of a DTT solution to a final concentration of 5 mM and cleavage was carried 
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out at 37° C for 2 hours. At this time, 2 ). lOX ficol loading buffer was added 
to each reaction and they were loaded onto a 0.3% non-denaturing agarose gel 
containing 0.25 f..£g/mL ethidium bromide. The gel was run in the cold room 
(4°C) for 12-20 h with the buffer recirculated by a peristaltic pump until the 
XC marker dye was about 2-3 inches from the bottom of the gel. It is important 
to run these gels in the cold room because at room temperature they have the 
consistency of warm jello. Recirculating the buffer is necessary because the long 
electrophoresis times cause a pH gradient to be set up which becomes great 
enough to destroy the gel. After electrophoresis, the gels were photographed 
with Polaroid type 55 positive/negative film or Polaroid type 667 film. 
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